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SUMMARY 
 
Dopamine is an intercellular messenger in both vertebrates and invertebrates. It 
exerts its physiological functions by binding to specific dopamine receptors. 
Dopaminergic systems in mammals control several important physiological functions 
ranging from voluntary movement and reward to general aspects of hormonal 
regulation and the regulation of blood pressure to name only few. Alterations in the 
dopaminergic system have been associated with several psychiatric and 
neurological disorders such as Schizophrenia and Parkinson’s disease (PD). On the 
contrary, the dopaminergic system in Drosophila is not well characterized. For this, 
characterization of the dopaminergic system in normal flies before further analyses 
was a basis of this study. The aim was to elucidate the expression patterns of 
dopamine receptors in the central nervous system (CNS) and the digestive tract and 
to analyze the function of these receptors at cellular and/or behavioral level in 
Drosophila. With this respect, I used immunohistochemical, RNAi, overexpression 
and pharmacological approaches. The findings from this part of study were striking. 
A wide distribution of four dopamine receptors present in Drosophila was apparent in 
the CNS and in the digestive tract. In the CNS, one receptor, DopR, was localized in 
dopamine producing cells, which suggests an auto-receptor function of this receptor 
at least in this subset of dopamine producing cells. More importantly, two receptors; 
DopR and DopR2 where localized in a subset of clock neurons that expresses the 
neuropeptide PDF (pigment dispersing factor) indicative for the hypothesis that these 
receptors control circadian rhythms in Drosophila melanogaster. Localization was 
also observed in higher order brain structures such as mushroom bodies and the 
central complex, regions that are implicated in controlling of learning/memory and 
locomotion, respectively. In the digestive tract, dopamine receptors were distributed 
differently in the major cells of the midgut. The wide distribution of dopamine 
receptors in neurons and non-neuronal tissues provides insights into the roles played 
by these receptors in controlling different physiological functions and behaviors in the 
fruit fly. 
Summary 
10 
 
Advanced age is a major risk factor for many neurodegenerative disorders including 
Parkinson’s disease Preventing or stopping the development of this neurological 
disorder and the search for alternative treatment strategies is a major scientific 
challenge. Both genetic and environmental factors seem to contribute to PD 
development. Unfortunately, clinically relevant symptoms of PD appear when 
degeneration of the nigrostriatal dopamine producing (DA) neurons is at an 
advanced stage. For this reason, the second aim of this study focused on elucidating 
molecular responses involved during the asymptomatic phase of PD in-order to 
identify potential targets for therapeutic intervention. I used the pesticide rotenone to 
induce Parkinsonism in Drosophila melanogaster. Moreover, rotenone-induced 
Parkinsonism was combined with a focused transcriptomic analysis of DA neurons. 
This study provides evidences that the outcome of various highly relevant signaling 
pathways is modified in the dopamine producing neurons that are in an early stage 
of PD. Amongst these affected systems are the Wnt-, MAPK/EGFR-, TGF-β-, and 
TOR-signaling pathways, which are known to be important for cell survival and/or 
cell death in the CNS. Thus, further studies involving these pathways may provide 
new insights into the molecular events underlying pathogenesis and, hopefully, lead 
to the identification of new potential targets for neuroprotective interventions for PD. 
 
Lastly, this study focused on the development of alternative therapeutic strategies for 
treatment of PD. In this, I tested whether modulation of intracellular second 
messenger systems by employing so-called DREADD (Designer Receptors 
Exclusively Activated by Designer Drugs) receptors in DA-producing neurons during 
rotenone treatment can prevent or delay development of the disease phenotype. 
Manipulation of these second messenger systems (cAMP or Ca2+) in DA-producing 
neurons did not prevent development of the disease phenotype induced by rotenone 
in the Drosophila model of PD.  
 11 
 
ZUSAMMENFASSUNG 
 
Dopaminerge Systeme steuern verschiedene wichtige physiologische Funktionen in 
Säugetieren wie die spontane Bewegung, Belohnung sowie generelle Aspekte der 
hormonellen Regulation und der Steuerung des Blutdrucks. Funktionsstörungen des 
dopaminergen Systems wurden mit verschiedenen psychatrischen und 
neurologischen Störungen wie Schizophrenie und Parkinson in Verbindung gebracht. 
Da das dopaminerge System von Drosophila noch nicht sehr gut erforscht ist, war 
das grundlegende Ziel dieser Arbeit, das Expressionsmuster der Dopaminrezeptoren 
im Zentralnervensystem (ZNS) und im Gastrointestinaltrakt sowie deren Funktionen 
auf zellulärer und/oder verhaltensbiologischer Ebene zu untersuchen. Hierfür habe 
ich immunhistochemische und pharmakologische Ansätze sowie RNA-Interferenz 
und Überexpression verwendet. Die Ergebnisse dieser Untersuchungen waren 
beachtlich. Die vier Dopaminrezeptoren von Drosophila zeigten eine weite 
Verbreitung im ZNS und im Gastrointestinaltrakt. Im ZNS wird der Rezeptor DopR in 
DA-Neuronen exprimiert, was auf eine Autorezeptorfunktion schließen lässt. Darüber 
hinaus wurden DopR und DopR2 in einer Gruppe von Zeitgeber-Neuronen gefunden, 
die das Neuropeptid PDF (pigment dispersing factor) exprimieren. Dies deutet 
daraufhin, dass diese Rezeptoren den circadianen Rhythmus von Drosophila 
melanogaster steuern. Die Rezeptoren wurden außerdem in übergeordneten 
Strukturen wie den Pilzkörpern bzw. dem Zentralkomplex, Regionen, die an der 
Steuerung von Lernen und Gedächtnis bzw. der Bewegung beteiligt sind, detektiert. 
Im Gastrointestinaltrakt zeigten die Rezeptoren unterschiedliche Expressionsmuster 
in den verschiedenen Zelltypen des Mitteldarms. Die weite Verbreitung der 
Dopaminrezeptoren in Neuronen und nicht neuronalen Geweben liefert Hinweise auf 
die Beteiligung dieser Rezeptoren an der Steuerung physiologischer Funktionen und 
Verhaltensweisen in der Taufliege. 
Der größte Risikofaktor für Parkinson und viele andere neurodegenerative 
Erkrankungen ist fortgeschrittenes Alter. Es stellt eine große Herausforderung für die 
Wissenschaft dar, das Auftreten dieser neurologischen Störung mithilfe alternativer 
Behandlungsmethoden zu verhindern oder deren Entwicklung aufzuhalten.
Zusammenfassung 
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An der Ätiologie von Parkinson scheinen genetische sowie Umweltfaktoren beteiligt 
zu sein. Leider treten die klinischen Symptome der Erkrankung erst auf, wenn die 
Degeneration der nigrostriatalen Dopamin-produzierenden Neurone (DA-Neurone) 
bereits fortgeschritten ist. Deshalb war das nächste Ziel dieser Arbeit, die 
molekularen Mechanismen aufzuklären, die während der asymptomatischen Phase 
zur Entwicklung von Parkinson beitragen, um potentielle Zielstrukturen für 
therapeutische Interventionen zu identifizieren. Ich habe das Pestizid Rotenon 
verwendet, um in Drosophila melanogaster Parkinson zu induzieren. Mithilfe dieses 
Modells war es möglich, das Tanskriptom der DA-Neurone zu analysieren. Die 
Ergebnisse dieser Untersuchung zeigen, dass verschiedene relevante Signalwege in 
der frühen Phase der Erkrankung moduliert werden. Unter diesen finden sich der 
Wnt-, MAPK/EGFR-, TGF-β- sowie der TOR-Signalweg, die wichtige Funktionen bei 
der Steuerung von Zellüberleben und -tod im Zentralnervensystem (ZNS) haben. Die 
genauere Untersuchung der identifizierten Signalwege kann neue Einblicke in die 
molekularen Ereignisse, die der Pathogenese zugrunde liegen, geben und helfen, 
neue potentielle Ziele für therapeutische Interventionen zu identifizieren. 
Ein dritter Hauptaspekt der Arbeit beschäftigte sich mit der Entwicklung alternativer 
Therapiestrategien von Parkinson. Hierbei habe ich untersucht, ob die Modulation 
verschiedener intrazellulärer second messenger-Systeme in DA-Neuronen die 
Entwicklung des Krankheitsbildes verhindern oder verzögern kann. Die second 
messenger-Systeme wurden mithilfe von sogenannten DREADD-Rezeptoren 
(Designer Receptors Exclusively Activated by Designer Drugs) während der 
Rotenon-Behandlung manipuliert. Die Modulation der second messenger-Systeme 
(cAMP oder Ca2+) in DA-Neuronen verhinderte die Entwicklung des Krankheits-
Phänotyps im Drosophila-Modell von Parkinson nicht. 
. 
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1 INTRODUCTION 
1.1 OVERVIEW OF THE DOPAMINERGIC SYSTEM IN MAMMALS 
1.1.1 DOPAMINE NEUROTRANSMISSION 
Dopamine (DA) is a catecholamine neurotransmitter, which controls several 
important physiological functions ranging from voluntary movement and reward to 
hormonal regulation and hypertension. DA was first synthesized in 1910 by George 
Borger and James Ewens at the Wellcome Laboratories in London, England. It was 
named dopamine because it is a monoamine whose precursor is levodopamine (L-
DOPA). In 1958, Arvid Carlsson and Nils-AkeHillarp were the first to recognize DA 
functions as a neurotransmitter. Carlsson was awarded the 2000 Nobel Prize in 
Physiology or Medicine for showing that dopamine is not only a precursor of 
norepinephrine (noradrenaline) and epinephrine (adrenaline), but also a 
neurotransmitter. 
Dopamine is produced in several areas of the brain including the Substantia nigra 
and the ventral tegmental area. It is also synthesized in non-neuronal cells such as 
the adrenal glands’ medulla. DA is synthesized from the amino acid L-Tyrosine, 
which is consumed from dietary proteins. L-Tyrosine is converted into L-DOPA by 
the enzyme tyrosine hydroxylase (TH) with tetrahydrobiopterin, O2, and ferrous ion 
(Fe2+) as cofactors. In turn, L-DOPA is converted into dopamine by the enzyme 
aromatic amino acid decarboxylase (AAAD also known as DOPA decarboxylase 
(DDC) with pyridoxal phosphate as cofactor. Upon synthesis, DA is transported into 
synaptic vesicles by the vesicular monoamine transporter 2 (VMAT2). In these 
vesicles DA is stored until an action potential occurs and forces them to merge with 
the cell membrane by exocytosis, thereby releasing DA into synapses. Once in the 
synaptic cleft, DA binds and activates postsynaptic dopamine receptors to propagate 
a pre-synaptic signal to the postsynaptic neuron. DA also binds to pre-synaptically 
located dopamine receptors called autoreceptors, which inhibit neurotransmitter 
synthesis and release. They serve to keep DA levels normalized. Following the 
transmission of the signal, DA is transported back either through high affinity DA 
transporter (DAT) or low-affinity plasma membrane monoamine transporter (PMAT).
 
1 Introduction  
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1.1.2 DOPAMINE RECEPTORS CLASSIFICATION AND EXPRESSION 
DA exerts its physiological action by binding to specific dopamine receptors. These 
receptors are G-protein coupled receptors (GPCRs), whose signaling is primarily 
mediated by interaction with, and activation of heterotrimeric GTP-binding proteins 
(G-proteins) (Neve et al., 2004). The contributions of Kobilka and Lefkowitz, the 
winners of Nobel prize in Chemistry 2012, on studies of GPCR signaling provided 
evidences that GPCRs signal in a G-protein dependent manner and/or a G-protein 
independent manner. The latter mechanism depends on other regulatory proteins 
such as arrestins (Lefkowitz and Shenoy, 2005).  
In mammals, five distinct subtypes of DA receptors have been isolated, 
characterized and subdivided into two major classes; D1- and D2-like, on the basis 
of their structural, pharmacological and biochemical properties. D1-class receptors 
comprise of D1 and D5, which stimulate Gαs/olf proteins to stimulate cAMP 
production by adenylate cyclase (AC) (Herve et al., 1993). In contrast, D2-class 
receptors (D2, D3 and D4) couple to Gαi and thus induce inhibition of AC (Missale et 
al., 1998, Vallone et al., 2000, Neve et al., 2004, Beaulieu and Gainetdinov, 2011).  
Dopamine receptors have broad expression patterns in the brain and in the 
periphery. In the brain, D1-dopamine receptors are expressed at highest levels in the 
nigrostriatal, mesolimbic, mesocortical areas such as caudate-putamen (striatum), 
Nucleus accumbens, olfactory bulb, frontal cortex, cerebellum, thalamic and 
hypothalamic areas. On the other hand, D2-dopamine receptors are abundant in the 
striatum, the Nucleus accumbens, and the olfactory tubercle. D2 receptors are also 
expressed at significant levels in the Substantia nigra, ventral tegmental area, 
cortical areas, amyglada and hippocampus. In the periphery, all subtypes of DA 
receptors have been observed in the kidney, adrenal glands, gastrointestinal tract, 
blood vessels and heart (Missale et al., 1998, Sokoloff et al., 2006, Iversen and 
Iversen, 2007, Rondou et al., 2010, Beaulieu and Gainetdinov, 2011). 
1 Introduction  
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1.1.3 DOPAMINE RECEPTOR SIGNALING MECHANISMS 
As pointed out earlier, the D1-class receptors couple primarily to the stimulatory G-
protein, Gαs/olf and stimulate the production of the second messenger cAMP. At its 
active state, Gαs/olf binds and activates AC, the enzyme, which catalyzes the 
conversion of ATP to cAMP, which in turn activates the protein kinase A (PKA). 
Protein kinase A then phosphorylates and regulates the downstream substrates 
including the 32-kDA dopamine and cAMP regulated phosphoprotein (DARPP-32), 
the transcription factor CREB, the ionotropic glutamate receptors (AMPA and NMDA) 
and certain voltage gated ion channels. The DARPP-32 is a multifunctional signal 
transduction molecule enriched in medium spiny neurons in the striatum (Missale et 
al., 1998, Neve et al., 2004, Beaulieu and Gainetdinov, 2011). It inhibits PP1 (protein 
phosphatase 1) activity when phosphorylated at threonine 34 by PKA and is 
converted to a PKA inhibitor when phoshorylated at threonine 75 by cyclin-
dependent kinase 5 (Cdk5) (Bibb et al., 1999). 
Several reports have described D1-class receptors activation of mitogen-activated 
protein (MAP) kinases including ERK (extracellular regulatory kinase) (Gerfen, 
2003), p38 MAP kinase and c-Jun amino-terminal kinase (JNK) (Zhen et al., 1998). 
Regulation of the latter two MAP kinase pathways are mediated by PKA, whereas 
D1-like receptor activation of ERK may be partially independent of PKA or cAMP. 
One possible PKA-independent but cAMP-dependent mechanism for activation of 
ERK by D1-class receptors is activation of Rap GTPase by guanine nucleotide 
exchange factor directly activated by cAMP, Epac (de Rooij et al., 1998, Neve et al., 
2004). 
In contrast to D1-class receptors, D2-class receptors are coupled to Gαi that 
negatively regulate the production of cAMP resulting in decrease in PKA activity 
(Kebabian and Greengard, 1971, Kebabian and Calne, 1979, Beaulieu and 
Gainetdinov, 2011) (Fig. 1)  
1 Introduction  
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Figure 1: Signaling networks regulated by dopamine in D1 and D2-class dopamine receptor responding neurons. 
D1-class through Gαs/olf stimulates cAMP/PKA signaling while D2-class through Gαi inhibits it. Blue arrows 
indicate activation, blue-T arrows indicate inhibition, and black arrow indicates actions that can be either 
activating or inhibitory on the function of specific substrates. Based on Neve et al., 2004, Beaulieu and 
Gainetdinov, 2011. 
 
In addition to their effects on cAMP-regulated signaling, D1-like receptors, 
particularly the D5 receptor couples to Gαq to regulate phospholipase C (PLC) (Fig. 
2). Upon activation, PLC cleaves phosphotidylinositol-4,5-biphosphate (PIP2) into 
two second messengers, inositol triphosphate (IP3) and diacylglycerol (DAG). The 
latter remains on the plasma membrane and activates protein kinase C (PKC) that 
phosphorylates downstream substrates. On the other hand, IP3 diffuses into the 
cytoplasm and binds to the IP3 receptor in the endoplamic reticulum thereby 
mobilizing intracellular calcium. Calcium in turn activates calcium-dependent proteins 
such as protein phosphatase 2B (calcineurin) and Ca2+/calmodulin-dependent 
protein kinase II (CaMKII) and PKC (Fig. 2). 
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Figure 2: Regulation of Gαq/PLC signaling by D1-class dopamine receptors. Upon activation, PLC cleaves PIP2 
to IP3 and DAG that initiate intracellular calcium release and PKC activation. Blue and black arrows indicate 
activation. Modified from: http://eb.wikipedia.org/wiki/Inositol-1,4,5-triphosphate. 
 
The D2-like receptors also regulate PLC-pathways through Gβγ-subunits. Several 
evidences have shown that activation of D2-like receptors through Gβγ stimulate 
MAP kinase pathways such as ERK. These mechanisms are at least mediated by 
transactivation of a receptor tyrosine kinase (RTK), thus recruiting the RTK-signaling 
cascade in response to DA (Neve et al., 2004). 
 
1.1.4 FUNCTIONS OF DOPAMINE RECEPTORS 
The functional roles of the different DA receptors have been extensively 
characterized. The most studied role involves the effects of DA on locomotor activity. 
Several lines of evidence indicate that locomotor activity is primarily controlled by 
D1, D2, and D3 dopamine receptors. Activation of D1 dopamine receptors that are 
exclusively expressed on the postsynaptic neurons has a moderate stimulatory effect 
on locomotor activity. On the contrary, presynaptically localized autoreceptors, D2-
class, generally provide an important negative feedback mechanism that adjusts 
neuronal firing rate, synthesis and release of the neurotransmitter levels in response 
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to changes in extracellular neurotransmitter levels. Generally, activation of D2-class 
autoreceptors causes a decrease in DA release that results in decreased locomotor 
activity, whereas activation of postsynaptic receptors stimulates locomotion. D2 in 
particular, is present in two splice variants, D2-long (D2L) and D2-short (D2S) (Giros 
et al., 1989, Monsma et al., 1989). D2S is predominantly found presynaptically and 
D2L postsynaptically. D3 dopamine receptors seem to exert a moderate inhibitory 
action on locomotion either by acting as autoreceptors or through the involvement of 
postsynaptic receptor populations. The roles of D4 and D5 dopamine receptors, 
which have a limited expression pattern in the primary motor regions of the brain, are 
involved in control of movement to much lesser extents. Therefore, activation of both 
the postsynaptic D1 and D2-class DA receptors is necessary for the full 
manifestation of dopamine induced locomotor activity (Missale et al., 1998, Sokoloff 
et al., 2006, Rondou et al., 2010, Beaulieu and Gainetdinov, 2011).  
Dopamine receptors are also involved in other vital functions. D1, D2 and, to lesser 
extent, D3 are critically involved in reward and reinforcement mechanisms. 
Alterations of DA receptors by pharmacological and genetic approaches have shown 
a significant modulation of the responses to natural rewards and addictive drugs 
(Missale et al., 1998, Sokoloff et al., 2006, Beaulieu and Gainetdinov, 2011, Blum et 
al., 2012). Moreover, both D1 and D2 dopamine receptors have been shown to be 
critical for learning and memory. Parallel with this, D3 and D4 and potentially D5 
receptors seem to have a minor modulatory influence on some aspects of cognitive 
functions that are mediated within the hippocampus (Missale et al., 1998, Beaulieu 
and Gainetdinov, 2011, Xu et al., 2012). Other functions mediated by DA receptors 
that are localized outside the CNS include: olfaction, vision, and hormonal regulation 
such as pituitary D2 dopamine receptor-mediated regulation of prolactin secretion; 
kidney D1 dopamine receptor-mediated rennin secretion; adrenal gland D2 
regulation of aldosterone secretion; the regulation of sympathetic tone; D1, D2 and 
D4 receptors-mediated regulation of vasodilation; renal function; blood pressure 
regulation; and gastrointestinal motility (Aperia, 2000, Witkovsky, 2004, Li et al., 
2006, Beaulieu and Gainetdinov, 2011). The fact that dopamine and its receptors are 
involved in a variety of critical functions, it is not surprising that multiple human 
disorders such as Schizophrenia, Attention Deficit Hyperactivity Disorder, drug 
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addiction and PD have been related to dopaminergic dysfunctions. The most 
recognized dopamine-related disorder is PD. 
 
1.2 PARKINSON’S DISEASE 
Parkinson’s disease is the second most prevalent neurodegenerative disorder with 
an incidence of about 1% in people older than 65 years (Whitworth, 2011). 
Pathologically, the disease is characterized by a selective and progressive loss of 
dopaminergic (DA) neurons and the presence of Lewy bodies in the neurons of the 
Substantia nigra pars compacta (Forno, 1996). PD is typically recognized by the 
classical motor system disturbances such as bradykinesia, resting tremor, rigidity 
and postural instability. In addition to motor dysfunction, PD patients also suffer from 
non-motor symptoms such as constipation, sleep disorder and at an advanced 
stage, dementia and cognitive dysfunction (Whitworth, 2011, Xu et al., 2012). There 
are two forms of PD; a rare heritable form due to mutations in certain genes and a 
sporadic form mainly of idiopathic causes. Unfortunately, the majority of cases occur 
sporadically. Generally, it is considered that both genetic susceptibility and 
environmental factors play a role in pathogenesis. Despite of extensive studies, there 
is currently no cure or treatment that can stop disease progression. While the precise 
pathologic mechanisms remain unclear, epidemiological and genetic studies have 
begun to obtain insights into causes underlying pathogenesis. Currently, the favored 
mechanisms include mitochondrial dysfunction, calcium imbalance, aberrant protein 
degradation and inflammation. In addition, oxidative stress is a prominent and 
common feature in all forms of PD and likely represents a convergent toxin event 
leading to neuronal cell death (Gupta et al., 2008).  
Due to ethical and technical reasons in using human as experimental system, animal 
models are the major tools for studying PD pathogenesis. Vertebrate models have 
been used in the PD field for many years. They include non-human primates, 
rodents (mice and rats), zebrafish, frogs, and chickens with rodent models 
predominating the field. However, rodent models, especially murine ones do not 
recapitulate the human disease pathology, especially regarding the final aspects of 
the pathology, the dying of dopaminergic cells (Dawson et al., 2010). Thus, 
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alternative models, including very simple ones may have a substantial relevance for 
future research. 
A Drosophila model to study basic aspects of PD was introduced more than a 
decade ago (Feany and Bender, 2000). Targeted overexpression of normal and 
mutant forms of the human protein alpha synuclein induces symptoms typically seen 
in human PD patients. These include the development of Lewy-body like filamentous 
intraneuronal inclusions and the adult-onset loss of DA neurons. Not only alpha-
synuclein, but also other PD susceptibility genes have been characterized in 
Drosophila models of the disease (Bilen and Bonini, 2005, Lessing and Bonini, 2009, 
Whitworth, 2011). In addition, a very simple, pharmacologically induced PD model, 
dependent on the pesticide rotenone has been introduced in flies and triggers DA 
neuron degeneration leading to a drastically impaired climbing ability (Coulom and 
Birman, 2004). Surprisingly to some, Drosophila models have replicated many 
pathological processes related to human neurological disorders (Zoghbi and Warren, 
2010, Guo, 2012). 
 
1.3 ADVANTAGES OF USING DROSOPHILA AS A MODEL ORGANISM 
D. melanogaster, commonly referred to as fruit fly, was first used for genetic 
experiments more than a century ago by William Ernest Castle and his colleagues, 
who studied inbreeding and selection, the work which was published in 1906. It was 
through Castle’s influence that D. melanogaster became known to geneticists, most 
notably to T. H. Morgan, and work with this species became the basis of Morgan’s 
1933 Nobel Prize in Medicine for identifying chromosomes as the vector of 
inheritance for genes (Snell and Reed, 1993). Since that, Drosophila has been used 
extensively for investigating fundamental biological processes such as cell 
proliferation, growth, cell death and migration. In addition, behavioral studies have 
shown that Drosophila can perform complex behaviors such as learning and 
memory, circadian rhythms, sleep and aggression (Bellen et al., 2010), some of 
which were first assumed to be exclusively performed by mammals/humans. 
Therefore, these studies from more than a century coupled with the versatility and 
rapidity of techniques have left the modern fly field with powerful molecular genetics 
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tools (Adams and Sekelsky, 2002, Venken and Bellen, 2005, Venken and Bellen, 
2007). 
Drosophila has a short generation time of approx. 10-12 days at 25 °C and an 
average life span of 50-60 days. The fly genome has been completely sequenced 
and annotated (Adams et al., 2000). It requires little labor and is cost effective to 
maintain fly stocks. Mutant flies and transgenic ones are available from public stock 
centers at low cost and only small space is required for their maintenance. 
Importantly, it has been estimated that nearly 75 % of all human disease associated 
genes are conserved in D. melanogaster (Bier, 2005). In particular, the Drosophila 
genome encodes the currently identified PD-related genes LRRK2/Dardarin, parkin, 
PINK1, Omi/HtrA2, DJ-1, UCH-L1, GIGYF2, PLA2G6, and GBA (Whitworth et al., 
2006, Gupta et al., 2008, Whitworth, 2011). This set of features makes D. 
melanogaster an excellent model system to study the functions of disease genes in 
vivo including those involved in neurodegenerative disorders such as PD and to 
dissect genetic pathways related to these disease genes. 
There are several tools available in Drosophila but I will only mention those that are 
relevant to disease models particularly to PD and that were used in this study. One 
particularly powerful approach is the transposon-mediated transgenesis (Rubin and 
Spradling, 1982). The fly community has generated a number of transposon insertion 
lines that can be used for insertional mutagenesis in Drosophila. Another powerful 
and versatile approach in Drosophila is the GAL4/UAS system. It is a bipartite 
transcription activation system (Brand and Perrimon, 1993), which allows a gene of 
choice to be expressed in a defined set of cells or tissue of interest. In this system, 
one transgene consists of a yeast transcriptional factor (GAL4), driven by a tissue 
specific promoter such as the dopaminergic neuron-specific tyrosine hydroxylase 
(TH) one. The second transgene consists of a gene of interest that is under the 
control of the UAS (upstream activation sequence), which drives transcription in 
response to GAL4 binding. This could be for example a reporter gene such as green 
fluorescent protein (GFP) or an RNAi gene (Fig. 3). RNAi stands for RNA 
interference. This is another highly favorable approach in Drosophila to knock down 
the gene of interest (Kalidas and Smith, 2002). This approach capitalizes on the 
finding that double stranded RNA (ds-RNA) molecules corresponding in sequence to 
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endogenous transcripts can trigger the degradation of the endogenous transcripts. It 
requires the construction of a transgenic construct bearing an inverted repeat 
sequence corresponding to the target transcript (Whitworth, 2011, Guo, 2012). This, 
in combination with the GAL4/UAS system to target expression of the dsRNA to the 
desired tissue, can simply be achieved by performing the appropriate cross (Fig. 3). 
 
 
Figure 3: GAL4/UAS system. The system is used for overexpression or silencing of a gene of interest in 
Drosophila.The transcript of the targeted gene will be expressed in the F1 generation (GAL4/UAS progeny) only 
in those tissues/cells where GAL4 is present. 
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1.4 THE DOPAMINERGIC SYSTEM IN DROSOPHILA 
The Drosophila nervous system contains approximately 100,000 neurons including a 
subset of approximately 200 DA neurons. Although the anatomy of the fly brain and 
distribution of DA neurons in the Drosophila CNS differs from that of the vertebrate 
brain, previous work indicated that many fundamental cellular and molecular 
biological features of neuronal development and function are conserved between 
vertebrates and invertebrates (Whitworth, 2011). Thus, this conservation again 
makes Drosophila a powerful system for cell biological studies of neuronal 
dysfunction. 
In Drosophila, likewise, four dopamine receptors have been isolated and 
pharmacologically characterized, leading to a subdivision into the two subtypes D1-
and D2-like receptors. D1-like receptors that activate cAMP comprise the DopR, the 
DopR2 and the dopamine/ecdysteroid receptor-DopEcR (Gotzes et al., 1994, 
Sugamori et al., 1995, Feng et al., 1996, Han et al., 1996, Srivastava et al., 2005), 
while the D2-like subtype consists of only one member, the D2R/DD2R (Hearn et al., 
2002). 
Spatial expression patterns in the CNS have been described (Kim et al., 2003, 
Draper et al., 2007) based on immunoreactivity using the antibodies against DopR, 
DopR2 and D2R. Comparison of DopR and DopR2 immunoreactivities showed 
overlapping, yet distinct, expression patterns in the mushroom bodies (mb) and the 
central complex (cc) (Kim et al., 2003). Studies using genetic and pharmacological 
manipulations revealed the mb to be involved in higher order brain function such as 
learning and memory as reviewed in Kim and colleagues (Kim et al., 2003, Rahn et 
al., 2013). In addition, appetitive and olfactory learning was impaired in dopamine 
receptor mutants (Selcho et al., 2009). The cc has been implicated in controlling 
motor functions such as movement (Strauss, 2002) and functional ethanol tolerance 
(Scholz et al., 2000, Kong et al., 2010). Lebestky and colleagues reported that a 
loss-of-function mutation in DopR leads to a decrease in sleep-wake arousal 
(Lebestky et al., 2009). It has also been reported that DopR is essential to control 
temperature preference behaviors through αβ lobes of mb (Bang et al., 2011). The 
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D2R was shown to be expressed in the cell groups that include the Ap-let cohort of 
peptidergic neurons (Draper et al., 2007) and more recently, qPCR analysis revealed 
that DopR, D2R and DopEcR are expressed in the Gr5a Gustatory Receptor 
Neurons (Inagaki et al., 2012b). 
 
1.5 BASIC ANATOMY OF LARVAL AND ADULT DROSOPHILA CNS 
The anatomy of the larval and adult fly CNS has been analyzed and several 
nomenclature systems exist. In this study, I used a simplified larval nomenclature 
system as described by Selcho and colleagues (Selcho et al., 2009). To locate the 
different types of neurons and their processes in the brain, they divided each 
hemisphere into four subregions; dorsomedial protocerebrum, dorsolateral 
protocerebrum, basomedial protocerebrum and basolateral protocerebrum separated 
by the mb region (Fig. 4A). To ease comparison with the adult brain this 
nomenclature is based on the body-axis of the larva. This terminology does not 
reflect the flattening of the CNS during mounting and therefore ignores its 90° 
rotation near the intersection between subesophageal ganglion (sog) and ventral 
nerve cord (vnc) (dashed line in Fig. 4A). Cell clusters are delineated according to 
the position they occupy in the CNS, e.g. in the larval brain hemispheres, DM 
(dorsomedial), DL1 (dorsolateral 1), and DL2 (dorsolateral 2). In the sog, the two 
anteromedial clusters are SM1 and SM2, respectively and a more lateral cluster SL 
(Fig. 4B). 
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Figure 4: Anatomy and nomenclature of the larval brain regions and cell clusters. The orientation refers to the 
body axis (A: d: dorsal; l: lateral; p: posterior). (A) Shows the brain at a middle anteroposterior level. (B) Shows 
the anatomy of the dopaminergic system in the larval CNS based on the TH-GAL4 driver. Source: Selcho et al., 
2009. 
 
As pointed out earlier, the adult Drosophila brain contains approximately 100,000 
neurons, whose projections cluster in internal neuropil structures, while cell bodies 
are found in the outer brain regions. To better understand the connection between 
these neurons and their projections at the single-cell level resolution, Chiang and 
colleagues (Chiang et al., 2011) generated a standard model brain, which was 
segmented into 58 morphologically distinguishable neuropil regions (see figure 5 for 
names). 
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Figure 5: Nomenclature of the adult fly 
brain regions. AL, Antennal Lobe; 
AMMC, Antennal Mechanosensory and 
Motor Center; Cal, Calyx; CCP, 
Caudalcentral Protocerebrum; CMP, 
Caudalmedial Protocerebrum; 
CVLP, Caudal Ventrallateral 
Protocerebrum; DLP, Dorsolateral 
Protocerebrum; DMP, 
Dorsomedial Protocerebrum; EB, 
Ellipsoid Body; FP, Fanshaped Body; 
FSPP, Frontal 
Superpeduncular Protocerebrum; IDFP, 
Inferior Dorsofrontal Protocerebrum; 
IDLP, Inner Dorsolateral 
Protocerebrum; LH, Lateral Horn; Lob, 
Lobula; LoP, Lobula Plate; LatTri, 
Lateral Triangle; MB, Mushroom Body; 
Med, Medulla; Nod, Noduli; OG, Optic 
Glomerulus; OPTU, Optic Tubercle; 
PAN, Proximal Antennal 
Protocerebrum; SOG, Subesophageal 
Ganglion; SPP, 
Superpeduncular Protocerebrum; VLP, 
Ventrolateral Protocerebrum; VMP, 
Ventromedial Protocerebrum. Source: 
Chiang et al., 2011. 
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1.6  AIMS OF THE STUDY 
The aim of this study was to elucidate the expression patterns of dopamine receptors 
in the central nervous system and periphery system particulary, the digestive tract 
and to analyze the function of these receptors in Drosophila melanogaster. 
The second major aim of this study was to understand the changes in dopaminergic 
cells in the fruit fly Drosophila melanogaster during induced Parkinsonism. For this, 
rotenone-induced Parkinsonism in the dopaminergic system should be analyzed 
using genetic and pharmacological manipulations, transcriptomic analyses of the 
targeted DA neurons as well as behavioral assays. This relies on two major research 
questions: 
1. What are the target genes/pathways induced during disease development? 
2. Does modulation of the intracellular signaling in dopaminergic neurons alters 
disease progression? 
. 
1.7 SIGNIFICANCE OF THE STUDY 
Dopaminergic system in Drosophila is not well characterized. In this study I have 
analyzed the distribution of four Drosophila dopamine receptors using 
immunohistochemistry to elucidate the morphological architecture of dopaminergic 
signaling. This information is the basis to understand the role played by these 
receptors in controlling different physiological functions and behaviors in the fruit fly. 
Parkinson’s disease in humans is a gradual progressive neurodegenerative disease 
that becomes clinically apparent after an estimated 70 % of vulnerable DA neurons 
in the Substantia nigra have already died. Postmortem studies are limited by tissue 
availability and hardly ever allow identification of the initial pathological events during 
pre-symptomatic stages. Hence, modeling PD at pre-symptomatic phase in vivo is 
essential for understanding the development of the disease and possibly identifies 
potential targets for neuroprotection measures for PD at pre-clinical stages. The 
gene expression analysis carried out in this study is, to my knowledge, the first of its 
own kind in rotenone-induced Parkinsonism in Drosophila that performed specifically 
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on sorted DA neurons. Moreover, the molecular mechanisms underlying the cause of 
PD remain largely unknown. The current treatment relying more on the symptoms of 
the disease, which most of them have got devastating side effects. Thus, identifying 
novel molecular pathways that may enhance the survival of DA neurons may provide 
future alternatives for causal therapies..  
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2 MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 CHEMICALS 
Table 1: Name and source of chemicals 
Chemicals from Carl-Roth GmbH Chemicals from other Sources 
Agar-Agar, Chloroform Bovine serum albumin-Sigma Aldrich 
Calcium chloride, Ethanol (≥ 99.8 %) Normal goat serum-Sigma Aldrich 
Ethidium bromine, Glucose Rotenone-Sigma Aldrich 
HEPES, Isopropanol Clozapine-N-Oxide- C.D Nichols, LSU 
Magnesium chloride hydrated (Mgcl2 .6H2O RNA Magic-Bio-Budget 
Nipagin (Methyl-4-Hydroxybenzoate SureClean-Bioline 
Propionic acid, Pottasium chloride (Kcl) Yeast-Leiber 
Potassium dihydrogen phosphate (KH2PO4) Paraformaldehyde-Polysciences 
Sodium chloride ( Nacl), Sucrose dNTPs-Promega 
Sodium bicabornate (NaHCO3) Agarose-Biozym 
Sodium dihydrogen phosphate (NaH2PO4) Beet syrup-Reform house 
Trehalose, Triton X-100 Maize meal-Reform house 
Roti-Mount FluorCare DAPI Melasse-Reform house 
 FocusClear- CelExplorer Labs.Co 
 
RiboLock Ribonuclease- Inhibitor- 
Fermentas 
 
2.1.2 DNA LADDER 
1kb-GeneRuler     Fermentas GmbH, St. Leon-Rot 
50bp GeneRuler     Fermentas GmbH, St. Leon-Rot 
2.1.3 ANTIBODIES 
2.1.3.1 PRIMARY ANTIBODIES 
 
Rabbit α-delta Developmental Studies Hybridoma 
Bank, Iowa 
Rabbit α-dopa decarboxylase Gift from Uwe Homberg, University of 
Marburg 
Rabbit α-DILP2     Gift from Manfred Schmid, ETH
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Rabbit α-GFP     Invitrogen, Karlsruhe 
Rat α-GFP      Santa Cruz Biotechnology, 
Heidelberg 
Mouse α-Nc82 Developmental Studies Hybridoma 
Bank, Iowa 
Rabbit α-Notch Developmental Studies Hybridoma 
Bank Iowa 
Mouse α-Prospero (MR1A) Developmental Studies Hybridoma 
Bank, Iowa 
Mouse α-PDF C7 Developmental Studies Hybridoma 
Bank, Iowa 
 
2.1.3.2 SECONDARY ANTIBODIES: 
 
Goat α-rabbit Dylight 488    Jackson ImmunoResearch 
Donkey α-rat Dylight 488    Jackson ImmunoResearch 
Goat α-mouse Dylight 549    Jackson ImmunoResearch 
Goat α-rabbit Dylight 549    Jackson ImmunoResearch 
Rat α-mouse CD8a Biotin     eBioscience 
Phalloidin-TRITC     Life technologies 
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2.1.4 ENZYMES 
Taq DNA polymerase      Fermentas, St. Leon-Rot 
Pwo DNA polymerase      Peqlab Biotechnologie 
PrimerScript Reverse Transcriptase  Takara Bio Europe SAS,  
St. Germain-en-Laye 
 
2.1.5 REAGENT SYSTEM 
 
T7 Megascript      Ambion, Austin 
Nucleospin RNA II Kit     Macherey Nagel, Düren 
 
2.1.6 BUFFER AND SOLUTIONS 
• Hemolymph-like 3-Saline (HL3): 70 mM Nacl, 5 mM Kcl, 1.5 mM Cacl2.2H20, 20 
mM Mgcl2.H2O, 10 mM NaHCO3, 5 mM Trehalose, 115 mm Sucrose, 5 mM 
HEPES (pH 7.1). 
• Phosphate-Buffered Saline (PBS) (10X): 80 g Nacl, 2 g Kcl, 14.4 g, 
Na2HPO4.H2O, 2.4 g KH2PO4 in 1 l ddH2O, (pH 7.4) 
• Washing buffer for microarray: 20XSSC: 175.3 g Nacl, and 88.2 g Sodium citrate 
in 1 L ddH2O 
 L1 = 1 X SSC 
 L2 = 1 X SSC + 0.1% Triton X-100 
 L3 = 0.1 X SSC + 0.1% Triton X-100 
 L4 = 0.1 X SSC 
• Paraformaldehyde (4% PFA): 4 g in 100 ml of 1x PBS+0.3% Triton X-100 
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2.1.7 DROSOPHILA STOCKS/LINES 
Table 2: Name, function and source of fly lines. 
Name Function Source 
W
1118
 Wild type 
Bloomington Drosophila 
Stock Center 
Canton S (CS) Wild type Bloomington Drosophila 
Stock Center 
DopR1-Gal4 
Expresses Gal4 in the pattern of DopR1 
(Dopamine receptor 1) BestGene Inc 
DopR2-Gal4 
Expresses Gal4 in the pattern of DopR2 
Dopamine receptor 2) BestGene Inc 
D2R-Gal4 
Expresses Gal4 in the pattern of D2R 
Dopamine receptor 2- like) BestGene Inc 
DopEcR-Gal4 Expresses Gal4 in the pattern of Dopamine/ecdysteroid receptor 
Bloomington Drosophila 
Stock Center 
DopR
f02676
 DopR1 deficient in CS background 
Gift from David Anderson 
HHMI 
TH-Gal4  Expresses Gal4 in dopaminergic neurons 
Bloomington Drosophila 
Stock Center 
NP1-Gal4 Expresses Gal4 in enterocytes Gift from D. Ferrandon 
nsyb-Gal4 
(Synaptobrevin) Expresses Gal4 to all neurons Gift from Julia Simpson 
DopR2-RNAi Expresses dsRNA for RNAi of DopR2 under UAS control VDRC 
DopR-RNAi Expresses dsRNA for RNAi of DopR under UAS control VDRC 
D2R-RNAi Expresses dsRNA for RNAi of D2R under UAS control VDRC 
PDF-Gal4 Expresses Gal4 in PDF (clock) neurons Gift from Chris Wegener 
UAS-M4D1 Decreases cAMP in response to CNO Gift from C.D Nichols, LSU 
UAS-M5Dbar Increases cAMP in response to CNO Gift from C.D Nichols, LSU 
UAS-M1D1 Increases Ca2+ in response to CNO Gift from C.D Nichols, LSU 
20XUAS-
IVSmCD8::GFP 
Expresses mCD8-tagged GFP under the control of 20 UAS-sequences 
with an intron (IVS) interposed between the UAS and coding sequences 
Bloomington Drosophila 
Stock Center 
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2.1.8 OLIGONUCLEOTIDES 
Table 3: Name of oligonucleotides used for RT-PCR analysis 
Name Sequence (5’ to 3’) 
Capfinder-Sp6-rG1  CAGCGGCCGCAGATTTAGGTGACACTATAGArGrGrG 
Adaptor-SP6-PCR GACGCCTGCAGGCGATGAATTTAGG 
Oligo-dT T7 II GAGAGAGGATCCAAGTACTAATACGACTCACTATAGGG 
Oligo-dT-T7 I GAGAGAGGATCCAAGTACTAATACGACTCACTATAGGG 
Droso.DopR1 * GGCGTCAATTCTGAACCTGT 
Droso DopR1 ** GAGATGGGCACAAAGGAGAC 
Droso DopR2 * AACTCCTGCGAGCAGACCTA 
Droso DopR2 ** AGGAGTGGTGCTGGTGATG 
Droso D2R * CGATGTATGCGCCTTCTACA 
Droso D2R ** GTCTGGGCAATGTTCTCGAT 
Droso DDC * GCCAAGACAATGGTCGACTT 
Droso DDC ** GGCATGAAACTTGGGACTGT 
DopEcR * CTTTGCATTCTGGGTGTCCT 
DopEcR ** AATATGCCGATCCAGACGAC 
* Forward ** Reverse 
Table 4: Nucleotides used for qRT-PCR analysis 
Name Sequence (5’ to 3’) 
Rpl32_fwd TTGGCTTCGGTTTCCGGCAAG 
Rpl32_rev ATCGATCCGACTGGTGGCGGAT 
Dad_fwd CAGATCCACTCGGTGGGTGCC 
Dad_rev CAGATCCACTCGGTGGTGCC 
Armadillo_fwd CTCATTCGCCAGCAGTCGGT 
Armadillo_rev CAAAGAACGCCAGCAGCCAC 
Spitz_fwd AATATTGGGCCTGGGCGTGG 
Spitz_rev CCGCGCCTCTTCGATCTCCTC 
l(2)NC136-fwd TCCTACTGTGGCAGCTATCG 
l(2)NC136-rev ACTGTCCGAGACAGGAAGAC 
CaM-fwd GCTGCAGGACATGATCAACG 
CaM-rev TCTCGGATCTCCTCTTCGCT 
Dat-fwd GGCGCATTAGGCCCACTTAT 
Dat-rev GCTTCCCAGAGACGGTCAAT 
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2.1.9 MICROSCOPES 
Fluorescence microscope Imager. Z1 with 
Apotome and AxioCam MRm camera 
and HXP 120 lamp      Zeiss Oberkochen 
Laser scanning confocal microscope TCS SP 1  Leica, Heidelberg 
Inverted microscope Axiovert S 100 Zeiss, Oberkochen 
Stereo microscope SZX12 with  
U-CMAD3 camera      Olympus GmbH, Hamburg 
Stereo light microscope SMZ 745T   Nikon, Tokyo 
Stereo light microscope     WILD M3, Heerbrugg 
 
2.1.10 EQUIPMENTS 
Agarose Gel ectrophoresis unit;    Biometra, Göttingen 
Centrifuge      Thermo electron cooperation 
Digital graphic printer UP-D897    Sony, Tokyo 
Drosophila Activity Monitor DAM2    Trikenetics, Waltham 
Incubator     Thermo electron cooperation 
Microarray scanner     GenePix 4000B, Oldendorf 
Kontes glass tissue grinder (7 ml) and pestle  Kimble Chase Kontes 
Microwave      AFK, Hamburg 
MagnaRack      Invitrogen, Karlsruhe 
Spectrophotometer      Nanodrop ND-1000, Peqlab,  
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StepOne Real time PCR system    Applied Biosytems,  
Life Technologies GmbH 
Thermocycler (Labcycler)     SensQuest GmbH, Göttingen 
Thermo block HB 130     Unitek 
UV-transilluminator      PHASE GmbH 
Vortex      Heidolph, Schwabach 
Water bath (thermostat 2761)    Eppendorf, Hamburg 
 
2.1.11 OTHERS 
Blotting paper       A. Hartenstein GmbH 
Cell filters 30 µm      Miltenyi Biotec 
Cover slips (24 X 40 mm)     Roth, Karlsruhe 
Dynabeads MyOne Streptavidin T1   Invitrogen, Oslo 
Plastic vials 22 ml, 68 ml, 178 ml    Greiner Bio-One 
Microscope slides      Roth, Karlsruhe 
Microarray slide     Canadian Drosophila  
     Microarray Centre 
Vial stoppers     Greiner Bio-One 
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2.2 METHODS 
2.2.1 FLY FOOD PREPARATION 
Fly food was prepared depending on the amount needed. For a volume of 500 ml 
medium: 31.25 g beer yeast, 31.25 g maize meal, 5 g agar-agar, 10 g glucose, 15 g 
melasse and 15 g beet syrup were mixed with H2O and boiled for 15 min. It was 
autoclaved for 10 min and let it cool to about 55 °C. Then, 5 ml of 10 % propionic 
acid and 15 ml Nipagin were added to inhibit the growth of mold and bacteria. Under 
a clean bench, the medium was dispensed into the sterile vials. The medium was 
stored at 4 °C until use. 
 
2.2.2 DROSOPHILA CULTURE AND CROSSES 
Unless otherwise stated, flies were reared on a standard Drosophila medium at room 
temperature (RT). The RT was approximately 21 °C. Flies were dump-transferred 
into new vials after every 4 weeks. In case of breeding, flies were maintained in a 
controlled incubator with 12 hrs on/off light cycle at 25 °C. Virgin females from UAS 
strains were crossed to GAL4 males. Crosses were transferred to new vials after 2 
days. The eclosion was within 10-14 days. After eclosion of first progeny, F1 
generation progenies were collected at least once a day for 5 consecutive days. 
Progenies were maintained at 25 °C for 3 days before subjected to different 
experiments. 
 
2.2.3 APPLICATION OF ROTENONE 
To induce Parkinsonism in flies, rotenone was administered orally. The compound 
was prepared as follows: 0.02 g of rotenone was dissolved in 1 ml DMSO to get a 50 
mM stock solution. Following this, 100 µl of the stock solution was added to 1 ml of 
10 % glucose. The final concentration of rotenone was 5 mM. Then, 300 µl out of this 
solution was used to soak a blotting paper placed on top of normal medium to avoid 
desiccation (Fig. 6). Flies were shifted to new vials containing fresh contents every 
48 hrs. 
2 Materials and Methods 
 
40 
 
Figure 6: A 22 ml vial for culturing Drosophila. The experimental flies feeding on rotenone added onto blotting 
paper. 
 
2.2.4 APPLICATION OF CLOZAPINE-N-OXIDE (CNO) 
To activate DREADD receptors in vivo, CNO was also applied to flies through food. A 
calculated amount of this synthetic ligand was dissolved in 1 x PBS to obtain a 10mM 
stock solution. This was mixed with a calculated volume of Drosophila medium 
depending on the amount needed. The final concentration of CNO in the medium 
was 1 mM. 
2.2.5 BEHAVIORAL ASSAYS 
2.2.5.1 CLIMBING ABILITY (NEGATIVE GEOTAXIS) 
Twenty male adult flies were placed into a 17 cm long glass tube at a given time point 
(see Figure 7). The flies were tapped to the bottom of the tube and let to climb the 
tube. After 20 secs, a photo was taken in which most of the healthy flies are expected 
to have crossed the escape line at a height of 6 cm. The height/distance climbed by 
each fly was analyzed by using Image J software. Three independent experiments 
were used for the analysis. 
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Figure 7: Climbing ability assay. A glass tube of 17 cm long, showing the ability of flies to climb. The normal 
healthy flies will be able to cross the line at a height of 6 cm after 20sec. 
 
2.2.5.2 LOCOMOTOR ACTIVITY ASSAY 
Individual 3-5 days old male flies were placed into glass tubes (5 mm diameter) 
containing food at one end and capped with a cotton plug at the other end. The tubes 
were then placed into the Drosophila Activity Monitor (DAM) (Fig. 8). The DAM was 
then placed into the 25 °C incubator and entrained for at least 7 days under light/dark 
(LD) cycles of 12 hrs light and 12 hrs darkness or constant darkness (DD). The DAM 
connected to a computer, automatically recorded the number of infrared beam 
crossings per 5 minutes for each fly. Twenty four hours interval locomotor activity 
(column graphs) was generated by averaging 5 min activity across the animals, then 
averaging 5 min activity profiles for 24 hrs over 3 days in LD or DD. For the line 
graphs, the average of every one hour was taken as a single data point. Zeitgeber 
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(ZT), ZT0= 8.00 a.m and ZT12= 20.00 p.m. Two to three independent experiments 
were used for analyses, with 8 flies per group. Difference on the effect of 1 mM CNO 
between different genotypes was tested by Two-way-ANOVA followed by Bonferroni 
post test for multiple comparisons using α ˂ 0.05. 
 
 
Figure 8: Drosophila activity monitor. It takes 32 individual activity tubes. A single activity tube is shown in place. 
 
2.2.6 LIVE IMAGING 
The practice of examining or acquiring the image of the living cells, tissues or whole 
flies under fluorescent microscope before fixation or staining was considered as a live 
imaging. Firstly, it was performed to control the UAS-GFP parental lines to make sure 
that there is not any specific expression of the GFP reporter. Second, to examine 
whole flies obtained from crossings of specific GAL4 drivers to the UAS-GFP 
responder lines, to understand the activity of the promoter. Third, to examine the 
tissues in which the GFP was observed before performing further analyses such as 
immunohistochemistry. 
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2.2.7 IMMUNOHISTOCHEMISTRY 
2.2.7.1 IMMUNOFLUORESCENT STAINING OF WHOLE-MOUNT LARVAL AND 
ADULT CENTRAL NERVOUS SYSTEM (CNS) 
Larval and adult CNSs were dissected in ice-cold 1 x PBS and immediately fixed in 
4 % paraformaldehyde in PBS containing 0.3 % Triton X-100 (PBT) for 20 min at RT. 
Samples were then washed with PBT three times 10 mins each, blocked for 30 mins 
with 10 % normal goat serum in PBT at RT, and subsequently incubated with a 
primary antibody in blocking buffer at 4 °C overnight. After washing the samples five 
times for 10 mins each in PBT, they were incubated with a secondary antibody in 
PBT overnight at 4 °C or 4 hrs at RT. Washing was done six times 10 mins each with 
PBT, and mounted on glass slides and cover slips with Focus clear. Fluorescent z-
series images were acquired by Leica TCS SP 1 or Zeiss Axio Imager Z1 with 
Apotome. Next, images were processed with either AxioVision Rel.4.8 or ImageJ and 
corrections for brightness, contrast and cropping were done with the Adobe 
Photoshop 7.0. The following antibodies were used. Primary antibodies: Rabbit α-
dopadecarboxylase (1:10), Rat α-GFP (1:200), Rabbit α-GFP (1:400), Mouse α-Nc82 
(1:5), Rabbit α-DILP2 (1:100), Mouse α-PDF C7 (1:5). Secondary antibodies: Dylight 
488 conjugated Goat α-Rabbit (1:500), Dylight 488 conjugated Donkey α-Rat (1:500), 
Dylight 549 conjugated Goat α-Mouse (1:200) and Dylight 549 conjugated Goat α-
Rabbit (1:500). 
 
2.2.7.2 IMMUNOFLUORESCENT STAINING OF DIGESTIVE SYSTEM 
Larval and adult guts were dissected, fixed and stained with specific antibodies as 
described in section 2.2.7.1 above. Primary antibodies used were: Rabbit α- delta 
(1:100), Mouse α-prospero (1:10), Mouse α-notch (1:10), Rat α-GFP (1:200) and 
Rabbit α-GFP (1:500). For the secondary staining the following antibodies were used: 
Dylight 488 conjugated Goat α-Rabbit (1:500), Dylight 488 conjugated Donkey α-Rat 
(1:500), Dylight 549 conjugated Goat α-Mouse (1:200), Dylight 549 conjugated Goat 
α-Rabbit (1:500) and TRITC conjugated Phalloidin (1:1000). Mounting was done in 
RotiMount containing DAPI for nuclei staining. The images were captured by 
fluorescent microscope Zeiss Axio Imager Z1 with Apotome. 
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2.2.8 MAGNETIC BEADS PREPARATION 
This protocol was adopted from (Iyer et al., 2009) with some minor modifications. 
Briefly, Streptavidin T1 coated Dynabeads (100 µl) were washed three times 2 min 
each in 1 ml HL3- buffer by placing a micro-centrifuge tube on a magnetic block to 
pellet the beads and discard the supernatant. The washed beads were then 
resuspended in 100 µl undiluted biotinylated rat anti-mouse CD8a antibody (antibody 
concentration is 500 µg/ml). Dynabeads T1 can bind 20 µg/ml of biotinylated Ig. The 
beads-antibody mixture was incubated for 30 min at room temperature (RT) with 
gentle rotation of the tube. After incubation, the tube was placed on the magnet for 
2 min and the supernatant was discarded. The Dynabeads coupled to antibody was 
again washed three times 2 min each with HL3 buffer using the magnet. Finally, the 
antibody coupled beads were then resuspended in 100 µl of HL3 buffer and stored at 
4 °C and used within 4 weeks. 
 
2.2.9 DISSOCIATING THE TISSUE INTO A SINGLE CELL SUSPENSION 
A schematic procedure for dissociation and magnetic bead cell-sorting of 
dopaminergic neurons is shown in Figure 9. In details, about 70 heads of F1 
generation male adult flies from the TH-GAL4 crossed to 20XUAS-mCD8::GFP were 
dissected in pre-chilled HL3 buffer and transferred to a micro-centrifuge tube. The 
tube was vortexed for 1 sec. With the use of a fire polished glass pipette the 
supernatant was discarded and the procedure was repeated 3-4 times until the 
supernatant became clear. The heads were transferred to a pre-chilled 7 ml Kontes 
tissue grinder, which was rinsed with 1 % BSA in HL3 buffer in order to avoid the 
cells from sticking to the glass surface. About 4 ml of HL3 buffer were added to the 
tissue grinder containing the tissues. Gently, using a pestle, the tissues were given 
30-32 douncing strokes. The solution was then triturated 5 times using the fire-
polished glass pipette narrowed to approximately 50 % of the standard tip diameter. 
The level of dissociation was assessed by putting 50 µl of the solution on a 
microscope slide and observed under the fluorescent microscope with a GFP filter. 
Then the solution was filtered through a 30 µm cell filter and the filtrate was collected 
in 4 tubes of 1.5 ml each. 
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Figure 9: Schematic of the procedure for magnetic bead cell sorting of Drosophila dopaminergic neurons. (a) Age 
matched, intact adult heads carrying the TH-GAL4 and UAS-mCD8::GFP transgenes are dissected. (b) The 
heads are transferred to a 1.5 ml tube and washed/vortexed to remove any debris. (c) The heads are then 
transferred into a 7 ml glass tube, dounced to homogenize the brain tissue followed by trituration to further 
dissociate the tissue into a cell suspension. (d,e) The homogenate is then filtered using a 30 µm cell filter to 
remove any large cellular debris, including the cuticle from the head and filter out the single cell suspension. The 
filtrate solute contains a single cell of different cell types including neurons and glia. (f) Biotinylated anti-mouse-
CD8a antibody coated magnetic Streptavidin T1 Dynabeads are added to the cell suspension and incubated on 
ice for 60 min. (g) The magnetic beads specifically bind to the dopaminergic neurons that express a mouse CD8 
tagged GFP fusion protein under the control of the TH-GAL4 driver. (h,i) The magnetic bead coated cells are 
separated by placing the cell solution in a strong magnetic field. The supernatant is discarded and the cells are 
washed 3 times to remove any non-specific cells, resulting in (j) highly enrichment of specific dopaminergic 
neurons. Panels (b, d-j) are adopted from (Iyer et al., 2009). 
 
2.2.10 MAGNETIC BEADS CELL SORTING 
A volume of 15 µl of antibody-bound beads was added in 1 ml cell suspension and 
incubated for 1 hour on ice with occasional hand-mixing via inversion of the tube. 
Following this, the tubes were placed on the magnet for 2 min to pellet the beads 
along with GFP positive cells. Slowly, the supernatant was pipetted out without 
disturbing the pellet and was discarded. The cells were washed three times with ice 
cold HL3 buffer by putting the tubes on the magnet to remove non-specific cell 
binding. Cells bound to the coupled beads were resuspended in 30 µl of HL3 buffer. 
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Cell purity and yield were controlled by taking 5 µl and observe it under the 
fluorescent microscope. Approximately, 8-10 GFP-positive cells were counted at one 
time point (see Fig. 38 in result section). 
 
2.2.11 RNA ISOLATION FROM MAGNETIC BEAD SORTED CELLS 
After assessing yield and purity of the targeted cells, the tubes were again placed on 
the magnet to pellet the cells and the supernatant was discarded. RNA magic was 
used as an extraction buffer in which 100 µl of it was added in each of the 4 tubes. 
The tubes were vortexed shortly, before incubated for 30 mins at 42 °C. To ensure 
removal of the coupled beads it was necessary to centrifuge for 2 min at 2000 x g 
and immediately place the tubes on the magnet for 2 mins. The supernatant was 
transferred to a new tube and total RNA (from approx. 200 DA neurons) was isolated 
using the RNA magic kit (Bio- Budget Technologies GmbH). The RNA pellet was 
resolved in 10 µl RNase-free H2O and stored at -80 °C. 
 
2.2.12 COMPLEMENTARY DNA (cDNA) SYNTHESIS 
First strand cDNA was synthesized by using PrimeScript Reverse Transcriptase 
(Takara) according to the manufacturer’s protocol. A volume of 10 µl mixture 
containing: 2.5 µl CapFinder Sp6rG primer (10 pmol/µl), 2.5 µl anchored Oligo-dT T7 
I primer (10 pmol/µl), 1 µl dNTP mixture (10 mM) and 4 µl of template RNA (≤ 5 µg 
total RNA) was heated at 65 °C for 5 min and immediately cooled on ice. Then, this 
template-primer mixture was again mixed thoroughly with 4 µl of 5 X PrimeScript 
buffer, 0.5 µl RNase inhibitor, 1 µl PrimeScript Reverse Transcriptase enzyme and 
4 µl RNase free H2O. The mixture was incubated at 42°C for 50 min. The enzymatic 
activity was stopped by heating the mixture at 70°C for 10 min and lastly cooled on 
ice. The cDNA synthesized was used immediately for second strand synthesis or 
temporarily stored at -20 °C. 
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2.2.13 cDNA-PCR 
Subsequently, the obtained cDNA from above was used for second strand synthesis 
by PCR. A 50 µl PCR reaction was carried out as shown in (table 5) containing the 
following: 5 µl 10x LA buffer (Mg2+ plus), 8 µl dNTPs (10 mM), 2 µl cDNA template, 2 
µl adaptor Sp 6 (10 pmol/µl), 2 µl OdT T 7 II (10 pmol/µl), 0.5 µl Taq/Pwo (20.1) and 
30.5 µl distilled H2O. 
 
Table 5: PCR program 
S/No. Step Temperature Time No. of cycles 
1 Initial denaturation 95°C 1 min 1 
2 Denaturation 95°C 20 sec 35 
3 Annealing 58°C 20 sec 35 
4 Extension 72°C 2 min 30 sec 35 
5 Final elongation 72°C 5 min 1 
6 Final hold 4°C ∞  
 
2.2.14 CLEANING OF cDNA 
The PCR product from section 2.2.13 was cleaned with Sureclean reagent. Shortly, 
the PCR products were pooled in one micro-tube and an equal volume of Sureclean 
was added and mixed thoroughly before incubated at RT for 10 min. The mixture was 
then centrifuged at 17,000 X g for 10 min and the supernatant was discarded. The 
obtained pellet was washed twice with 70 % alcohol by centrifugation as previous. 
The pellet was air-dried for at least 5 min and resolved in 10 µl distilled H2O. The 
concentration and purity of DNA was measured twice by Nanodrop spectrophotomer. 
 
2.2.15 AMINO ALLYL-CRNA (AA-CRNA) SYNTHESIS 
Amino allyl-cRNA was synthesized by using T7- MegaScript (Ambion kit). The 
following reagents were mixed at RT: 2 µl ATP (75 mM), 2 µl GTP (75 mM), 2 µl CTP 
(75mM), 1 µl UTP (75 mM), 1.5 µl aa-UTP (50 mM) and 2 µl buffer (10x). Then, 3 µl 
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template cDNA (approx. 400-800 ng), 2 µl T7 enzyme and 4 µl of H2O water was 
added to the mixture and incubated at 37 °C for 16 hours. 
 
2.2.16 CLEANING OF aa-cRNA 
The aa-cRNA was purified using Nucleospin RNA II kit.  
• The volume of RNA above was filled up to 100 µl with RNase-free H2O. 
• 350 µl of RA1 lysis buffer were added and vortexed shortly. 
• Followed by 350 µl of 70 % ethanol and vortexed again. 
• About 400 µl of the mixture was loaded to the purification column and 
centrifuged at 11,000 x g at 4 °C for 30 sec. 
• Then, the collected flow was loaded to the column again and centrifuged as 
before and the same procedure was done for the rest of the mixture. 
• The column was then washed twice with 600 µl RA3 washing buffer and 
centrifuged like before. 
• Using a new collection tube, 250 µl of RA3 was added and centrifuged at 
11,000 x g at 4 °C for 2 min. 
• The column was then transferred into the new tube and RNA was eluted twice 
with 50 µl RNase-free H2O (65 °C) and incubated at 65 °C for 1 min before 
centrifuged at 11,000 x g at 4 °C for 1 min each. 
• Next, 10 µl of 3 M Sodium acetate and 250 µl of 96 % ethanol were added and 
vortexed. 
• Precipitation was performed at -20 °C for at least 30 min and centrifuged at 
17,000 x g for 60 min. 
• The supernatant was discarded and the pellet was washed twice with 70 % 
ethanol by centrifugation at 17,000 x g for 10 min each. 
• Lastly, the pellet was air-dried and resuspended in 6 µl of RNase-free H2O. 
Samples were diluted 1:20 in H2O. The amount and purity of aa-cRNA was 
measured twice by spectrophotometer. The yield should be at least 5 µg RNA 
per sample. 
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2.2.17 LABELING OF cRNA AND CLEANING OF LABELED cRNA 
The cRNA was labeled by Alexa fluor dyes. The dyes were dissolved with 40 µl 
DMSO and used within one week. Alexa fluor 555 was used to label a control sample 
and Alexa fluor 647 to label a treated sample. Approximately, 20 µg of aa-cRNA was 
used for each sample. Basically, a reaction mixture composed of 1 volume template 
aa-cRNA, 2 volumes NaHCo3 buffer (0.3 M, pH 9) and 3 volumes dye. The mixture 
was then incubated at RT for 2 hrs in darkness conditions and the labeled cRNA was 
cleaned as described in section 2.2.16. The concentration of the dyes was measured 
by spectrophotometer.  
2.2.18 HYBRIDIZATION OF THE ARRAY 
The labeled samples were mixed and hybridized to one single microarray glass slide. 
In brief, the hybridization buffer composed of 400 µl DIG Easy hybridization buffer, 
2.2 µl salmon sperm DNA and 2.2 µl yeast tRNA. The dye mixture consisted of 
200 pmol/µl Alexa fluor 647 and 400 pmol/µl Alexa fluor 555. The hybridization buffer 
was added to the dye mixture and incubated at 65 °C for 10 mins. Slowly, the whole 
solution was pipetted onto the array. The array was then placed on the hybridization 
chamber and incubated on the thermoshacker at 42 °C with mild shaking for 18 hrs. 
 
2.2.19 WASHING OF THE ARRAY 
To avoid photo-oxidation the washing steps was performed in the darkness 
conditions. The array was placed into 50 µl falcon tube wrapped with aluminium foil 
containing the washing buffer at different series with gently rotation. 
a. The array was washed with 1 X SSC buffer at RT for 1 hour. 
b. Washed twice with 1 X SSC + 0.1% Triton-X-100 at 60°C for 30 min each 
c. Washed twice with 0.1 X SSC + 0.1% Triton X-100 at 37 °C for 30 min each 
d. Washed with 0.1 X SSC at RT for 30 sec 
e. Washed with ddH2O at RT for 30 sec 
f. Quickly rinsed with ddH2O at RT and immediately dried with N2 gas. 
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2.2.20 SCANNING AND ANALYSIS OF THE MICROARRAYS 
The microarray slides were scanned by Gene Pix 4000B scanner with Gene Pix Pro 
6.0 software. The analysis was performed first by aligning the features (spots) in all 
the blocks by the help of Gene Pix Pro software. Second, the normalization of the 
probe signal intensity levels across the arrays was performed by Acuity 4.1 program. 
Lastly, the enrichment of Gene Ontology terms, and visualization of genes on KEGG 
(Kyoto Encyclopedia of Genes and Genomes) pathway maps were done with the 
help of the online s FlyBase (http://flybase.org/) and DAVID (Database for 
Annotation, Visualization and Intergrated Discovery) (Huang da et al., 2009) 
(http://david.abcc.ncifcrf.gov) databases. 
 
2.2.21 REVERSE TRANSCRIPTASE PCR (RT-PCR) 
A 25 µl PCR reaction consisted of 2.5 µl 10x PCR buffer, 0.5 µl dNTPs (10mM), 
0.5 µl forward primer (5 pmol/ul), 0.5 µl reverse primer (5 pmol/ul), 0.25 µl 
Taq polymerase, 0.5 µl cDNA template (100 ng), and 20.75 H2O.  
 
The PCR amplification program was as shown below.  
95°C  1 min 
95°C  30 sec 
55°C  30 sec 
72°C  1 min 
72°C  5 min 
4°C   ∞ 
 
 
 
28 cycles 
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2.2.22 QUANTITATIVE REAL TIME PCR (qRT-PCR) 
In a 10 µl qRT-PCR reaction mixture, a 10 ng of the 28 cycle’s pre-amplified cDNA 
was used. cDNA synthesis was performed as described in 2.2.12. The reaction 
mixture contained the following: 0.5 µl forward primer, 0.5 µl reverse primer, 0.25 µl 
ROX, 5 µl Sybr Green, x µl cDNA, which was brought to final volume of 10 µl by 
HPLC grade H2O. The program used in this analysis is shown in table 6. 
Table 6: qRT-PCR program 
S/No. Step Temperature Time No. of cycles 
1 Initial denaturation 95°C 10 min 1 
2 Denaturation 95°C 10 sec 40 
3 Annealing 60°C 20 sec 40 
4 Extension 72°C 35 sec 40 
5 Melting curve 95°C 15 sec  
6 Melting curve 60°C + 0.3°C 
until 95°C 
  
 
A fold change of expression of a gene was calculated according to (Pfaffl, 2001) that 
put into consideration the primer efficiencies of both target and reference genes. The 
primer efficiencies were obtained by (1:2) serial dilutions of cDNA from 50 ng to 
3.125 ng. After runs of primer efficiency the program in the amplification machine 
(StepOne) automatically gives the standard curve and the slope. Then the slope was 
used to calculate the efficiency with the following formula: 
E=10-1/slope 
From this the relative expression ratio of target gene to reference gene (Rpl32) was 
calculated as follows  
Ratio = (E target) ∆ct target (control-treated) 
E (ref) ∆ct ref (control-treated) 
Where ∆ct is change of cycle threshold (ct) calculated by the StepOne program 
during amplification. 
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2.2.23 GEL ELECTROPHORESIS 
Agarose gel electrophoresis was used to separate the sizes of the nucleic acids. The 
1.5 % agarose gel in TBE buffer was made by boiling the mixture. The gel was left to 
cool to about 55 °C before adding 2.5 µl ofethidium bromide (10 mg/ml). Samples 
were mixed with 6 X DNA loading dye and loaded onto the gel. A volume of 2 µl of 50 
bp or 1 kb Gener ruler marker was loaded depending on the expected size of the 
nucleic acid. The electromotive force of 100 V was applied for 30 to 40 min. The gels 
were visualized and captured with an UV transilluminator equipped with a camera. 
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3  RESULTS 
3.1 EXPRESSION PATTERN OF DOPAMINE RECEPTORS IN THE CNS AND 
DIGESTIVE SYSTEM 
To analyse the expression pattern of the four dopamine receptors; DopR (CG9652), 
DopR2 (CG18741), DopEcR (CG18318) and D2R (CG33517), the GAL4/UAS 
system was employed (Brand and Perrimon, 1993) to express a marker green 
fluorescent protein (GFP) under transcriptional control of gene specific promoters. 
The GAL4 driver lines were crossed to the responder strains carrying either a 
20xUAS-IVS-mCD8::GFP (Pfeiffer et al., 2010) or a UAS-Cameleon 2.1 (Diegelmann 
et al., 2002) and their progenies were used for analyses. All nomenclatures of the 
larval brain regions are according to Selcho and colleagues (Selcho et al., 2009), the 
nomenclature of the cell clusters and adult ventral brain is according to Busch et al. 
(Busch et al., 2009) and the nomenclature of the adult brain hemispheres is after 
Chiang et al. (Chiang et al., 2011). 
 
3.1.1 DOPR EXPRESSION IN LARVAL AND ADULT CENTRAL NERVOUS AND 
DIGESTIVE SYSTEMS 
A previous immunohistochemical analysis of the expression pattern of Drosophila 
dopamine receptor 1, DopR, in the larval and adult brain revealed prominent 
immunoreactivity in the mb, the cc and some neurosecretory cells (Kim et al., 2003). 
This study was based on an antibody raised against the putative third cytoplamic loop 
of the DopR. To further investigate the localization of this receptor, I analysed the 
expression of the DopR using the Gal4/UAS system. The DopR-GAL4 was used to 
drive the Green fluorescent protein (GFP) transgene (20xUAS-IVS-mCD8-GFP 
(Pfeiffer et al., 2010)) under transcriptional control of UAS promoter. Using double-
labeling immunohistochemical analysis, anti GFP immunohistochemistry (green) was 
used to visualize the neurons and their processes, and a neuropil-specific antibody 
nc82 to visualize overall brain structures (red).  
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Figure 10: DopR-GAL4 expression in the whole-mount third instar larval 
CNS. Figures (A-C) show immunofluorescence by GFP staining (green) 
in the cell bodies and the processes of DopR-expressing neurons. The 
brain was counterstained with an anti-nc82 antibody (red) for neuropils. 
Each panel shows a projection of optical sections, illustrating the brain 
hemispheres (br); and ventral 
nerve cord (vnc). Throughout 
the figures, cell clusters and 
brain regions are labeled with 
upper and lower cases, 
respectively. (A) Two large 
neurosecretory cells located on 
the pars intercerebrallis regions 
(arrows) and a group of 5-6 cell 
bodies are seen innervating the 
dendritic calyx (ca). (B) Shows 
the br with the strong GFP 
signal on the axonal terminal of 
the mushroom body lobes (mb) 
and the dendritic ca. Anterior 
and posterior to ca are two 
clusters; the dorsal lateral 1-2 
(DL1,DL2), respectively. GFP is 
also seen in the subesophageal 
ganglia (sog) and the cluster 
lateral to it (SL). (C) Close-up-
view of the vnc. Asterisks mark 
the cell bodies located on the 
cellular area and to the edge of 
the neuropil, sending their 
processes horizontally across 
the midline (arrow). At the tip of 
vnc, two large cells with 
multiple neurites are seen 
(dotted arrows). Scale bars: A-
B = 20µm, C = 100 µm 
 
In the larval CNS the GFP-expressing neurons innervated the entire protocerebrum 
(br), the subosephageal ganglion (sog), as well as the ventral nerve cord (vnc) (Fig. 
10A). In the brain lobes, DopR-GAL4 was strongly expressed in the mb lobes (Fig 
10B) and the calyx (ca) (Fig. 10A, B). The latter was innervated by two intensely GFP 
labeled clusters; DL1 and DL2 (Fig. 10B). Two large neurosecretory cells, one on 
each side of the brain hemisphere at the pars intercerebralis region, were also 
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strongly labeled (Fig.10A, arrows). In the sog, one cluster (SL) was also intensely 
labeled by GFP (Fig.10B). The vnc of the larval CNS also contained DopR-GAL4 
expressing neurons. The cell bodies of some of these cells are located on the cellular 
area while others are located in the neuropil region. These neurons send their 
processes medially across the midline to join other processes from the adjacent 
neurons (Fig. 10C, asterisks and arrow). Characteristically, in each larval CNS 
examined, two strongly GFP labeled neurons laterally located at the tip of last 
abdominal neuromere sent their primary neurites dorsally (Fig. 10C, dotted arrows). 
 
In contrast to what was observed in the larval CNS, the DopR-GAL4 was highly 
expressed in the adult brain neurons (Fig. 11A). GFP decorated several neuronal cell 
bodies, some of which form characteristic clusters. About six to eight larger neurons 
along the midline in the ventral part of the sog form the ventral medial cluster (VM) 
(11 B). Two joined intensely labeled cell bodies were visible on each side of the brain 
hemisphere sending their projections to the sog (11B white arrows). The Insulin 
producing cell cluster (IPCs) was strongly decorated by GFP (Fig. 11B). This cluster 
sends its bulky axonal projections to the sog/ tritocerebrum (Fig. 11B, yellow arrow). 
The anterior superior medial cluster (ASM) comprises several discrete cell bodies on 
the supra-dorsal-frontal-protocerebrum (sdfp). Two clusters were visible around the 
antennal lobes (al); AL1 and AL2. Cluster AL1 is located at the anterior margin of the 
al whereas cluster AL2 is located ventromedial to the al. Another cluster that was 
highly labeled by GFP comprises of the large lateral ventral neurons (l-LNvs), which 
are located between the optic lobes (ol) and the brain hemispheres (Fig. 11B). In 
addition, DopR-GAL4 was expressed in cell bodies located between the ca and the 
protocerebral bridge (PB1; Fig. 11E), and ventral to the protocerebral bridge (PB2; 
Fig. 11E). A robust GFP signal was observed in the area surrounding the 
subesophageal opening (oes) in the posterior slope and to the tracts between the 
brain hemispheres and the ol (Fig. 11A). 
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Figure 11: DopR-GAL4 expression in the adult CNS. Figures (A-F) show immunofluorescence by GFP staining 
(green) in the cell bodies and the processes of DopR-expressing neurons. The brain was counterstained with an 
anti-nc82 antibody (red) for neuropils. Each panel shows a projection of optical sections except (C-E), which are 
single optical sections. (A-B) Show the major regions and cell clusters that express DopR-GAL4. To avoid 
overcrowding of words, the brain regions are named in (A) and the cell clusters in (B). (A) The major regions 
shown are the dorsal lateral protocerebrum (dlp), optic tubercle (optu), super-dorsofrontal protocerebrum (sdfp) 
and the pedunculus (p). Others are the ventrolateral protocerebrum (vlp), the antennal lobe (al), the optic lobe (ol) 
and the subesophageal ganglion (sog) below the esophageal opening (oes). (B) Shows the cell clusters that 
express DopR-GAL4. The yellow arrow shows the midline projections from the Insulin producing cell cluster 
(IPCs) and the white arrows show the two joined cell bodies projecting to the sog. Ventral to the sog is a ventral 
medium cluster (VM). Clusters AL1 and AL2 are located anterior and ventromedial to the al, respectively. The 
ASM cluster is located on the sdfp and the l-LNvs cluster is seen at the margin of the ol and the brain 
hemispheres. (C) Shows the major neuropils named in (A) and the β-lobe of the mushroom bodies. (D-E) 
Posterior view of the adult brain showing DopR-Gal4 expression in the fan shaped body (fb) and noduli (no; D). 
(E) Shows the two clusters expressing DopR-GAL4; the PB1 and PB2 located dorsal and ventral to protocerebral 
bridge (pb) which itself lack the GFP signal. The calyx (ca) is faintly labeled by GFP. (F) DopR-GAL4 is 
expressed in all the thoracic ganglia 1-3 (tg1-3) and the abdominal ganglion (ag). Scale bars: A, B, F: 20 µm, C-
E: 96 µm. 
 
With respect to the neuropil regions, DopR-GAL4 was highly expressed in the outer 
layer surrounding the pedunculus (p) (Fig. 11A, D). As in the larval CNS, only the 
outer margin of the entire mb lobes was labeled by GFP with a weak signal, but the 
moderate signal was evident on the β-lobe (Fig. 11C). The calyx was also faintly 
marked by GFP (Fig. 11E). In the cc, GFP labeled the fan-shaped body (fb), and the 
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paired noduli (no; Fig. 11D). The protocerebral bridge (pb) was devoid of GFP signal 
(Fig. 11E), while the ellipsoid body (eb) was moderately labeled only on its outer 
margin (data not shown). Furthermore, GFP marked the superior dorsofrontal 
protocerebrum, the dorsal and ventral lateral protocerebrum, the optic tubercle, the al 
and the sog (Fig. 11A, C). In the adult ventral CNS (thoracicoabdominal ganglia), 
DopR-GAL4 was strongly expressed along the midline and the cell bodies located 
lateral to this midline in each segment (Fig. 11F).  
A previous transcriptomic study (Shang et al., 2011) showed that dopamine receptor 
mRNAs are present in purified l-LNvs, a subset of clock neurons. Moreover, Renn 
and co-author (Renn et al., 1999) reported earlier that there are ten l-LNvs (five on 
each side of the brain) that have related neurons nearby, the eight small LNvs (s-
LNvs). Both l-LNvs and s-LNvs express a neuropeptide pigment dispersing factor 
(PDF). To test this immunohistochemically, I stained several brains with an anti-PDF 
antibody. A high degree of colocalization of signals was observed between the GFP 
and the anti-PDF on the l-LNvs. There was no specific signal for anti PDF on the s-
LNV (Fig. 12A-D). 
 
 
Figure 12: Colocalization of DopR expressing cells with clock neurons expressing pigment dispersing factor 
(PDF). (A-D) show immunofluorescence by GFP staining and co-staining with anti PDF. (A) Large and small 
ventral lateral clock neurons (dotted box). (B-C) Enlargement of A, anti GFP (green, arrow) and anti PDF in (red, 
arrow). (D) The l-LNvs show a high degree of colocalization with DopR-expressing cells (merge, yellow, arrow). 
Scale bars: 200 µm 
 
In mammals it is known that D2 receptors have a presynaptic location (Civelli et al., 
1991). To test this in Drosophila, several brains from DopR were stained with anti 
dopa-decarboxylase (DDC) antibody. Since DDC encodes an enzyme catalyzing the 
biosynthesis of dopamine from its precursor L-3,4-dihydroxyphenylalanine (L-DOPA), 
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the dopaminergic neurons will express DDC. Some of the DopR-GAL4 expressing 
neurons were strongly positive for DDC (Fig. 13A-D), suggesting an auto-receptor 
function of this receptor at least in these cells. This was further confirmed by a semi-
quantitative reverse transcriptase (RT-PCR) analysis (Fig. 13E). The cDNA used for 
this analysis was isolated from specific dopaminergic cells and tested against specific 
primers for all four dopamine receptors. A single band of approximately 160 bp was 
detected for DopR. DDC was used as a positive control. No single band was 
detected in DopR2 and D2R with exception of DopEcR. The expression patterns of 
these three receptors are discussed in later sections. 
 
 
Figure 13: Expression and detection of DopR in 
dopamine producing cells indicate DopR as an 
autoreceptor. (A-D) Single optical section stained 
with anti GFP (green) and co-stained with anti DDC 
(red) in the adult brain of DopR-Gal4>UAS-GFP. (A) 
Shows colocalization of anti-GFP and anti-DDC 
signals (dotted box). (B-D) Enlargement of A 
showing DopR expressing neurons, (green, arrows); 
DDC expressing neurons, (red, arrows); and a 
composite image (yellow, arrows). Scale bars: 200 
µm. (E) RT-PCR analysis of the RNA isolated from 
dopamine producing cells. Specific single bands 
were detected in DopR1 and DopEcR with DDC as 
a positive control. No single bands were detected in 
DopR2 and D2R. Marker is a 50 bp GeneRuler. 
 
In the fly there are seven insulin like peptides (DILP1-7) with striking homology with 
mammalian and human insulin and insulin like growth factor (Rulifson et al., 2002). 
The IPC cluster observed in the Pars Intercerebralis region (Fig. 11B) has been 
shown to express DILP2, 3, and 5 (Rulifson et al., 2002). To test this in flies bearing 
the transgenes DopR-Gal4;UAS-mCD8-GFP several larval CNS and adult brains 
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were stained with anti GFP and co-stained with anti-DILP2 antibodies. The result 
showed no colocalization of fluorescent signals between the two antibodies (Fig.14). 
 
 
Figure 14: Expression of DopR in Insulin-Producing Cells (IPCs). (A-H) DopR-Gal4 driven GFP in IPCs 
immunostained with anti GFP (green) and anti DILP2 (red). (A) Larval brain median neurosecretory IPCs (dotted 
box). (B-D) Enlargement of A; Two cell bodies located on pars intercerebralis region (green, arrows) are not 
superimposed with DILP2 expressing cell bodies (red, arrows). E. Adult brain IPCs cluster (dotted box). (F-H) 
Closer view shows no colocalization between DopR expressing neurons with DILP2 expressing neurons. Scale 
bars: 20 µm 
 
With respect to peripheral nervous system, DopR was found to be expressed in the 
mid-gut secretory enteroendocrine cells (EEs). This was confirmed by staining the 
DopR-Gal4>UAS-mCD8-GFP midguts with anti-prospero antibody. Prospero is a 
transcription factor expressed in EEs (Ohlstein and Spradling, 2006). All the GFP 
positive cells were positive for prospero expressing cells, suggesting the expression 
of DopR in a subset of EEs (Fig. 15B-F). Similar results were obtained when the gut 
tissues were stained with anti NC82 (Appendix 1, Fig. A1). 
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Figure 15: DopR is expressed in the Enteroendocrine cells (EEs).  (A) Schematic diagram showing the structure 
of the third instar larval gut system modified from http://www.docstoc.com/docs/89461663/ANATOMY-AND-
DEVELOPMENT-OF-DROSOPHILA-LARVA. Throughout the gut system figures, the posterior midgut is the part 
that was analyzed unless otherwise noted. (B) Enhancement of GFP reporter for DopR-Gal4 expression in EEs 
by anti-GFP antibody. (C) Prospero positive cells stained by anti prospero antibody. (D) DNA/nuclei marker, 
DAPI. (E) A composite image, all the GFP positive cells overlap with a subset of prospero positive cells. Prospero 
is a transcription factor hence localizes nuclearly, yellow. (F) Enlargement of dotted box in E. Scale bars: 20 µm 
 
3.1.2 DOPR2 EXPRESSION IN LARVAL AND ADULT CENTRAL NERVOUS AND 
DIGESTIVE SYSTEMS 
Immunohistochemical analysis from a previous study (Kim et al., 2003) showed that 
DopR2 receptor is localized specifically in the mb lobes. However, when I analysed 
the expression of DopR2 in the larval CNS using GFP as reporter under 
transcriptional control of the DopR2 promoter, I detected no GFP signal in this region; 
instead it was possible to see a large number of neurites spreading all over the entire 
neuropil. These neurites formed a mesh- like structure, (Fig 16A, B) in which some of 
them project to the ol. For every specimen examined, the terminal tracheal branches 
were strongly labeled with GFP (see arrow, Fig.16B). As shown in Fig 16A, GFP was 
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strongly detected in the two clusters; DM and DL (dorsomedial and lateral 
protocerebrum), respectively. 
In the ventral nerve cord, I observed pairs of well labeled neurons (Fig 16B dotted 
arrows). Each neuron projects to the midline. They form a “fishbone”-like structure 
like it was described by Draper et al. (Draper et al., 2007) for another dopamine 
receptor (D2R). 
 
Figure 16: DopR2-GAL4 expression in the whole mount third instar larval CNS. (A) Shown is the maximum 
projection of optical stacks of the larval CNS. Neuropils and cell bodies and their processes are visualized by anti-
nc82 (red) and anti-GFP (green), respectively. GFP labels cells of the dorso-medial and lateral (DM, DL,) 
respectively. (B) Higher magnification of a single optical section of the larval brain hemispheres and part of 
ventral nerve cord. Networks of neurites, some projecting to the optic lobe (ol) are seen. The arrow shows the 
terminal branches of the tracheal system running close to the neurites. Laterally located cell bodies (dotted 
arrows) projecting to the midline (a “fishbone-like” structure) are also seen. Scale bars: 200 µm. 
 
In the adult brain, DopR2 is reported to be localized in mb and cc (Han et al., 1996, 
Kim et al., 2003). As for the DopR, the enhancement of GFP expression by an anti-
GFP antibody revealed an additional distribution pattern for this receptor in all brains 
examined. Both, the lower and the upper layers of the fb were strongly positive for 
GFP. The latter was found to be connected with a highly DopR2 enriched area, the 
frontal super peduncular protocerebrum (fspp; Fig. 17A). Moreover, it was observed 
that some of the cell bodies located on the fspp as well as those located at the dorsal 
midline send their putative axonal projections to the lower layer of the fb. However, 
GFP expression on the mb was weakly detected only on the β lobe (Fig. 17B). A 
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remarkable signal was evident in the fibers that innervate the sog, as well as the cell 
bodies located lateral to it. The signal was also present in the al, the entire 
protocerebra including dorsal and ventral protocerebrum. In addition, GFP decorated 
the lamina monopolar cells in the ol (Fig 17A). 
As for the DopR, DopR2 was found to be well expressed in the thoracicoabdominal 
ganglion. A group of four cell bodies, arranged in a row, was seen between the 
junction of the brain and the thoracicoabdominal ganglia. They send their projections 
towards the midline. Most of the cell bodies were located along the midline and send 
their fine ramification to either ipsilaterally or contralaterally nearby ganglia (Fig 17C). 
 
 
Figure 17: DopR2-GAL4 expression in the adult CNS. Figures (A-C) show immunofluorescence by GFP staining 
(green) in the cell bodies and the processes of DopR-expressing neurons. The brain was counterstained with an 
anti-nc82 antibody (red) specific for neuropile regions. (A) Dorsal view of the adult brain showing DopR2-GAL4 
expression in neuropils and cell bodies. The frontal-super-peduncular-protocerebrum (fssp), fan-shaped body (fb) 
antennal lobes (al) and the ventral lateral protocerebrum (vlp) are the most stained neuropils above the 
esophageal opening (oes) i.e. in the Supraesophageal ganglion. The subesophageal ganglion (sog) is innervated 
by strongly GFP labeled fibers. GFP decorates the lamina monopolar cells in the optic lobe (ol). Other cell bodies 
are seen around the vlp, between vlp and ol, around the al and lateral to the sog. (B) Single optical section 
showing the major neuropil named in (A) and the ß-lobe and pedunculus (p) of the mushroom bodies. (C). 
DopR2-GAL4 is expressed in the thoracic ganglia 1-3 (tg1-3) and the abdominal ganglion (ag). Scale bars: A-B: 
20 µm, C: 200 µm. 
 
Regarding the PDF expressing cells, as for DopR, DopR2 was also expressed in 
these cells. DopR2-GAL4 driver labeled the clock neurons that colocalized with PDF 
positive cells, indicating the expression in l-LNvs (Figure 18A-D) and a relatively 
weak GFP signal was seen in s-LNvs clock neurons (data not shown).  
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Figure 18: Colocalization of DopR2 expressing cells with clock neurons expressing pigment dispersing factor 
(PDF). (A-D) Single optical sections; DopR2-GAL4 expressing cells stained with anti GFP (green), in the ventral 
lateral clock neurons and anti PDF in red. Both labels, specific for DopR2 neurons and for PDF show an 
unequivocal colocalization (merge, yellow). Scale bars: 20 µm. 
 
In contrast to DopR, DopR2 is not expressed in the dopaminergic neurons as 
evidenced by immunostaining with anti DDC antibody. There was no colocalization of 
signals between anti GFP and anti DDC (Fig. 19) and also DopR2 transcript was not 
detected by RT-PCR (Fig. 13E). 
 
 
 
Figure 19: DopR2 is not expressed in the dopaminergic neurons. (A) A projection of optical sections from adult 
central brains immune-stained by anti-GFP antibody (green) and (B) co-stained by anti DDC (red). (C) No 
overlaps between the two fluorescent signals. Scale bar: 20 µm. 
 
In the third instar larval guts, DopR2 was found to be expressed in the absorptive 
Enterocytes (ECs) of the mid and hind guts. In the midgut the GFP positive ECs were 
identified by their large nuclei size stained by DAPI (Fig. 20A).  
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Figure 20: DopR2 is expressed 
in the Enterocytes of the 
midgut. Section of the larval 
midgut stained by anti GFP 
(green) and co-stained with 
nuclear marker, DAPI (blue). 
Due to fusion of mCD8 protein 
to GFP (mCD8-GFP) the 
localization is seen in the cell 
membrane. Scale bar: 50 µm. 
 
In the hindgut it was important to counter stain with fluorescent phalloidin to rule out 
the expression of DopR2 in the gut muscles. Phalloidin binds to F-actin filaments in 
the cells. There was no overlap between phalloidin stain and GFP that was observed 
in stained hindguts (Fig. 21A-C). 
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Figure 21: DopR2 is expressed 
in enterocytes of the larval 
hindgut. Immunofluorescence 
staining by anti-GFP (A), 
phalloidin marking actin 
filaments in muscle cells (B) 
and a composite image of A 
and B, plus nuclei marker, 
DAPI (C). Scale bars: 50 µm. 
 
3.1.3 DopEcR EXPRESSION IN LARVAL AND ADULT CENTRAL NERVOUS AND 
DIGESTIVE SYSTEMS 
A previous in situ hybridization study (Srivastava et al., 2005) showed that the 
DopEcR expression level was downregulated in third instar larval CNS. The 
expression was restricted to a narrow band of cells extending from the anterior dorsal 
to the posterior ventral regions of the brain lobes. Noteworthy, this study sought to 
determine the expression pattern using the GAL4/UAS system. In general, the 
expression pattern of DopEcR in larval CNS is similar to what was described for 
DopR. In the brain lobes, the GFP signal was strong in the mb lobes and the ca. 
Both, the mb lobes and the ca were innervated by strongly GFP labeled clusters: the 
DM, DL1, and DL2 (Fig.22B). Concerning the sog, I was able to distinguish one 
anteriomedial cluster, SM1 (Fig 22A) and a lateral cluster SL (Fig 22B). The GFP 
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signal was barely seen in the larval vnc, except in the few cell bodies located within 
or lateral to the neuropil (Fig 22A, asterisks). 
In contrast to what was observed in the larval CNS, the DopEcR-GAL4 was weakly 
expressed in the adult brain. There was no single cell or cluster of cells which was 
labeled by GFP. A faint GFP signal was detected in the mb lobes (Fig 22C). The 
antennal mechanosensory and motor center (ammc), the ca and the laminal layer 
(lm) were the only regions with the moderate GFP signal (Fig 22C, D). GFP was also 
seen in the few nerve fibers within the sog (Fig 22D). There was no specific GFP 
signal detected in the thoracicoabdominal ganglia (data not shown). 
 
 
Figure 22: DopEcR-GAL4 expressions in whole-mount third instar larval and adult CNS. (A-D) Shown is the 
immunofluorescence obtained with anti- GFP staining (green) in the cell bodies and the processes of DopEcR-
expressing neurons. The brain was counterstained with an anti-nc82 antibody (red) for neuropils. (A) Shows the 
DopEcR expression in the brain hemispheres (circled area) and the vnc below the sog. Antero-medial to sog is 
the cluster SM1. In the vnc, few cell bodies are positive for GFP (see asterisks). (B) Higher magnification of the 
brain hemispheres showing the strong GFP signal on the axonal terminal of the mushroom body lobes (mb) and 
the dendritic ca. Three clusters the DM, DL1 and DL2 with their processes projecting to the mb lobes and the ca 
are also positive for GFP. GFP is also seen in the sog and in another cluster located lateral to it, the SL. (C-D) 
Show a subset of optical sections of the adult brains, anterior and posterior views, respectively. The GFP signal is 
seen in the antennal mechanosensory and motor centers (ammc), laminal layer (lm), ca and the sog. A faint 
signal is also detected in the mb lobes. Scale bars: 20 µm. 
 
The intestinal system was not subjected to a detailed analysis using DopEcR>UAS-
mcD8-GFP progenies, as no expression was detected via live imaging by fluorescent 
microscope. 
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3.1.4 D2R EXPRESSION IN LARVAL AND ADULT CENTRAL NERVOUS AND 
DIGESTIVE SYSTEMS 
Hearn and colleagues (2002) reported the existence of eight isoforms of the D2R 
transcript. In connection with the spatial expression pattern of the D2R, (Draper et al., 
2007) showed that the D2R is expressed in the larval and adult CNS. Their results 
were based on the anti-D2R antibody, which was produced from a sequence that 
corresponds to the third extracellular loop of D2R, a segment conserved among all 
known D2R variants (Hearn et al., 2002). 
Unlike for D1-like receptors, D2R-GAL4 was used to drive either the expression of 
the responder strains UAS-Cameleon 2.1 (Diegelmann et al., 2002) or 20xUAS-IVS-
mCD8-GFP) (Pfeiffer et al., 2010) (data not shown). As reported before by Selcho 
and colleagues (Selcho et al., 2009) regarding the anatomy of the dopaminergic 
system, a significantly stronger signal was obtained with UAS-Cameleon 2.1 
compared to UAS-mCD8-GFP. By double labeling with anti-GFP (Fig. 23B) and anti-
nc 82 (Fig. 23C) antibodies, it was possible to visualize a comprehensive network of 
neurons spreading all over the larval CNS. Interestingly, their cell bodies were 
located on the lateral side of the neuropils including the mb regions, ca, the dorso-
and baso-medial protocerebra and the sog (Fig 23A). 
With respect to the ventral nerve cord, the pattern of expression for D2R-GAL4 
neurons was similar to that of DopR. Some of the neurons had their cell bodies 
located on the cellular area while others were located either to the lateral edge or 
within the neuropil region (Fig.23A asterisk, arrow head and arrow respectively). In 
general, this receptor was highly expressed in the larval CNS.  
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Figure 23: D2R-GAL4 expression in the third instar larval CNS. (A-C) Shown is the immunofluorescence by anti- 
GFP staining (green) in the cell bodies and the processes of D2R-expressing neurons. The brain was 
counterstained with an anti-nc82 antibody (red) for neuropils. Each panel shows the projections of optical stacks. 
(A) A composite image of B and C larval CNS showing the GFP labeled cells located around the dmp and dlp 
(dorsomedial and lateral protocerebrum, respectively), and the basalmedial and lateral protocerebrum (bmp and 
blp, respectively). Other areas include the dendritic ca and the sog. In the vnc, some of the neurons have their 
cell bodies located on the cellular area while others are located either on the lateral edge or within the neuropil 
region (asterisk, arrow head and arrow, respectively. Scale bars: 20µm. 
 
Similar to what was observed in the larval CNS, the D2R was expressed in the outer 
margin of the major neuropils, such as the mb lobes, ca, pedunculi and the cc in the 
adult brain. Because of the weak signal in the mb lobes, they were not visible when 
the maximum projection of z-optical stacks was made (Fig 24A, B). The GFP signal 
was also detected in all the cc substructures. The strongest signal was displayed in 
the pb (Fig 24B, white arrow). D2R was weakly expressed in the ol, al and the 
midline toward the sog (Fig 24A). 
In contrast to what was observed in the larval ventral nerve cord, the 
thoracicoabdominal ganglion was only weakly expressing D2R. The GFP signal was 
detected in few neurons, which were found along the midline between the third 
thoracic ganglion and the abdominal ganglion (Fig 24C). 
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Figure 24: D2R-GAL4 expression in the adult CNS. (A-C) Shown is the immunofluorescence obtained by anti- 
GFP staining (green) in the cell bodies and the processes of D2R-expressing neurons. The brain was 
counterstained with an anti-nc82 antibody (red) for neuropils. Each panel shows the projections of optical stacks. 
(A) Anterior view showing the neuropils, which are GFP positive; the central complex (arrow), around the 
pedunculus (p), weakly around the al, and few cells in the ol. (B) Posterior view showing GFP signal in the 
protocerebral bridge (white arrow), around the ca and the nodulus (blue arrow). (C) D2R-GAL4 expression in the 
adult ventral nervous system. The GFP signal is seen in the few cells located along the midline between the third 
thoracic ganglion, tg3 and the abdominal ganglion, ag. Scale bars: 20 µm. 
 
In conjunction with what was observed in the CNS, D2R was expressed in intestinal 
stem cells (ISC) and enteroblasts (EB). Earlier studies reported the expression of 
D2R in the cell bodies located in the posterior midgut (Draper et al., 2007; El-Kholy 
PhD thesis, 2010). To unequivocally specify the type of cells, several midgut tissues 
were first immunostained with anti GFP and anti prospero and anti Nc82 antibodies. 
These preparations show no colocalization of signals between GFP positive cells and 
either prospero positive cells or Nc82 positive cells (Appendix 1, Fig. A2 & A3). 
These findings suggested that D2R is not expressed in the EE cells. Based on their 
shapes and size of their nuclei they were definitely not EC cells. The only remaining 
possibility was them been either ISC or EB or both. To confirm this, several tissues 
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were first immunostained with anti delta antibody. Delta is used as a specific marker 
for ISC in the Drosophila midgut. It acts as an ISC membrane bound ligand to 
stimulate the receptor Notch in the neighboring EB. It was observed that a subset of 
GFP positive cells were also positive for anti delta antibody (Fig. 25A-D). This 
brought a speculation that the GFP positive cells, which were not delta positive, could 
be EB cells.  
 
Figure 25: D2R is expressed in the intestinal stem cells (ISC). (A-D) Shown is a projection of optical sections of 
the third instar larval midguts of D2R-Gal4>UAS-GFP. (A) Enhancement of GFP reporter for D2R-Gal4 
expression in ISC by anti GFP antibody. (B) Delta positive cells stained by anti delta antibody. (C) DNA/nuclei 
marker, DAPI. (D) A merged image showing overlaps of fluorescent signals, yellow and some GFP positive cells 
(green) which were not marked by delta. Dotted lines demarcate the tubular structure of the gut. Scale bars: 
20 µm. 
 
To confirm this, again several midgut tissues were immunostained with anti Notch 
antibody. It was clearly shown that the remaining GFP positive cells were also 
labeled by an anti Notch antibody, suggesting expression of D2R also in the EB cells 
(Fig. 26A-D). 
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Figure 26: D2R is expressed in the Enteroblast cells (EB). (A-D) D2R-Gal4 driven GFP in the larval midgut; 
immunofluorescence staining with anti GFP (green), anti Notch (red) and with DAPI (blue). (A) Dotted box shows 
a single EB with its enlargement shown in B-D. Scale bars: 20 µm. 
 
3.2 DOPAMINERGIC CELLS DISTRIBUTION IN THE LARVAL MIDGUT 
Having analyzed the expression patterns of dopamine receptors in the midgut 
system, it was interesting to show where dopamine is secreted within the system. 
The dopaminergic cells (DA) were identified by use of the TH-GAL4 driver. TH-GAL4 
is a driver that expresses GAL4 under the control of promoter sequences of the 
tyrosine hydroxylase gene (Friggi-Grelin et al., 2003). Tyrosine hydroxylase (ple) 
catalyzes the rate limiting step in DA biosynthesis, thus all DA cells express TH. 
Tissues from TH-GAL4>20xUAS-mcD8::GFP progenies were immunostained by anti 
GFP and anti prospero antibodies. Six GFP positive cells found at the anterior part of 
the midgut were also positive for prospero, suggesting their secretory role in the gut 
(Fig. 27A-C). 
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Figure 27: Distribution of Dopaminergic cells in the larval midgut. (A-C) Shown is a projection of optical sections 
of the third instar larval anterior midgut of TH-GAL4>20xUAS-mCD8::GFP. (A) Six GFP positive cells (green). (B) 
Prospero positive cells stained by anti prospero antibody (red, arrow heads). (C) A composite image showing 
overlaps of fluorescent signals (arrow heads) and a DNA marker, DAPI (blue). Scale bars: 20 µm. 
 
3.3 FUNCTIONAL ANALYSIS OF DOPAMINE RECEPTORS 
3.3.1 MODULATION OF INTRACELLULAR SIGNALING IN DOPAMINE 
RECEPTOR EXPRESSING NEURONS 
Designer Receptors Exclusively Activated by a Designer Drug (DREADDs) are 
modified G-protein coupled receptors that are activated only by a synthetic ligand, 
namely by Clozapine-N-Oxide (CNO) (Armbruster et al., 2007). In mammals, 
DREADD technology has been used to manipulate cellular signaling and control of 
behaviors (Nichols and Roth, 2009). Recently, the Nichols laboratory demonstrated 
the utility of this technology in Drosophila (pers. comm. CD Nichols, USA). They 
created three important UAS-DREADD transgenes, the UAS-M1D1 that allows to 
induce the increase of Ca2+ levels, UAS-M4D1 that decreases cAMP levels and UAS-
M5Dbar that increases the levels of cAMP. Dopamine receptors being GPCRs 
control many physiological and behavioral processes through either activity of 
adenylate cyclase, which increases or decreases the levels of cAMP or 
phospholipase C beta (PLC-β) that modulates the release of Ca2+ in the cytosol. To 
test whether DREADD expression in vivo modifies the locomotor behavior of adult 
flies, all four dopamine receptor Gal4 strains were used to drive the expression of 
matching UAS-DREADD transgenes. DopR-Gal4, DopR2-Gal4 and DopEcR-Gal4 
are known or are believed to induce activation of the adenylate cyclase, thus leading 
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to cAMP production. Thus, I used the corresponding Gal4 lines to drive expression of 
UAS-M5Dbar that allows to induce an increase in cAMP in these cells. The 
corresponding F1 flies were fed 1 mM CNO and compared with non-induced animals 
of the same genotype. CNO itself had no effects on the mean locomotor activity. 
Activation of the DopR and DopR2 led to decreased locomotor activity levels per 24 
hours. This was quantified using the DAM system (Fig. 28A). Monitored hourly 
(circadian activity), the same flies showed the bimodal pattern of activity with a 
prominent burst of activity around the light-off-to light-on transition (ZT0-ZT2, morning 
peak). The evening peak was observed around lights-on-to-light-off transition (Fig. 
28B-C). The DopEcR-Gal4 x UAS-M5Dbar F1 flies fed with 1 mM CNO showed a 
slightly decreased locomotor activity compared to control flies but the difference was 
not significant. Similar results were obtained when M1D1 was overexpressed in 
DopR2 cells with the DopR2-Gal4 driver (DopR2>M1D1). The overexpression of 
M4D1 in relation to D2R-Gal4 showed the same performance in activity between 
CNO fed and not fed flies. As already mentioned, the activity of wild type flies 
(Canton-S), which were used as an overall control was not affected (Fig. 28). 
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Figure 28: Locomotor activity of flies overexpressing DREADDs in the pattern of different dopamine receptors. (A) 
F1 flies obtained from DopRs-Gal4 drivers crossed to UAS-M5Dbar, UAS-M1D1 and UAS-M4D1, respectively. 
The patterned bars show activity levels of flies treated with 1 mM CNO compared to matching control flies (black 
bars), monitored using the DAM system for 3 days. Activation of M5Dbar in relation to DopR and DopR2 reveals 
3 Results  
 
75 
a significant decrease in total activity counts per 24 hours. No significant changes in activity observed in other 
groups including wild type strain, Canton S. *p<0.05, **p<0.01, two way ANOVA with Bonferroni post hoc test for 
multiple comparison; n = 16 flies per genotype and error bars represent SEM. (B-C) Line graphs showing the 
circadian activity per fly per every hour of F1 flies overexpressing M5Dbar in to the pattern of DopR and DopR2, 
respectively. Gray shaded area illustrates dark condition, ZT0= light on, ZT12= light off. 
 
3.3.2 EXPRESSION OF INTERFERENCE TRANSGENES IN VIVO IN THE 
PATTERN OF DOPAMINE RECEPTORS 
Expression of endogenous DopRs mRNA was silenced by an RNAi approach. Flies 
carrying either the UAS-ds-DopR, UAS-ds-DopR2 or UAS-ds-D2R transgene were 
crossed to the n-syb-Gal4 driver which drives expression in all neurons. These flies 
will be referred hereafter as DopR-RNAi, DopR2-RNAi and D2R-RNAi, respectively. 
To monitor their locotomor activity the DAM system was used again under the 
identical setting as described above. These analyses demonstrated that only D2R-
RNAi flies showed a significant decrease in total activity counts. DopR-RNAi and 
Dop2RNAi flies showed no significant change in their performances relative to 
negative control flies Nos-RNAi (Fig. 29). Nos stands for nitric oxide synthase, an 
enzyme that catalyzes the production of nitric oxide from L-arginine. Among other 
tissues, it is highly expressed in the nervous system. Importantly, there was a 
significantly different level of activity between DopR-RNAi and DopR2-RNAi and 
D2R-RNAi flies. Nevertheless, there was no significant difference in total activity 
between DopR2-RNAi and D2R-RNAi flies (Fig. 29). 
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Figure 29: Locomotor activity of DopRs-RNAi flies. 
Locomotor activity counts of four RNAi-interference 
fly lines (UAS-ds-DopR, UAS-ds-DopR2, UAS-ds-
D2R and UAS-ds-Nos) driven by n-syb-Gal4 driver 
and analyzed by the DAM system. D2R-RNAi flies 
showed substantially reduced locomotor activity 
counts per 24 hrs in comparison to control flies 
(Nos-RNAi) and DopR-RNAi flies. DopR-RNAi and 
DopR2-RNAi flies have no significant difference in 
activity with respect to control. However, there is a 
significant difference between DopR-RNAi and 
DopR2-RNAi flies. The levels of activity counts of 
DopR2-RNAi and D2R-RNAi flies seemed to be 
similar. *p<0.05, one way ANOVA with Tukey’s post 
hoc test for multiple comparison; n = 8 flies per 
genotype and error bars represent SEM. 
 
3.3.3 EFFECT OF LOSS-OF-FUNCTION MUTATIONS OF THE DOPR 
As explained in the section 3.3.2 above, the knockdown of DopR did not affect the 
basal locomotor activity of the tested flies. Locomotor activity in flies reflects sleep-
wake transitions. It has been shown that, dopamine controls this endogenous 
generated form of arousal through DopR (van Swinderen and Andretic, 2003) 
 
It was then interesting to test this behavior in flies with a hypomorphic mutation in 
DopR. These flies will be referred hereafter as DopRf02676 and the wild type strain 
Canton-S (CS) was used as a control. As it was the case for DopR-RNAi flies, the 
locomotor activity was monitored using the DAM system. In contrast to what was 
observed in DopR-RNAi flies, DopRf02676 mutant flies showed a decreased activity 
pattern over a 24 hours period in comparison to control flies in LD cycle (Fig.30A). 
The phenotype was stronger in constant darkness (DD) conditions (Fig. 30B). 
Monitoring at one hour intervals, DopRf02676 flies showed considerably decreased 
activity in comparison to control flies during the night phase (Fig. 31A). In constant 
DD conditions DopRf02676 maintained the morning and evening peaks but with highly 
reduced activity in comparison to control flies (Fig. 31B). 
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Figure 30: DopR mutant flies show reduced locomotor activity. (A-C) Total activity counts per 24 hrs in both 
light/dark (LD) and dark/dark (DD) conditions. (A) DopR mutant flies (DopRf02676) showed decreased locomotor 
activity in comparison to control, Canton-S (CS) flies in LD cycle. (B) The stronger effect of reduction is seen in 
DD cycle. *p<0.05, **p<0.01, Unpaired t-test with Welch’s correction; n = 16 flies per genotype and error bars 
represent SEM. 
 
To further confirm the observation that DopR deficiency leads to night hypoactivity 
during LD cycle, a DopR rescue experiment was performed. The DopRf02676 mutation 
was caused by a piggyback transposon insertion on the first intron of the DopR allele. 
Taking advantage of Gal4 UAS element in the first intron of the DopRf02676 allele (Fig. 
32A) (Lebestky et al., 2009), a Pdf-Gal4 driver was employed. This strategy has been 
used successfully to rescue the learning and memory deficit observed in DopR 
mutant flies (Kim et al., 2007). Interestingly, Pdf-Gal4x DopRf02676 F1 flies showed a 
partial rescue of this phenotype especially at and post evening peak hours relative to 
w1118x DopRf02676 F1 flies (Fig. 32B).  
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Figure 31: DopR mutant flies have reduced night phase activity. (A-B) Circadian activity of DopR mutants 
(DopRf02676) and matching controls, CS flies. (A) Note lessened activity of DopR mutants (red) relative to CS 
(blue) during the night phase. (B) Circadian activity of the DopR mutants and control flies in constant darkness 
conditions.
 
 
Figure 32: Rescue of the night 
hypoactivity phenotype of 
DopR mutant flies. (A) 
Structure of the DopRf02676 
insertional allele, the UAS is in 
the first intron (Lebestky et al., 
2009). (B) Circadian activity of 
control flies, w1118x 
DopRf02676 (blue) and rescue 
flies, Pdf-Gal4x DopRf02676 
(red). Note the partial rescue of 
night hypoactivity at and post 
evening peak (20-1 hrs). 
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3.3.4 ACTIVATION OF PHOSPHOLIPASE C-BETA (PLC-β) WITH REGARD TO 
DOPR2 
Stimulation of PLC-β activity leads to mobilization of intracellular Ca2+ within the cell. 
As shown earlier in Fig. 20, DopR2 was expressed in enterocyte cells of the midgut. 
This study then sought of testing whether activation of this receptor in vivo would 
trigger the action of PLC-β within the enterocytes. To achive this, NP1-Gal4 x UAS- 
PLC-β::mRFP F1 fly midguts were used for the experiment. Immediately upon 
dissection, the endogenous agonist for DopR2, 3-Hydroxytyramine (dopamine) was 
applied on top of the tissue. The concentration of agonist was ranging from 10-1M to 
10-9M and HL3 buffer was used as a vehicle control. As seen in Fig. 33 all the 
concentrations used trigger the translocation of PLC-β from the cytoplasm to the 
plasma membrane in comparison to the control. 
 
 
 
Figure 33: DopR2 mobilizes intracellular Ca2+ via PLC-β in enterocytes. (A-D) Optical sections of midgut 
enterocyte cells with native PLC-ß fused to monomeric Red Fluorescent Protein (PLC-ß::mRFP, red) and DAPI 
staining, blue. (A) Signal for PLC-ß::mRFP is seen in cytoplasm surrounding the nuclei (arrows) in a vehicle 
control (HL3 buffer). (B-D) Cytoplasm is devoid of signals after PLC-ß::mRFP has been recruited to the plasma 
membrane upon dopamine application (10-1 M, 10-3 M, 10-9 M). Scale bars: 20 µm 
 
3.4 INDUCTION OF PARKINSONIAN SYMPTOMS IN DROSOPHILA 
To model PD in a fly, the TH-GAL4 transgenic line was crossed to the 20xUAS-
mCD8::GFP reporter line and the progenies were used for the subsequent 
experiments. As described before in section 3.2, TH-GAL4 is a driver that expresses 
GAL4 under the control of promoter sequences of the tyrosine hydroxylase gene. 
Tyrosine hydroxylase codes for the enzyme catalyzing the rate-limiting step in DA 
biosynthesis. Thus, DA neurons express TH. 
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3.4.1 EFFECT OF ROTENONE TO FLIES IS DOSE DEPENDENT 
To determine the effect of rotenone in flies, a series of concentration was added to 
the food. After 9 days of exposure, the effect of rotenone was determined by using 
the climbing ability test. Normally, flies climb up the sides of the vial after mechanical 
stimulation (Le Bourg and Lints, 1992). This behavior was impaired in flies treated 
with higher doses of rotenone. Rotenone was applied at sublethal doses (<10 mM) 
i.e. concentration above this was lethal to flies. It was observed that in absence of 
rotenone most flies cross the escape line (see section 2.2.5.1) after 20 sec. On the 
contrary, flies, which were exposed to rotenone showed difficulties crossing this line 
and the effect was stronger with higher doses (Fig. 34). The 5 mM concentration was 
chosen for the subsequent experiments. 
 
 
Figure 34: Effect of rotenone to Drosophila is dose 
dependent. Climbing ability test of 12 days old male 
flies exposed to various concentration of rotenone 
for 9 days. The median distance/height climbed ± 
SEM (n=20) is shown. 
 
3.4.2 ROTENONE EXPOSURE AFFECTS LOCOMOTOR BEHAVIOR IN FLIES 
Locomotor behavior of flies treated with 5 mM rotenone for 9 days was quantified by 
negative geotaxis assay and the DAM system. In both assays, the treated flies 
showed reduced locomotor ability in comparison to untreated flies (Fig. 35 A&B). 
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Figure 35: Rotenone induced locomotor deficits in Drosophila. A. Negative geotaxis assay of flies treated with 
5 mM rotenone (+Rotenone) and control flies (-Rotenone) for 9 days, n = 20 flies per group. (B) Locomotor 
activity assay measured using the DAM system, n = 16 flies per group. 
 
3.4.3 EFFECT OF ROTENONE ON FLIES DEPENDS ON EXPOSURE TIME 
Chronic exposure of Drosophila to rotenone induced locomotor deficits and 
dopaminergic neurodegeneration (Coulom and Birman, 2004). In this study the 
symptoms of locomotor impairment induced by rotenone were observed after 9 days 
of exposure as shown in (Fig. 35). There was no obvious locomotor deficit observed 
in flies treated with 5 mM rotenone for 3 days. The phenotype was quantified by 
climbing ability (Fig. 36) and physical observation.  
 
3 Results  
 
82 
 
 
Figure 36: Rotenone effects depend on 
exposure time. Negative geotaxis 
assay of 3 days old male flies treated 
with rotenone (+Rotenone) and control 
flies (-Rotenone) for 3 days. Note: all 
flies showed the normal climbing ability, 
n = 20 flies per group. 
 
3.4.4 GENE PROFILING ANALYSIS AT PRESYMPTOMATIC STAGES OF 
INDUCED PARKINSON-LIKE PHENOTYPES 
This study was chosen to elucidate the molecular changes taking place in DA 
neurons, the most affected cells in PD patients, of presymptomatic flies (after 3 days 
of rotenone treatment). I chose this time-point because it has been shown in previous 
studies that the motor impairment and DA neuron loss begins after chronic exposure 
with rotenone for few days and that the symptomatic phase starts after the majority of 
DA cells already died (Coulom and Birman, 2004, Bayersdorfer et al., 2010). Thus, 
the time chosen ensures that the initial manifestation of PD, when neuronal 
dysfunction due to rotenone pathology starts or develops, while DA neurons are not 
yet lost. Consequently, I performed the whole transcriptome analysis with RNA 
isolated specifically from DA neurons at this stage.  
There are numerous DA neurons scattered throughout the adult fly brain but some 
form specific clusters. Six major DA clusters have been identified (Fig. 37A-B) that 
project to the specific regions such as mb and cc (Nassel and Elekes, 1992, Tanaka 
et al., 2008, Mao and Davis, 2009). 
Figures 37A’&B’ show the anterior and posterior views of adult brains, from which the 
DA neurons were dissociated. The DA neurons were sorted by biotinylated anti-
mouse-CD8 antibody coated magnetic Streptavidin T1 Dynabeads. As a result, the 
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magnetic beads bound to the mCD8::GFP expressing cells only i.e. DA neurons (Fig. 
38A-D). 
 
 
 
Figure 37: DA neurons in the adult brain of Drosophila as visualized with TH-GAL4>20xUAS-mCD8::GFP. (A, A’) 
Anterior view. (B, B’) Posterior view. (A, B) Schematic diagram of (A’, B’) designating the name and location of 
TH-GAL4 expressing cell clusters in the brain. Circles symbolize cell bodies. PAL: Protocerebral anterior lateral, 
PPL1: Protocerebral posterior lateral 1 (inferior), PPL2: Protocerebral posterior lateral 2 (superior), PPM (1/2, 3): 
Protocerebral posterior medial 1/2 and 3, respectively. Cell cluster nomenclature after (Nassel and Elekes, 1992, 
Mao and Davis, 2009). (A’, B’) Anti-GFP staining (green) showing cell bodies and processes of TH-GAL4 
expressing cells. The brain was counterstained with an anti-nc82 antibody (red) for neuropils. Scale bars: 20 µm. 
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Figure 38: Magnetic beads sorted DA neurons. (A) The purified GFP positive DA neurons sorted with magnetic 
beads from adult TH-GAL4>UAS-mCD8::GFP brains. (B) Single GFP positive neuron (green), (C) its nucleus 
stained with DAPI (blue). (D) A composite image of B and C plus differential interference contrast (DIC), note: the 
cell captured with the beads. 
 
3.4.4.1 ROTENONE INDUCES GENE EXPRESSION CHANGES 
While flies treated with 5 mM rotenone for three days appear to move normally (see 
Fig.36), 765 genes were up-regulated and 357 genes were down-regulated relative to 
DA neurons isolated from untreated animals. Analysis of differentially expressed 
genes was performed using the Acuity 4.0 program whereby fold change of >1.5 of 
the mean signal intensity of a specific gene in at least 2 arrays out of three was 
considered as upregulated and fold change < 0.67 as downregulated. A complete list 
of the differentially expressed genes is available in appendix 2, Table A2 & A3. To 
further filter and identify relevant regulated genes in the two lists, I used the online 
database DAVID (http://david.abcc.ncifcrf.gov/), which implements the Gene 
Ontology (GO) terms that associate gene products with biological processes, 
molecular functions and cellular components. Normally, the program gives several 
clusters of the overrepresented GO terms containing redundant genes. After removal 
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of redundant genes, a list of 381 upregulated genes was generated and further 
clustered into 12 relevant GO terms (referred to as functional categories hereafter). 
Among those transcripts whose levels were increased in rotenone treated flies were 
many synapse and protein synthesis related genes. A comprehensive functional 
categorization revealed that those genes with functions related to signal transduction 
and cell-cell signaling were changed with the highest frequency (90 genes), followed 
by cellular transport and extracellular matrix (87 genes), transcription or translation 
(58 genes), development (29 genes) and metabolism (28 genes). Other important 
categories are related to stress response (14 genes), regulation of apoptosis (13 
genes), protein folding (12 genes) and aging (10 genes) (Fig. 39). This trend might 
support neuronal viability or the defense mode response towards a mild toxic insult 
given by rotenone. 
 
Figure 39: Functional categories of genes upregulated by rotenone. Given are the numbers of genes whose 
expression levels were increased during rotenone treatment in 3 days old male flies for three days. Clustering 
was achieved by DAVID and further manually sorted in 12 Gene Ontology categories after removal of 
duplications. 
 
Likewise, a list of 176 downregulated genes was generated and clustered into 9 
relevant functional categories (Fig. 40). 
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Figure 40: Functional categories of genes downregulated by rotenone. Given is the number of genes whose 
expression levels were decreased during rotenone treatment in 3 days old male flies for three days. Clustering 
was achieved by DAVID and further manually sorted in 9 Gene Ontology categories after removal of duplications. 
 
Furthermore, the relevant clusters with high enrichment score and p < 0.05 and 
KEGG_pathways filtered by DAVID were selected and listed as shown in Table 7. 
For the sake of simplicity each of these pathways will be described separately below, 
while the clusters will be treated in one section. 
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Table 7: Enriched functional categories for genes differentially regulated by rotenone 
Database identifier Functional category  
(Enriched GO terms) 
Number of 
changed genes 
p-value 
<0.05 
Upregulated genes 
   
GO:0032535 Regulation of cell size/Neurogenesis 13 0.022 
GO:0042981 Apoptosis 10 0.030 
GO:0007568 Aging 10 0.030 
KEGG_PATHWAY MAPK signaling pathway 6  
 
   
KEGG_PATHWAY 
KEGG_PATHWAY 
mTOR signaling pathway 
TGF-beta signaling pathway 
4 
5 
 
SM00034 CLECT C-type 6 0.040 
GO:0007269 Cell-cell signaling/neurotransmitter 
secretion 
15 0.040 
GO:0000022 Motor activity 11 0.003 
GO:0046146 Tetrahydrobiopterin metabolic process 4 0.012 
Downregulated 
genes 
   
GO:0050877 Neurological system processes 20 0.014 
KEGG_PATHWAY Wnt signaling pathway 6  
GO:0010564 Regulation of cell cycle process 6 0.024 
GO:0009310 Amine catabolic process 4 0.040 
 
 
3.4.4.2 ROTENONE AFFECTS MAPK SIGNALING PATHWAY ASSOCIATED 
GENES 
Interestingly, even at this early stage of disease development rotenone affects 
signaling pathways associated with the pathology of neurodegenerative diseases. 
This includes among others, the mitogen-activated protein kinases (MAPK) that 
induce a variety of cellular functions such as gene expression, mitosis and apoptosis 
through the phoshorylation of specific serine and/or threonine residues of target 
proteins (Thomas and Huganir, 2004, Nagai et al., 2007).  
Six genes that were elevated by approximately 2-fold in rotenone treated flies (Table 
8) are associated with the MAPK signaling pathway. Three genes, Epidermal growth 
factor receptor (Egfr), Ras oncogen at 85D (Ras85D) and Ras GTPase activating 
protein 1 (RasGAP1) are depicted in the KEGG_PATHWAY map (Fig. 41).  
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Table 8: MAPK signaling pathway-associated genes upregulated by rotenone 
Gene name Symbol Mean  SEM 
Ras Oncogene at 85D Ras85D 2.184 ±0.145 
Epidermal growth factor receptor Egfr 1.837 ±0.025 
Ras GTPase activating protein 1 RasGAP1 1.892 ±0.042 
Rab14 Rab14 4.027 ±0.325 
Protein kinase at 92B Pk92B or DASK1 2.053 ±0.153 
Death associated protein kinase related Drak 1.966 ±0.060 
 
 
Figure 41: MAPK signaling pathway. Red stars indicate genes whose expression was affected by rotenone 
generated by KEGG_PATHWAY (http://david.abcc.ncifcrf.gov/). 
 
The three other genes were Death associated protein kinase related (Drak), Rab14 
and Protein kinase at 92B (Pk92) a.k.a DASK1. DASK1 is an ortholog of ASK1 
(Apoptosis signal regulating kinase 1) in mammals that is activated by various types 
of stress such as reactive oxygen species (ROS), endoplasmic reticulum stress, 
calcium influx, tumor necrosis factor, lipopolysaccharides and selectively activates 
JNK and p38 MAPK pathways reviewed in (Nagai et al., 2007). 
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3.4.4.3 ROTENONE AFFECTS TGF-β SIGNALING PATHWAY ASSOCIATED 
GENES 
The transforming growth factor beta (TGF-β) pathway is another signaling pathway, 
which was shown to be altered during early stages of PD phenotype development 
induced by rotenone in the flies. This pathway controls a plethora of cellular 
processes in both embryos and adult organisms such as cell growth, cell 
differentiation, apoptosis, cellular homeostasis and other cellular functions (Raftery 
and Sutherland, 1999, Bruce and Sapkota, 2012). Expression levels of SkpF, 
Daughters against dpp (Dad), Smad anchor for receptor activation (Sara) and Rho-
kinase A (rok) were altered during rotenone treatment (Table 9 and Fig. 42). 
 
Table 9: TGF-β signaling pathway-associated genes regulated by rotenone 
Gene name Symbol Mean  SEM 
SkpF skpF 2.261 ±0.005 
Daughters against dpp Dad 1.842 ±0.100 
Smad anchor for receptor activation Sara 1.364 ±0.095 
Rho-kinase A rok 1.335 ±0.060 
 
3.4.4.4 ROTENONE AFFECTS mTOR SIGNALING PATHWAY ASSOCIATED 
GENES 
Another signaling pathway whose genes were altered during rotenone treatment was 
the mTOR (mammalian target of rapamycin) pathway. This is a serine/threonine 
protein kinase that regulates cell proliferation, cell motility, cell survival, protein 
synthesis and transcription (Hay and Sonenberg, 2004, Lieberthal and Levine, 2012). 
In addition few important genes, which are involved in mTOR pathway were 
differentially regulated in rotenone treated flies. It includes, target of rapamycin (Tor), 
Akt1, and Eukaryotic initiation factor 4B (elF4B) (Table 10 & Fig. 43). 
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Figure 42: TGF-β signaling pathway. Red stars indicate genes whose expression was affected by rotenone 
generated by KEGG_PATHWAY (http://david.abcc.ncifcrf.gov/). 
 
Table 10: mTOR signaling pathway-associated genes regulated by rotenone 
Gene name Symbol Mean  SEM 
Eukaryotic initiation factor 4B elF-4B 1.870 ±0.185 
Akt1 Akt1 1.409 ±0.110 
Target of rapamycin Tor 2.228 ±0.016 
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Figure 43: mTOR signaling pathway. Red stars indicate genes whose expression was affected by rotenone 
generated by KEGG_PATHWAY (http://david.abcc.ncifcrf.gov/). 
 
3.4.4.5 ROTENONE AFFECTS Wnt SIGNALING PATHWAY ASSOCIATED GENES 
Wnt signaling was also distinctively regulated. Five genes depicted in Figure 44 by 
KEGG_PATHWAY and listed in Table 11 were downregulated while one gene was 
upregulated. 
Table 11: Wnt signaling pathway-associated genes regulated by rotenone 
Gene name Symbol Mean  SEM 
skpA skpA 0.133 0.068 
Calcineurin A1 CanA1 0.828 0.139 
Smad on X smox 0.545 0.035 
Shaggy sgg 0.665 0.229 
CG32568 CG32568 0.070 0.084 
Cyclin D CycD 1.546 0.033 
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Figure 44: Wnt signaling pathway. Red stars indicate genes whose expression was affected by rotenone; generated by KEGG_PATHWAY (http://david.abcc.ncifcrf.gov/).
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3.4.4.6 ROTENONE AFFECTS MULTIPLE CELLULAR AND BIOLOGICAL 
PROCESSES 
Shown in Table 7 are assorted sets of differentially regulated genes from rotenone 
treated flies with significantly (p < 0.05) and highly enriched GO terms provided by 
DAVID. Most of these groups are connected to cell fate through neurogenesis, 
regulation of apoptosis, aging and regulation of cell cycle processes. Other relevant 
functional categories include neurotransmitter secretion/cell-cell signaling, stress 
response and oxidative phosphorylation, motor activity, amine metabolism, c-type 
lectins, and neurological processes (Fig. 45 & 46).  
Apoptosis and aging are hallmarks of neurodegeneration. Surprisingly, even at this 
early stage of PD development, rotenone induced changes in genes involved in these 
processes. Among others it includes Death associated molecule related to Mch2 
(Damm), Death caspase 1 (Dcp-1), Bax Inhibitor 1(BI-1), Thioredoxin peroxidase 2 
(Jafrac2), thread (th), Programmed cell death 5 (PDCD-5), Hsp60D, Outsiders (out) 
and Sox box protein 15 (sox15). Relative expression changes of these genes are 
shown in Fig. 45 A & B.  
Morover, significant functional categories whose genes were differentially regulated 
were neurogenesis and neurotransmitter secretion/cell-cell signaling. Because it is a 
long list of about 26 genes, the full names of these genes are only given in the figure 
legend (Fig. 45 C & D). The expression levels of the genes involved in stress 
response and oxidative phosphorylation processes were also altered by rotenone 
(Fig. 45E). Among seven altered genes, three were cytochrome P450 coding genes: 
Cyp6a2, Cyp12a5, which were upregulated whereas Cyp12a4 was downregulated. 
Peroxiredoxin 2540-2 (Prx2540-2), and Su(TpI) are other stress response genes that 
were upregulated.  
Furthermore, seven genes involved in motor activity/behavior were differentially 
expressed. Surprisingly, Tau was the highest upregulated gene in all categories. Its 
expression level was increased by 18 fold. Other genes that fall under this functional 
category were: Dynein heavy chain at 93AB (Dhc93AB), Dynein light chain 90F 
(Dlc90F) Osm-1, Chromosome bows (chb), Jaguar (jar), and Calmodulin (cam). 
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Expression of the two genes Cryptochrome (cry) and Moladietz (mol) was repressed 
(Fig. 46F).  
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Figure 45: Gene expression pattern changes in cellular processes affected by rotenone. Functional categories 
overrepresented in the lists of genes differentially expressed in rotenone treated flies identified by DAVID 
(http://david.abcc.ncifcrf.gov/), (Table 7, p < 0.05). (A) Fold changes for genes in regulation of apoptosis (B) Aging 
(C) Neurogenesis (D) Neurotransmitter secretion/cell-cell signaling (E) Stress response and (F) Motor activity. 
Error bars represent SEM. Btk29A (Btk family kinase at 29A), CycD (Cyclin D), chico, sh (Shaker), Tor (target of 
rapamycin), Wnt5 (Wnt oncogene analog 5), gek (Genghis khan), rut (Rutabaga), l(2)NC136 (lethal (2) NC136), 
wcd (wicked), Ephrin, RfC4 (Replication factor c subunit 4), l(2)35Bg (lethal (2) 35 Bg, RanGAP (Ran GTPase 
activating protein), HipHop (HP1-HOAP-interacting protein), Csp (Cysteine string protein), Fas2 (Fasciclin2), Frq1 
(Frequenin 1), Hsc70-4 (Heat shock protein cognate 4), Sap47 (Synapse associated protein 47kD), Syx1A 
(Syntaxin 1A), EndoA (Endophilin A), Usnp (Ubisnap), clumsy, and MstProx. 
 
Similarly, there was a significant differential expression of four genes involved in 
dopamine and other catecholamine metabolism. These include punch (pu), purple 
(pr), Sepiapterin reductase (Sptr) and Dopamine N acetyltransferase (dat) (Fig. 46A). 
Another functional category, which was highly enriched in GO terms provided by 
DAVID, was c-type lectin (carbohydrate binding). Relative expression levels of four 
genes were increased. These genes were; lectin-46Cb, CG14500, C-type lectin 27kD 
(Clect27) and Uninflatable (uif) (Fig. 46B).  
Regulation of cell cycle and neurological processes were the other enriched 
functional categories. The expression levels of the genes controlling these processes 
were repressed. Some of these genes such as Dat, CanA1, cry, sgg and mol are 
already described in other categories above. Others include; 14-3-3 epsilon, 
Darkener of apricot (Doa), Odorant-binding protein 44a (Obp44a), Guanylyl cyclase 
alpha-subunit at 99B (Gycalpha 99B), Gustatory receptor 39b (Gr39b), Gustatory 
receptor 59e (Gr59e), Gustatory receptor 93a (Gr93a), Microtubule-associated 
protein futsch (futsch), Nicotinamide mononucleotide adenylytransferase (Nmnat), 
Odorant binding protein 51a (Obp51a), Rhodopsin 2 (Rh2), Syntaxin 5 (Syx5), 
Crinkled (ck), Kurtz (krz), orange (or), SkpA associated protein (Skap), skpA, fascetto 
(feo), four way stop (fws), and missing oocyte (mio) (Fig. 46C & D). In addition, three 
immune response genes were more than 2 fold upregulated. These genes were 
Peptidoglycan recognition protein LA (PGRP-LA), Drosomycin like 4 (Drsl4) and 
Immune induced molecule 1 (Im1) (Fig. 46C). 
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Figure 46: Gene expression pattern changes in cellular processes affected by rotenone. Functional categories 
overrepresented in the lists of genes differentially expressed in rotenone treated flies identified by DAVID 
(http://david.abcc.ncifcrf.gov/), (Table 7, p < 0.05). Fold changes for genes in regulation of (A) Amine metabolism, 
(B) c- type lectins and (C) Neurological processes, (D) Regulation of cell cycle processes (E) Immune response. 
Error bars represents SEM. 
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3.5 VALIDATION OF MICROARRAY DATA BY qRT-PCR 
Quantitative Real Time PCR is one of the methods that are used to validate the 
accuracy of microarray data. The qRT-PCR was performed on magnetic sorted DA 
neurons from the 3 control samples and 3 rotenone treated samples. The total RNA 
samples are the ones, which were used for the microarray analysis. From the 
microarray analysis every gene that was deregulated seems to be important and 
relevant and that makes it hard to choose the genes for further analysis. Given the 
fact that pathway analysis is expected to provide more informative data than single 
gene analysis; (Ohnuki et al., 2010; pers. comm. K. Kallsen, FZB-Kiel), I chose the 
four deregulated pathways for qRT-PCR. For a respective pathway, a target gene, a 
key regulator or a key ligand was selected for analysis. For the MAPK/EGFR 
signaling pathway, a ligand spitz was chosen. Armadillo a homology of mammalian 
β-catenin, is a key regulatory component of Wnt signaling pathway. In case of TGFR-
β and mTor signaling pathways, Dad and Ash2 target genes, respectively, were 
selected for qRT-PCR. In addition, three genes that represent three functional 
categories were chosen. These genes include; l(2)NC136 that represents the 
neurogenesis category, dat represents genes involved in catecholamine metabolism 
and Calmodulin for motor activity category. The fold differences of relative gene 
expression in control versus rotenone treated samples were determine by the method 
described in (Pfaffl, 2001). This method takes into consideration the efficiencies of all 
the primers including the efficiency of the reference gene. The results from qRT-PCR 
experiments largely confirmed the results from the microarray (Fig. 47). However, I 
also observed some variability between samples particularly for Ash2 gene (data not 
shown). 
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Figure 47: Validation of microarray data by qRT-PCR. (A-E) show the fold change in expression of genes 
selected for qRT-PCR experiments from three control samples versus three rotenone treated samples. (A) Shows 
increased expression of spitz gene, a key ligand of EGFR signaling pathway in the rotenone group while (B) 
shows the decreased expression of armadillo, a key regulatory component of Wnt signaling pathway. The 
increased expression of Dad, a target gene for TGFR-β signaling pathway is shown in (C). (D) shows decreased 
expression of dat and upregulation of lethal2NC136 and Calmodulin. Dad: Daughters against dpp, dat: Dopamine 
N acetyltransferase, EGFR: Epidermal Growth Factor Receptor, TGFR-β: Transforming Growth Factor Receptor-
β. *p < 0.05, **p < 0.01, Student’s t-test, n = 3 per group and error bars represent SEM. 
 
3.6 MODULATION OF INTRACELLULAR SIGNALING IN DOPAMINE 
PRODUCING NEURONS 
I have used Drosophila to test whether the increase or decrease of second 
messengers namely, cAMP and Ca2+ may be beneficial during rotenone-induced DA 
neuronal cell death. To obtain these transgenes, UAS-M1D1, UAS-M4D1, and UAS-
M5Dbar were overexpressed in DA neurons by TH-GAL4 driver. As explained earlier 
in section 3.3.1 the UAS-M1D1 allows to induce increase of Ca2+ levels. Progenies 
from TH-GAL4 x UAS-M1D1 referred hereafter as, TH>M1D1 were subjected to four 
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different experimental conditions. First set of TH>M1D1, 3 day old male flies, were 
chronically fed 0.5 mM rotenone in 10 % glucose to induce the Parkinsonism 
phenotype. A second set of these flies was fed 1 mM CNO in 10 % glucose to 
activate the DREADD receptors. The third set of flies was fed CNO and rotenone and 
lastly, another set were fed glucose only as an experimental condition control. 
Concurrently, F1 flies from TH-GAL4 x w1118, (TH> w1118) were used as control group. 
For the period of 10 days treatment, no difference was observed in climbing ability 
measured by negative geotaxis assay for experimental and control flies when fed 
with glucose or CNO alone (Fig. 48 A & B). A dramatic climbing disability was 
observed in day 7 and 10 in those flies fed with rotenone alone and in day 7 for CNO 
+ rotenone. The effect was similar in both TH>M1D1 and TH> w1118 flies whereby the 
majority of the flies did not climb above the height of 6 cm in 20 sec (Fig.48 C & D). 
The same effect was observed in TH>M4D1 flies which have decreased cAMP 
levels. For UAS-M5Dbar, which increases cAMP levels, F1 flies fed with CNO alone 
showed a decreased climbing ability on day 7 and 10, red line, (Fig. 48 B) compared 
to other tested flies. The effect was stronger for the flies fed with rotenone only and 
CNO + rotenone (Fig. 48 C&D). These flies seem to be more sensitive to CNO and 
rotenone compared to other experimental lines and the control line. Generally, these 
results indicate that the modulation of second messengers either enhance the toxicity 
of rotenone, or alternatively, CNO gives some stress to DA neurons as exemplified 
by the TH>M5Dbar and TH> w1118 flies. 
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Figure 48: Overexpression of DREADD receptors to DA neurons did not rescue the climbing disability induced by 
rotenone. Climbing ability test measured at 3, 7 and 10 day, respectively. (A) Shows all genotypes tested fed with 
10 % glucose alone, (B) 1 mM CNO in 10 % glucose, (C) 0.5 mM rotenone in 10 % glucose and (D) CNO and 
rotenone.
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4 DISCUSSION 
Dopamine is used as an intercellular messenger in both vertebrates and 
invertebrates (Cottrell, 1967). It is produced in cells of the nervous system, but also 
by those outside the CNS. The dopaminergic system comprises dopamine itself and 
all pathways and mechanisms required to synthesize and inactivate it, as well as of 
the specific dopamine receptors. Dopaminergic systems in mammals control several 
important physiological functions ranging from voluntary movement and reward to 
general aspects of hormonal regulation and the regulation of blood pressure to name 
only few. Surprisingly, the dopaminergic system in Drosophila is not well 
characterized. Emerging studies from the last decade have begun to elucidate the 
spatial expression patterns and functional roles of this system (Scholz et al., 2000, 
Strauss, 2002, Kim et al., 2003, Draper et al., 2007, Kim et al., 2007, Lebestky et al., 
2009, Selcho et al., 2009, Inagaki et al., 2012a). Taking advantage of genetic tools 
available in Drosophila, such as the GAL4/UAS system (Brand and Perrimon, 1993), 
this study analyzed the distribution and physiological functions of the dopaminergic 
system in both CNS and digestive tract in detail. The system plays a central role in a 
number of important medical conditions, including Schizophrenia, Attention Deficit 
Hyperactivity Disorder, drug addiction and PD. For PD, despite of extensive studies, 
there is currently no cure or treatment that can stop disease progression and the 
precise pathologic mechanisms remain unclear. The fruit fly Drosophila shares many 
important molecular components with human, in particular the Drosophila genome 
encodes orthologs of the currently identified PD-related genes (PARK genes): 
LRRK2/Dardarin, parkin, PINK1, Omi/HtrA2, DJ-1, UCH-L1, GIGYF2, PLA2G6, and 
GBA, which makes it a suitable model to study PD. To gain insight into molecular 
mechanisms underlying PD pathogenesis, I performed trancriptome studies during 
the pre-symptomatic stage of rotenone induced Parkinsonism. In addition, I used a 
new approach that combines genetic and pharmacological manipulations 
(pharmocogenetic) to control neuronal signaling in Drosophila. In this, I tested 
whether modulation of intracellular signaling by overexpressing DREADD (Designer 
Receptors Exclusively Activated by Designer Drugs) receptors on DA-producing 
neurons during rotenone treatment might prevent development of the disease 
phenotype. 
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4.1 DOPAMINE RECEPTOR EXPRESSION IN THE BRAIN AND THE DIGESTIVE 
TRACT 
The characterization of the dopaminergic system in normal flies to be able to 
manipulate this system was a basis of this study. The expression patterns of four 
dopamine receptors DopR (CG9652), DopR2 (CG18741), DopEcR (CG18318) and 
D2R (CG33517) were analyzed. The GAL4/UAS system was employed (Brand and 
Perrimon, 1993) to express the green fluorescent protein (GFP) under transcriptional 
control of receptor coding gene specific promoters. The analysis was carried out in 
both larval and adult flies focusing on the central nervous system and the digestive 
tract. The detailed localization of specific cell nuclei and structures were analyzed 
microscopically with tissue stained with specific antibodies. The results generated in 
this study give a good impression about the localization and provide insights into the 
roles played by these receptors in controlling different physiological functions and 
behaviors in the fruit fly. 
Strikingly, this study showed clearly that two receptors, DopR and DopR2, are 
localized in l-LNvs, a subset of clock neurons that expresses the neuropeptide PDF 
(pigment dispersing factor). A previous transcriptomic study (Shang et al., 2011) 
showed that dopamine receptor mRNAs are present in purified l-LNvs neurons. 
Moreover, Renn and co-authors (Renn et al., 1999) reported earlier that there are ten 
l-LNvs (five on each side of the brain) that have related neurons nearby, the eight 
small LNvs (s-LNvs). Both l-LNvs and s-LNvs express the neuropeptide PDF. 
Neuropeptide PDF is a key transmitter in the circadian clock in Drosophila. Out of the 
75 bilaterally organized pairs of circadian neurons, only l-LNvs and s-LNvs secrete 
PDF (Wulbeck et al., 2008, Choi et al., 2012). This result indicates the involvement of 
DopR and DopR2 receptors in controlling circadian rhythms in Drosophila 
melanogaster. 
More importantly, this part of the study demonstrated the existence of DopR in 
dopamine producing cells, which suggests an auto-receptor function of this receptor 
at least in this subset of dopamine producing cells. This was approached with anti 
DDC (dopamine decarboxylase) antibodies and confirmed with a semi-quantitative 
reverse transcriptase analysis using sorted DA neurons. Since DDC encodes an 
enzyme catalyzing the biosynthesis of dopamine from its precursor L-DOPA, the 
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dopaminergic neurons will express DDC. To the best of my knowledge no evidence 
has been reported for the existence of dopamine autoreceptor in Drosophila. In 
mammals it is known that D2 receptors have a presynaptic location that inhibit 
neuronal firing, DA synthesis and release through negative feedback mechanisms in 
response to changes in extracellular neurotransmitter levels (Civelli et al., 1991, De 
Mei et al., 2009, Beaulieu and Gainetdinov, 2011).  
The expression pattern of dopamine receptors in the digestive tract was also very 
striking. Notably, three dopamine receptors were expressed differently in the major 
cells present in the midgut. The DopR was found to be expressed in the mid-gut 
secretory enteroendocrine cells, while DopR2 was found to be expressed in the 
absorptive Enterocytes and D2R was expressed in the intestinal stem cells and 
enteroblasts. For the D2R, this study confirmed previous findings (Draper et al., 
2007, El-Kholy PhD thesis, 2010) who reported the expression of D2R in the cell 
bodies located in the posterior midgut. In addition, this study showed that activation 
of DopR2 receptor localized in enterocytes triggered the action of PLC-β that leads to 
mobilization of intracellular Ca2+ in vivo. The concentration of dopamine agonist was 
within a pharmacologically relevant range (10-1M to 10-9M). This strongly supports the 
hypothesis that DopR2 receptors are present in enterocytes and that they play an 
important role in changing the physiological state of these cells. The wide distribution 
of dopamine receptors in neurons and non-neuronal tissues given by this study 
indicate that these receptors play various major physiological and behavioral roles in 
Drosophila melanogaster. Further studies should focus on dissecting the functions of 
the specific cell discussed above to gain a better knowledge of their functions with 
respect to dopamine signaling. 
 
4.2 LOCOMOTOR ACTIVITY PATTERN 
With the initial effort of dissecting the function of dopamine receptors in Drosophila 
melanogaster, I silenced the expression of endogenous DopRs mRNA by an RNAi 
approach. Flies carrying either the UAS-ds-DopR, UAS-ds-DopR2 or UAS-ds-D2R 
transgenes were crossed to the n-syb-Gal4 driver, which drives expression in all 
neurons. The daily locomotor activity was monitored by the DAM system. Results 
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obtained in this study showed that only D2R-RNAi flies showed substantially reduced 
locomotor activity counts per 24 hrs in comparison to control flies. This result 
suggests that D2R is necessary for controlling locomotor activity in Drosophila. This 
finding is consistent with previous RNAi studies (Draper et al., 2007) which showed 
that locomotor activity in Drosophila is regulated by D2-like receptor. Moreover, 
locomotor activity in flies reflects sleep-wake transitions. It has been shown that, 
dopamine controls this endogenously generated form of arousal through DopR (van 
Swinderen and Andretic, 2003). Further analysis of DopR receptor was carried out in 
this study by employing flies with a hypomorphic mutation in DopR, DopRf02676. 
DopRf02676 mutant flies showed a decreased activity pattern over a 24 hours period in 
comparison to control flies in LD. The phenotype was stronger in constant darkness 
(DD) conditions. Monitoring at one-hour intervals, DopRf02676 flies showed 
considerably decreased activity in comparison to control flies during the night phase, 
the phenotype, which was rescued by overexpression of PDF. These results are 
consistent with previous findings from Lebestky and colleagues who reported that a 
loss-of-function mutation in DopR leads to a decrease in sleep-wake arousal 
(Lebestky et al., 2009). My findings provided an additional strong evidence of the 
involvement of DopR in controlling sleep-wake behavior in this species. 
 
4.3 GENE EXPRESSION CHANGES INDICATE EARLY SIGNS OF 
NEURODEGENERATION IN A DROSOPHILA MODEL OF PARKINSON’S 
DISEASE 
This study provides a genome-wide transcriptional analysis of changes associated 
with neurodegeneration in a Drosophila model of PD at a time point preceding DA 
cell death. Parkinson’s disease in humans is a gradual progressive 
neurodegenerative disease that becomes clinically apparent after an estimated 70 % 
of vulnerable DA neurons in the Substantia nigra have already died (Fearnley and 
Lees, 1991). Moreover, molecular mechanisms underlying the degenerative process 
of these neurons remain elusive. Identifying the molecular pathways that contribute to 
the etiology of PD was the major aim of this study. The gene expression analysis 
carried out in this study is, to my knowledge, the first for rotenone-induced 
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Parkinsonism in Drosophila that was focused on DA neurons. Prior studies of gene 
expression in Drosophila models of neurodegenerative diseases have been limited to 
studies of homogenates of brain tissue (Scherzer et al., 2003, Shieh and Bonini, 
2011). In human brain tissues, the laser capture microdissection (LCM) technique 
has recently been employed for capturing only DA neurons for transcriptional profiling 
studies (Cantuti-Castelvetri et al., 2007, Simunovic et al., 2009, Simunovic et al., 
2010). As a major result of the current study, the power of cDNA microarray analysis 
in investigating this neurodegenerative disease revealed regulation of four major 
pathways in presymptomatic DA neurons; EGFR/MAPK, TGF-β, mTor and Wnt. 
The downregulation of Wnt signaling pathways due to mild rotenone treatment in 
young adult flies was apparent in this study as depicted in Fig. 44. The term ‘Wnt’ is 
derived from a combination of the Drosophila wingless (wg) and the mouse homolog 
Int-1 proteins (Rijsewijk et al., 1987, Nusse et al., 1991). For the canonical Wnt 
pathway, Wnt signal to β-catenin, named armadillo in Drosophila, which enters the 
nucleus and activates transcription of Wnt target genes. Wnt signaling is also 
executed independently of β-catenin, in what is referred to as the non-canonical 
pathways; these include the planar cell polarity pathway (PCP pathway) and the Wnt-
Ca2+ pathway. Wnt pathways are known to be involved in controlling diverse cellular 
processes including developing adult tissues including tissue differentiation, neuronal 
survival, axon extension, synapse formation and plasticity, neurotrophin transcription, 
neurogenesis and neuroprotection (Inestrosa and Arenas, 2010, Marchetti et al., 
2013). Wnt signaling pathways are conserved throughout the animal kingdom (Liang-
Wei, 2013). Moreover, deregulated Wnt signaling pathways are suggested to 
represent important pathomechanisms for a number of neurological conditions 
including Alzheimer’s disease, PD and Schizophrenia (Inestrosa and Toledo, 2008, 
Berwick and Harvey, 2012). Thus Wnt cascades can be considered essential for the 
central nervous system at all stages of life. Several studies have shown the 
involvement of Wnt signaling pathways in midbrain DA neuron development and 
hippocampal neurogenesis through both canonical and non-canonical Wnt signaling 
pathways. The canonical Wnt/β-catenin signaling appears to be a key mechanism in 
controlling DA neuronal fate decision from neuronal stem cells or progenitors in the 
midbrain during embryonic development (Tang et al., 2009, Alves dos Santos and 
Smidt, 2011, Blakely et al., 2011, Liang-Wei, 2013). Notably, both GSK3-β inhibition 
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and β-catenin stabilization increased commitment into DA neurons of neural 
precursors in the ventral midbrain (Castelo-Branco et al., 2004). Interestingly, current 
studies illustrated the emerging role of Wnts in the adult nervous system (Inestrosa 
and Arenas, 2010). Importantly, current evidence points to dysregulation of Wnt 
signaling pathways associated with PD pathophysiology. Dysfunction of Wnt 
pathways signaling was shown to play a causal role in the pathophysiology of 
nigrostriatal DA neurons and in PD experimental models (Inestrosa and Arenas, 
2010, Berwick and Harvey, 2012). Cantuti-Castelverti and colleagues reported the 
downregulation of β-catenin in DA neurons of the Substantia nigra in PD patients 
(Cantuti-Castelvetri et al., 2007). Interestingly, emerging evidences in animal models 
of PD indicate that proteins encoded by PARK genes can modify Wnt pathways 
(Berwick and Harvey, 2012). In particular, PARK8, encoding LRRK2 (leucine-rich 
repeat kinase 2), which constitute a major cause of familial PD (Zimprich et al., 2004) 
was linked to Wnt signaling (Berwick and Harvey, 2012, 2013). On the other hand, 
Parkin, an E3 ubiquitin ligase linked to familial PD, regulated β-catenin protein levels 
in vivo (Rawal et al., 2009). In MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) 
mouse models of PD, contribution of Wnt/β-catenin signaling and interaction with 
reactive astrocytes in survival and protection of DA neurons (L'Episcopo et al., 
2011a, Francesca et al., 2011b, Marchetti et al., 2013) has been reported. Moreover, 
gene expression profiling in progressively MPTP-lesioned macaques indicated 
downregulation of β-catenin and dysregulation of key components of Wnt signaling 
(Ohnuki et al., 2010). My findings are consistent with the above findings suggesting a 
role of Wnt signaling pathways in PD development. The fact that Wnt signaling 
pathways have a crucial role for DA neuronal survival, neurogenesis and repair may 
be attributed to the downregulation of these pathways observed at pre-symptomatic 
stages indicative for the early signs of neurodegeneration. Hence, these results 
indicate that manipulation of this pathway may be a therapeutic target for treatment of 
PD. 
MAPK signal transduction pathways are evolutionarily conserved in eukaryotic cells 
and transduce signals in response to a variety of extracellular stimuli. MAPK is 
activated by serine and threonine phosphorylation catalyzed by a family of the dual-
specificity protein kinase MAP2K. MAP2K is in turn activated by phosphorylation 
mediated by MAP3K. Cascades of MAPKs mediate responses such as cell 
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proliferation, differentiation, survival, and death. There are multiple MAPKs in 
eukaryotes. Three subgroups of the MAPK superfamily have been identified in 
mammals: ERK, JNK, and p38 (Kim and Choi, 2010). Drosophila melanogaster 
expresses all three subgroups of MAPKs: Rl (Rolled; ERK homolog), dJNK/Basket 
(Drosophila homolog of JNK), and dp38a and dp38b (Drosophila homologs of p38) 
(Tateno et al., 2000, Takeda et al., 2008). Deviation from the strict control of MAPK 
signaling pathways has been implicated in the development of many human diseases 
including Alzheimer’s, PD and various types of cancers (Kim and Choi, 2010). 
Strikingly, even at this early stage of disease development, expression of four genes 
associated with the MAPK signaling pathway was elevated by approximately 2-fold in 
rotenone treated flies. These genes are Ras oncogene at 85D (Ras85D), Rab14 and 
Ras GTPase activating protein 1 (RasGAP1), which are all Ras proteins. All Ras 
protein family members belong to a class of protein called small GTPase, which are 
involved in cellular signal transduction. Another gene whose expression was 
increased was a receptor tyrosine kinase, namely the Epidermal growth factor 
receptor (Egfr). Epidermal growth factor receptor signaling plays essential roles in 
development and maintenance of adult tissues including the brain by regulating cell 
proliferation, growth, differentiation, migration and survival (Wong and Guillaud, 2004, 
Wieduwilt and Moasser, 2008). Transgenic mice lacking the EGFR develop 
neurodegenerative diseases and die within the first month after birth (Wong and 
Guillaud, 2004). EGFR has been shown to be expressed in the subventricular zone 
only in adult rats and in hippocampal neurons (Tucker et al., 1993, Cameron et al., 
1998). In neuronal culture models, EGF stimulated neurite outgrowth, increased 
dopamine uptake and enhanced long-term survival in cultured dopaminergic neurons 
(Yamada et al., 1997). Ectopic activation of ERK1/2 in rotenone rat models of PD 
protected dopamine neurons from cell death (Hsuan et al., 2006). Several evidences 
from mammalian studies indicate the involvement of MAPK cascade through 
activation of ERK in learning and memory (Thomas and Huganir, 2004). Moreover, 
reduced EGFR signaling in the CNS leads to impairment of olfactory learning in 
Drosophila larvae (Rahn et al., 2013). The increased expression of EGFR and Ras 
protein coding genes (Ras/MAPK or EGFR signaling) in rotenone induced 
Parkinsonism in Drosophila suggests that these neurons launch defensive 
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mechanisms due to stress given by rotenone. These findings support the view that 
EGFR signaling promotes cell survival also in the vulnerable DA neurons. 
TGF-β controls a plethora of cellular processes in both embryos and adult organisms 
such as cell growth, cell differentiation, apoptosis, cellular homeostasis and other 
cellular functions (Raftery and Sutherland, 1999, Bruce and Sapkota, 2012). When 
components of the TGF-β pathway are compromised, numerous human diseases, 
including cancer and neurodegeneration result (Katsuno et al., 2011, Bruce and 
Sapkota, 2012). There is growing support for a role of TGF-β signaling in neuronal 
maintenance function and degeneration (Koh et al., 2004, Andrews et al., 2006, 
Tesseur et al., 2006, Katsuno et al., 2011).  
As most of the other pathways mentioned above, the target of rapamycin (TOR) 
signaling pathway is evolutionary conserved. It regulates cell proliferation, cell 
motility, cell survival, protein synthesis and transcription (Hay and Sonenberg, 2004, 
Lieberthal and Levine, 2012). TOR is a serine/threonine protein kinase belonging to 
the phosphoinositide 3-kinase (PI3K) family. The major regulatory inputs for TOR are 
nutrients, growth factors, energy and stress. Mammalian TOR (mTOR) is implicated 
in diseases such as cancer, metabolic diseases and ageing (Zoncu et al., 2012). This 
pathway was also upregulated in flies treated with rotenone. This included the major 
key players of the pathway, TOR, Akt and the effector eIF4B, indicative for induction 
of survival mechanisms by increasing the rate of protein synthesis.  
Collectively, the expression of several genes involved in the MAPK/EGFR, TGF-β 
and TOR signaling pathways were increased. The upregulation of these growth 
factors and stress activated pathways signify the neuroprotective role to DA neurons 
to counteract the stress and presumably the first phases of cell death. The 
downregulation of Wnt signaling pathways indicate early signs of neurodegeneration. 
Thus, this study has given insights for further investigation of these pathways that 
may help to identify potential targets for neuroprotective measures for PD at pre-
clinical stages. 
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4.4 PREVENTION OF THE DISEASE PHENOTYPE INDUCED BY ROTENONE 
I have used Drosophila to test whether the increase or decrease of second 
messengers namely, cAMP and Ca2+ may be beneficial during rotenone induced DA 
neuronal cell death. This was done by overexpressing DREADDs in DA neurons 
using the dopamine containing cell specific TH-GAL4 driver. DREADDs are modified 
muscarinic acetylcholine G-protein coupled receptors that are activated only by a 
synthetic ligand, namely by Clozapine-N-Oxide (CNO) (Armbruster et al., 2007). This 
is a new technology that combines genetic and pharmacology approaches to 
manipulate cellular signaling and control of behaviors (Nichols and Roth, 2009). The 
results indicated that neither decrease of cAMP nor increase of cAMP or of Ca2+ 
rescues the climbing disability phenotype elicited by rotenone. Conventional medical 
approaches for treatment of PD aim to replenish dopamine levels in the striatum. The 
classical pharmaceutical drug that is used to alleviate symptoms is L-DOPA, which 
has got debilitating side effects and often worsens the situation over time. There are 
several emerging alternative therapies including nicotine and caffeine. 
Epidemiological studies and animal models have begun to establish nicotine and 
caffeine as promising therapeutic candidates against PD (Chen et al., 2001, Ho, 
2002, Hart et al., 2009, Seidl and Potashkin, 2011). Some toxin-induced Drosophila 
models of PD to assay the beneficial effects of certain compounds have been 
reported (Coulom and Birman, 2004, Hosamani and Muralidhara, 2010, Jimenez-Del-
Rio et al., 2010). All the approaches performed above target the postsynaptic cells 
(dopamine and other receptors). I have carried out chronic exposure to rotenone of 
control flies and flies with reduced or increased levels of cAMP and increased level of 
Ca2+ targeting the dopamine producing cells (presynaptic cells) by overexpressing 
DREADD receptors. These receptors are predicted to mimic the dopamine release. 
In Drosophila the effect of rotenone becomes apparent after six to seven days of 
exposure (Coulom and Birman, 2004, Bayersdorfer et al., 2010). Rotenone acts as 
an inhibitor of mitochondrial respiratory complex I, leading to decrease in ATP levels, 
production of mitochondrial ROS and subsequent increase oxidative stress to DA 
neurons (Betarbet et al., 2000, Sherer et al., 2003), finally leading to activation of 
various cell death pathways (Gupta et al., 2008, Sonia Angeline et al., 2012). The 
overexpression of the M5Dbar, DREADD receptor that is positively coupled to AC 
and modulates the production of cAMP in DA neurons was predicted to mimic the 
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D1-like receptor signaling and hence control the locomotion behavior. Unexpectedly, 
results indicated that flies overexpressing the M5Dbar receptor had a lower 
performance as compared to control flies when treated with rotenone. One possible 
explanation could be that the cells are critically affected by oxidative stress from 
rotenone and they are not in a situation to cooperate for their own survival. They 
rather need help to run away from the oxidative stress such as antioxidants that will 
scavenge the free radicals and reduce their stress rather than involving themselves 
into the repairing or rescue mechanisms. Secondly, it might be due to increase of L-
type calcium channels triggered by cAMP signaling.  
Overexpression of the M1D1 receptor was predicted to mobilize Ca2+ from 
intracellular stores that will affect aspects of neuronal and muscle physiology. As for 
M5Dbar overexpression, results indicated that flies overexpressing the M1D1 
receptor had a lower performance as compared to control flies when treated with 
rotenone. Basal cytosolic Ca2+ levels are controlled by an efficient interplay of 
calcium transport system from both surface plasma membrane and on the membrane 
of intracellular compartments such as endoplasmic reticulum. Also cytosolic Ca2+ 
levels depend on the presence of a number of Ca2+ binding proteins, which integrate 
changes with the downstream effectors. Given the fact that oxidative stress from 
rotenone interferes with the performance of the cells, it might contribute to 
impairment of such orchestrated systemic calcium signaling. Studies from genetic 
interaction screens have shown that mechanisms of maintaining Ca2+ homeostasis in 
Drosophila are cell specific (Chorna and Hasan, 2012). Moreover, it has been 
suggested that the vulnerability of DA neurons in PD may be related to unusual 
calcium ion-channel activity in the affected neuronal population, with increased 
calcium influx into the cell triggering neuronal dysfunction and cell death (Gupta et 
al., 2008). Application of calcium antagonists targeting L-type calcium channels in PD 
models (MPTP, rotenone, and 6-hydroxydopamine) demonstrated survival of 
dopaminergic Substantia nigra neurons (Chan et al., 2007). Epidemiological studies 
demonstrated that patients taking dihydropyridine-type calcium antagonists have a 
reduced incidence of PD (Surmeier, 2007).  
Similarly, flies overexpressing M4D1 (TH>M4D1), showed a decreased climbing 
ability. The overexpression of M4D1 was predicted to mimic D2-like receptor 
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signaling by silencing neurons via decreasing AC activity and cAMP production and 
closing of membrane potassium channels via βγ-mediated effects (Neve et al., 2004, 
Beaulieu and Gainetdinov, 2011). Disruption of short term learning and memory 
behavior in flies overexpressing M4D1 in the mushroom bodies has been observed. 
Although the exact mechanism for this phenotype was not determined, it was 
postulated that the effect is likely to be either through the opening of potassium 
channels to produce hyper-polarization of the cell membrane or due to decrease in 
cAMP levels (pers. comm. CD Nichols, USA). 
Transgenic mouse studies with all three DREADD receptors have demonstrated the 
utility of the DREADD technology. In particular, mice expressing M5Dbar in the 
hippocampus showed both increases in hippocampal neuronal activity and locomotor 
behaviors and seizures in a dose dependent fashion (Alexander et al., 2009). Other 
studies showed influences on feeding behaviors (Krashes et al., 2011) and the 
sleep/wakefulness state (Sasaki et al., 2011). However, the utility of this technology 
in Drosophila is at an infancy stage (pers. comm. CR Nichols, USA). Therefore, 
interpretation of the results from this study should be taken cautiously. It is assumed 
that CNO represents a “biologically inert synthetic ligand” that selectively activates 
the muscarinic receptor-based DREADD. In contrast, it has been reported that CNO 
has cell membrane permeability effects and can undergo redox cycling with clozapine 
(CNO/CN). Therefore CNO is biologically active and its conversion products are 
capable of undermining DREADD effects due to production of ROS/oxidative stress 
(Ray et al., 2011). This supports my findings, as all flies including control group die 
after day seven, suggesting a strong oxidative stress to the cells. To gain better 
insight of utility of this technology in Drosophila, future studies should focus first on 
testing basic behaviors (without manipulation with other chemicals) and/or measuring 
activity of certain specific neurons (cellular level), before moving to behaviors 
(systemic level). Taking together, the results obtained from this study did not confer 
the neuroprotective mechanism to DA neurons. Instead they support the current 
favored mechanisms for DA neuronal death in sporadic PD: mitochondrial 
dysfunction, calcium imbalance and oxidative stress (Gupta et al., 2008, Whitworth, 
2011).  
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4.5 CONCLUSIONS AND OUTLOOK 
One of the major aims of this study was to elucidate the expression patterns of 
dopamine receptors in the CNS and periphery system particulary, the digestive tract. 
This study provides comprehensive knowledge about the spatial distribution of 
dopamine receptors in the CNS and digestive tracts of Drosophila melanogaster both 
in larvae and adults. These findings provide insights into the roles played by these 
receptors in controlling different physiological functions and behaviors in the fruit fly. 
Taken together, the Drosophila dopaminergic systems seem to control diverse 
functions at both cellular and systemic levels, developing and adult stages as it 
happens in mammals. Further studies should focus on dissecting the roles played by 
the identified structures and specific cells to get better insights of their roles in the 
fruit fly with respect to dopamine signaling. 
The second major aim of this stuy was to gain insight into the molecular mechanisms 
underlying PD pathogenesis, with a focus on pre-symptomatic stages of the disease. 
This study provides evidences that the outcome of various highly relevant signaling 
pathways is modified in the corresponding dopamine producing neurons. Amongst 
them are the Wnt-, MAPK/EGFR-, TGF-β-, and TOR-signaling pathways, which are 
known to be important for cell survival and/or cell death in the CNS. Further 
investigation of these pathways may provide new insights into the molecular events 
underlying pathogenesis and, hopefully, lead to the identification of new potential 
targets for neuroprotective measures for PD at pre-clinical stages. 
Lastly, this study aimed at finding an alternative way for protection of DA neurons 
during induction of Parkinsonism in Drosophila. Overexpression of DREADD 
receptors in DA-producing neurons did not prevent development of the disease 
phenotype induced by rotenone in the Drosophila model of PD. Based on the 
sensitivity and vulnerability of DA neurons and the complexicity of the employed 
pharmocogenetic approach at the behavioral level, future studies should focus first 
on measuring the levels and activities of the cAMP and Ca2+ at the cellular level to 
get better insights of their mechanisms before moving to behavioral level and further 
employ complex manipulations. 
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APPENDICES 
 
Appendix 1: Immunofluorescence of larval midgut cells. 
 
 
 
Fig A1 DopR is expressed in the Enteroendocrine cells (EEs). (A) Enhancement of GFP 
reporter for DopR-Gal4 expression in EEs by anti-GFP antibody (green). (B) Nc 82 positive 
cells (red). (C) Co-localization of fluorescent signals, yellow, and a DNA/nuclei marker, DAPI 
(blue). Scale bars: 20 µm 
 
 
 
Fig A2 D2R is not expressed in the Enteroendocrine cells (EEs). (A) Enhancement of 
GFP reporter for D2R-Gal4 expression in EEs by anti-GFP antibody (green). (B) Prospero 
positive cells (red). (C) No co-localization of fluorescent signals between green and red is 
seen. DNA/nuclei marker, DAPI (blue). Scale bars: 20 µm 
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Fig A3 D2R is not expressed in the Enteroendocrine cells (EEs). (A) Enhancement of 
GFP reporter for D2R-Gal4 expression in EEs by anti-GFP antibody (green). (B) Nc 82 
positive cells (red). (C) No co-localization of fluorescent signals between green and red is 
seen. DNA/nuclei marker, DAPI (blue). Scale bars: 20 µm 
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Table A2. List of upregulated genes upon rotenone treatment 
 
id Symbol Mean  SEM 
CG100435 CG100435 1,942 0.085 
CG10045 GstD1 1,869 0.025 
CG10059 MAGE 1,365 0.191 
CG10079 Egfr 1,837 0.025 
CG10107 velo 1,566 0.174 
CG10119 LamC 1,355 0.073 
CG10134 beat-Va 1,901 0.054 
CG10158 CG10158 1,858 0.113 
CG10215 Ercc1 1,731 0.012 
CG10243 Cyp6a19 1,084 0.291 
CG10261 aPKC 2,220 0.070 
CG10264 CG10264 1,335 0.120 
CG10281 TfIIFalpha 2,005 0.043 
CG10303 Osi4 2,121 0.089 
CG10332 CG10332 1,667 0.057 
CG10333 CG10333 1,355 0.444 
CG10379 mbc 1,910 0.193 
CG10419 Gem2 1,286 0.191 
CG10428 CG10428 1,502 0.076 
CG10474 CG10474 1,658 0.014 
CG10477 CG10477 1,770 0.172 
CG10489 Pole2 1,575 0.018 
CG1056 5-HT2 2,083 0.107 
CG10560 CG10560 2,709 0.372 
CG10572 Cdk8 1,849 0.206 
CG10575 Ppat-Dpck 1,359 0.066 
CG10581 CG10581 1,598 0.055 
CG10669 CG10669 1,588 0.116 
CG10686 tral 2,289 0.134 
CG10747 CG10747 2,280 0.073 
CG10772 Fur1 1,655 0.006 
CG1079 Fie 1,710 0.074 
CG10801 CG10801 1,488 0.022 
CG10811 eIF4G 1,157 0.292 
CG10822 CG10822 1,620 0.069 
CG10837 eIF-4B 1,870 0.186 
CG10845 CG10845 1,052 0.182 
CG10849 Sc2 1,104 0.151 
    
CG10895 lok 1,390 0.154 
CG10933 CG10933 1,867 0.070 
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CG10952 eag 0.992 0.256 
CG110270 CG110270 1,768 0.174 
CG11035 CG11035 1,766 0.013 
CG11061 GM130 1,751 0.077 
CG11071 mamo 1,915 0.058 
CG11091 CG11091 3,235 0.141 
CG11141 CG11141 2,231 0.114 
CG1115 CG1115 1,106 0.145 
CG11151 CG11151 1,306 0.157 
CG11166 Eaf 1,156 0.184 
CG11173 usnp 2,209 0.152 
CG11183 Dcp1 1,717 0.008 
CG11206 Liprin-gamma 1,958 0.002 
CG11280 trn 1,898 0.076 
CG11303 TM4SF 1,828 0.087 
CG11314 Npc2g 1,612 0.113 
CG11348 nAcRbeta-64B 1,600 0.012 
CG11376 Zir 2,067 0.026 
CG11409 CG11409 2,409 0.020 
CG11423 CG11423 2,437 0.077 
CG114731 CG114731 1,810 0.014 
CG11474 CG11474 1,874 0.023 
CG1148 Osi2 1,951 0.012 
CG11488 mRpL10 1,932 0.020 
CG11489 srpk79D 2,018 0.064 
CG1149 MstProx 2,840 0.165 
CG11522 RpL6 2,389 0.036 
CG11585 CG11585 1,529 0.113 
CG11692 CG11692 1,312 0.068 
CG11765 Prx2540-2 1,810 0.042 
CG11771 CG11771 1,516 0.117 
CG11785 bai 1,597 0.066 
CG11807 CG11807 2,748 0.159 
CG11821 Cyp12a5 1,734 0.077 
CG11837 CG11837 1,553 0.032 
CG11893 CG11893 1,306 0.177 
CG11901 Ef1gamma 1,912 0.017 
CG11905 CG11905 3,067 0.257 
CG12056 CG12056 1,711 0.060 
CG12057 CG12057 1,227 0.222 
CG12081 CG12081 1,993 0.027 
CG12117 Sptr 1,910 0.057 
CG12141 Aats-lys 1,683 0.141 
CG12161 Prosbeta2R2 2,774 0.096 
CG12220 mRpL32 3,055 0.488 
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CG12227 skpF 2,261 0.005 
CG12231 CG12231 2,737 0.180 
CG12263 CG12263 1,549 0.131 
CG12284 th 1,799 0.089 
CG1233 CG1233 1,873 0.040 
CG12342 dgo 1,774 0.032 
CG12348 Sh 2,342 0.087 
CG12358 Paip2 2,284 0.087 
CG12363 Dlc90F 1,581 0.047 
CG12372 spt4 1,699 0.050 
CG12384 CG12384 2,391 0.065 
CG12391 CG12391 1,350 0.094 
CG12403 Vha68-1 2,362 0.112 
CG12418 CG12418 2,220 0.171 
CG12420 CG12420 1,734 0.082 
CG12661 CG12661 2,022 0.137 
CG12691 CG12691 2,512 0.015 
CG12729 CG12729 1,991 0.072 
CG1274 Jafrac2 1,986 0.053 
CG12768 CG12768 1,930 0.074 
CG12796 CG12796 2,633 0.528 
CG12817 CG12817 1,585 0.071 
CG12846 Tsp42Ed 3,071 0.135 
CG12853 CG12853 4,414 0.219 
CG12854 CG42254 1,682 0.039 
CG12860 CG12860 1,897 0.010 
CG12861 CG12861 1,490 0.104 
CG12883 CG12883 1,772 0.120 
CG12896 CG12896 2,109 0.088 
CG12905 Obp46a 2,805 0.106 
CG12911 CG12911 1,676 0.001 
CG12913 CG12913 1,401 0.144 
CG13070 CG13070 2,183 0.076 
CG13072 PDCD-5 1,937 0.242 
CG13073 CG13073 1,280 0.178 
CG13085 CG13085 1,481 0.061 
CG13120 CG44152 1,583 0.094 
CG13126 CG13126 1,437 0.093 
CG13157 CG13157 1,391 0.161 
CG13186 CG13186 1,543 0.040 
CG13260 CG42389 1,841 0.051 
CG13365 CG13365 1,416 0.115 
CG13389 RpS13 1,993 0.016 
CG13390 CG13390 2,107 0.125 
CG13397 CG13397 1,797 0.064 
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CG13415 Cby 1,525 0.008 
CG13420 CG42335 1,685 0.018 
CG13625 CG13625 2,060 0.143 
CG13631 CG13631 1,920 0.081 
CG13634 CG13634 1,967 0.066 
CG13720 CG13720 2,302 0.099 
CG13758 Pdfr 1,883 0.178 
CG13779 CG13779 1,586 0.046 
CG13786 CG13786 1,619 0.141 
CG13809 osm-1 1,847 0.137 
CG13826 cnc 1,812 0.136 
CG13843 CG13843 1,955 0.242 
CG13869 CG13869 1,714 0.066 
CG1387 CG1387 2,886 0.227 
CG13880 mRpL17 1,299 0.229 
CG13893 CG13893 1,897 0.147 
CG13913 mwh 1,524 0.100 
CG13939 Obp50e 2,028 0.142 
CG13964 sick 2,112 0.128 
CG13996 CG13996 1,596 0.133 
CG14033 CR14033 1,208 0.193 
CG1404 Ran 1,396 0.094 
CG1412 RhoGAP19D 2,036 0.002 
CG14122 CG14212 1,534 0.049 
CG14129 CG34420 2,369 0.186 
CG14186 CG14186 1,715 0.059 
CG14223 CG14223 1,865 0.161 
CG1429 Mef2 1,660 0.026 
CG14296 endoA 2,099 0.109 
CG14321 CG14321 1,090 0.161 
CG14330 CG14330 1,679 0.121 
CG14332 CG14332 2,011 0.001 
CG14442 CG14442 2,134 0.081 
CG14443 CG14443 1,675 0.020 
CG14469 dpr12 1,942 0.106 
CG14481 CG42561 1,507 0.130 
CG14497 CG34386 1,607 0.135 
CG14500 CG14500 1,557 0.057 
CG14560 msopa 2,630 0.053 
CG14646 CG14646 2,787 0.289 
CG14647 CG14647 2,575 0.077 
CG14680 Cyp12e1 2,203 0.165 
CG14691 CG14691 2,064 0.087 
CG14760 CG14760 1,730 0.126 
CG14780 CG14780 1,737 0.094 
Appendices 
 
138 
CG14788 ns3 1,560 0.162 
CG14895 Pak3 1,470 0.145 
CG14904 Scp2 1,509 0.046 
CG14905 CG14905 1,535 0.140 
CG14910 CG42747 2,022 0.061 
CG14960 CG14960 1,858 0.075 
CG14989 CG14989 1,661 0.024 
CG14997 CG14997 1,521 0.123 
CG14999 RfC4 2,344 0.034 
CG15004 Teh2 1,677 0.024 
CG15020 CG15020 2,096 0.040 
CG15067 CG15067 1,363 0.185 
CG1507 Pur-alpha 1,401 0.154 
CG15107 CG15107 1,413 0.048 
CG15141 CG15141 1,604 0.022 
CG15145 CG15145 1,639 0.020 
CG15180 glob2 2,321 0.161 
CG15191 e(y)2 1,078 0.237 
CG15200 CG15200 1,432 0.091 
CG15233 CG15233 1,830 0.059 
CG15282 CG15282 2,650 0.014 
CG15286 CG15286 1,344 0.275 
CG15347 CG15347 2,463 0.170 
CG1550 CG1550 2,502 0.033 
CG15523 CG15523 1,676 0.113 
CG15529 CG15529 1,899 0.007 
CG15530 CG15530 1,849 0.036 
CG15534 CG15534 1,574 0.069 
CG15536 CG15536 1,728 0.126 
CG15541 CG34433 1,762 0.028 
CG15592 Osi9 1,805 0.009 
CG15625 CG15625 2,382 0.144 
CG15667 Sara 1,364 0.095 
CG15676 FoxP 4,908 0.048 
CG1569 rod 1,169 0.217 
CG15697 RpS30 1,548 0.005 
CG15747 CG15747 1,656 0.032 
CG15785 CG42749 2,706 0.315 
CG158488 CG158488 1,534 0.087 
CG15881 CG15881 2,108 0.166 
CG15893 CG15893 2,004 0.286 
CG15899 Ca-alpha1T 2,012 0.104 
CG1591 REG 1,639 0.212 
CG15922 CG15922 2,218 0.223 
CG1602 CG1602 1,591 0.066 
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CG16245 CG16245 1,540 0.004 
CG1652 lectin-46Cb 2,136 0.084 
CG16700 CG16700 1,452 0.036 
CG16716 CG16716 1,187 0.128 
CG16771 CG16771 2,268 0.164 
CG16784 pr 1,934 0.141 
CG16786 CG16786 1,777 0.090 
CG16793 brv2 1,876 0.092 
CG16812 CG16812 2,024 0.031 
CG16827 ItgalphaPS4 5,261 603.331 
CG16848 CG16848 1,668 0.220 
CG16857 CG16857 1,646 0.152 
CG16899 FoxP 2,864 629.312 
CG16902 Hr4 1,720 0.107 
CG16903 CG16903 1,661 0.023 
CG16954 Hsp60D 2,717 0.091 
CG16963 Cry 1,655 0.029 
CG16964 CG16964 2,580 0.181 
CG16974 CG16974 2,424 0.114 
CG16987 daw 1,804 0.117 
CG17024 CR17024 1,559 0.209 
CG17029 CG17029 1,496 0.127 
CG17045 yellow-e3 2,550 0.049 
CG1707 CG1707 1,025 0.268 
CG17108 CG17108 2,251 0.106 
CG17136 Rbp1 2,442 0.281 
CG172287 CG172287 2,010 0.058 
CG17255 nocte 2,065 0.105 
CG17267 CG17267 2,060 0.053 
CG17283 CG17283 1,920 0.039 
CG17290 CG17290 1,592 0.042 
CG17295 Rcd4 1,622 0.093 
CG17331 Prosbeta4 1,828 0.044 
CG17332 VhaSFD 1,372 0.116 
CG17349 CG17349 1,701 0.022 
CG17404 CG17404 1,586 0.064 
CG17514 CG17514 2,005 0.030 
CG17515 Rab21 2,269 0.054 
CG17523 GstE2 1,457 0.030 
CG17525 GstE4 1,331 0.166 
CG17544 CG17544 1,076 0.180 
CG17569 gry 1,598 0.113 
CG17611 eIF6 1,311 0.083 
CG176973 CG176973 2,054 0.102 
CG17738 CG17738 1,628 0.040 
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CG1774 CG1774 1,317 0.199 
CG1775 Med 1,320 0.177 
CG17777 CG17777 1,150 0.185 
CG17781 CG17781 1,617 0.068 
CG17795 mthl2 1,745 0.046 
CG17834 CG17834 1,309 0.248 
CG17870 14-3-3zeta 1,653 0.154 
CG17922 CG17922 1,624 0.117 
CG17928 CG17928 1,303 0.205 
CG17952 LBR 1,312 0.140 
CG17957 Sry-alpha 2,082 0.059 
CG18081 CG18081 1,357 0.110 
CG18088 CG18088 4,008 0.217 
CG18108 IM1 3,387 0.187 
CG18132 CG18132 2,160 0.166 
CG18136 CG18136 2,243 0.076 
CG18171 CG18171 1,618 0.030 
CG18188 Damm 1,455 0.107 
CG18193 CG18193 1,839 0.075 
CG18212 alt 1,659 0.234 
CG18231 CG18231 1,449 0.097 
CG1827 CG1827 1,543 0.114 
CG183433 CG183433 1,708 0.006 
CG18368 CG18368 2,261 0.005 
CG18420 CG18420 2,013 0.007 
CG18468 Lhr 1,343 0.124 
CG18497 spen 2,360 0.055 
CG18539 CG18539 1,477 0.121 
CG18555 CG44002 1,607 0.021 
CG18581 CG18581 1,631 0.147 
CG1862 Ephrin 4,281 0.324 
CG18627 betaggt-II 1,418 0.089 
CG18641 CG18641 1,353 0.084 
CG1865 Spn43Ab 1,857 0.069 
CG18660 Nckx30C 1,813 0.040 
CG1867 Or98b 2,310 0.078 
CG18809 CG18809 1,500 0.109 
CG18817 Tsp42Ea 2,159 0.040 
CG1916 Wnt2 1,309 0.085 
CG19215 CG19215 1,763 0.051 
CG1938 Dlic 1,914 0.028 
CG2021 CG2021 1,833 0.134 
CG20823 CG20823 2,384 0.038 
CG2146 didum 1,393 0.107 
CG2227 Gip 1,570 0.136 
Appendices 
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CG2252 fs(1)h 1,147 0.186 
CG2469 CG2469 1,647 0.016 
CG2533 CG2533 2,034 0.087 
CG2701 CG2701 1,939 0.055 
CG2715 Syx4 1,321 0.103 
CG2720 Hop 2,055 0.107 
CG2819 Pph13 1,581 0.095 
CG2839 CG2839 1,242 0.111 
CG2861 CG2861 1,495 0.090 
CG2924 CG2924 1,648 0.115 
CG2947 HIP-R 2,757 0.150 
CG2952 proPO59 1,668 0.133 
CG2958 lectin-24Db 1,391 0.073 
CG2986 RpS21 1,316 0.174 
CG3001 Hex-A 1,795 0.048 
CG30011 gem 2,101 0.059 
CG30015 CG30015 1,744 0.070 
CG30021 metro 1,766 0.030 
CG30035 Tret1-1 1,502 0.088 
CG30094 CG30094 2,465 0.088 
CG30100 CG30100 2,594 0.040 
CG30125 Ir56a 1,466 0.096 
CG30142 Obp57b 1,648 0.232 
CG30151 CG30151 1,410 0.184 
CG30171 Unc-89 1,354 0.073 
CG30291 CG30291 1,775 0.181 
CG30376 CG30376 1,723 0.073 
CG30395 CG30395 1,523 0.004 
CG30430 CG30430 1,399 0.105 
CG30440 CG30440 1,507 0.115 
CG3081 CG3081 2,090 0.048 
CG31038 CG31038 1,437 0.086 
CG31057 tau 18,793 0.017 
CG31060 Gr98c 1,840 0.039 
CG31136 Syx1A 2,491 0.179 
CG31141 CG31141 2,332 0.101 
CG31145 CG31145 1,520 0.038 
CG31183 CG31183 3,520 0.156 
CG31198 CG31198 1,700 0.188 
CG3126 C3G 1,794 677.232 
CG31347 CG31347 2,079 0.068 
CG31550 CG31550 1,937 0.070 
CG31595 CG31595 2,016 0.057 
CG31637 CG31637 1,895 0.148 
CG31663 CG31663 1,473 0.148 
Appendices 
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CG31665 wry 2,189 0.080 
CG31708 CG31708 1,451 0.119 
CG3174 Fmo-2 1,913 0.043 
CG31764 vir-1 2,865 0.079 
CG31769 CG31769 2,005 0.099 
CG31779 Acp24A4 1,769 0.193 
CG31828 CG31828 2,266 0.062 
CG31898 CG31898 2,326 0.120 
CG31922 CG31922 1,290 0.180 
CG31955 CG31955 2,483 0.116 
CG319907 CG319907 2,056 0.115 
CG32031 Argk 1,920 0.133 
CG32042 PGRP-LA 4,003 0.076 
CG32114 CG32114 2,342 0.159 
CG32208 825-Oak 1,751 0.150 
CG32217 Su(Tpl) 2,559 0.036 
CG32264 CG32264 2,732 0.112 
CG32278 CG32278 2,367 0.032 
CG32280 CG32280 1,609 0.111 
CG32282 Drsl4 2,025 0.017 
CG32353 CG43078 2,524 0.100 
CG32368 CG32368 1,438 0.200 
CG32394 dikar 2,362 0.071 
CG32401 Or65a 1,660 0.006 
CG3242 sob 1,975 0.131 
CG32435 chb 2,421 0.046 
CG3244 Clect27 1,528 0.136 
CG32453 CG32453 1,644 0.061 
CG32483 CG32483 1,645 0.135 
CG32487 CG32487 2,088 0.147 
CG325295 CG325295 1,567 0.074 
CG32543 CG42450 1,913 0.068 
CG32551 CG32551 2,419 0.079 
CG32556 chas 2,003 0.062 
CG3259 CG3259 1,410 0.038 
CG32614 CG32614 1,895 0.126 
CG32642 CG32642 1,997 0.064 
CG32666 Drak 1,966 0.060 
CG32668 CG32668 2,617 0.069 
CG32682 alpha-Man-I 2,595 0.165 
CG32695 CG32695 1,984 0.065 
CG3274 Bap170 1,628 0.001 
CG32755 CG32755 2,053 0.018 
CG3277 CG3277 2,287 0.007 
CG3281 CG3281 1,633 0.003 
Appendices 
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CG32835 CR32835 2,150 0.080 
CG3285 CG3285 1,853 0.039 
CG32852 Csk 1,794 0.095 
CG32859 eIF4E-7 1,702 0.117 
CG3295 CG3295 2,172 0.029 
CG3299 Vinc 2,044 0.073 
CG33057 CG33057 1,458 0.212 
CG33083 Gr97a 1,496 0.120 
CG33110 CG33110 1,546 0.112 
CG331262 CG331262 1,627 0.038 
CG331290 CG331290 2,267 0.222 
CG332170 CG332170 1,877 0.024 
CG3322 LanB2 1,881 0.081 
CG33298 CG33298 1,476 0.050 
CG33482 CG42685 2,898 0.423 
CG3351 mRpL11 1,790 0.026 
CG34970 CG34970 1,725 0.029 
CG3527 CG3527 1,924 0.195 
CG3542 CG3542 1,926 0.173 
CG3589 CG3589 1,130 0.180 
CG3631 CG3631 1,442 0.087 
CG3665 Fas2 1,770 0.120 
CG3675 Art2 1,376 0.055 
CG3705 aay 1,974 0.010 
CG3717 bcn92 2,057 0.025 
CG3723 Dhc93AB 1,595 0.011 
CG3776 CG3776 1,769 0.008 
CG3788 CG3788 2,107 0.016 
CG3796 ac 1,618 0.008 
CG3849 Lasp 1,515 0.139 
CG3853 Glut3 1,940 0.071 
CG3871 Six4 2,130 0.105 
CG3896 Nox 1,451 0.089 
CG3906 CG3906 1,732 0.118 
CG3924 Chi 1,594 0.036 
CG3945 Rad9 1,483 0.084 
CG3949 hoip 1,359 0.091 
CG3955 CG3955 1,126 0.206 
CG3967 CG3967 1,608 0.099 
CG3991 TppII 1,633 0.062 
CG3994 ZnT35C 1,901 0.001 
CG4004 CG4004 2,588 0.368 
CG40049 mRpS5 1,332 0.142 
CG4006 Akt1 1,409 0.119 
CG4012 gek 1,568 0.344 
Appendices 
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CG40128 CG40128 2,206 0.158 
CG40221 CG40221 1,500 0.047 
CG40244 CG40244 2,121 0.084 
CG404522 CG404522 2,005 0.095 
CG4046 RpS16 1,772 0.005 
CG4054 Fili 2,190 0.032 
CG4064 CG42699 1,705 0.005 
CG4090 Mur89F 1,719 0.150 
CG41050 CG41050 1,484 0.098 
CG41074 CG41074 1,881 0.104 
CG41123 CG41123 1,724 0.005 
CG4162 lace 1,356 0.134 
CG4184 MED15 1,705 0.150 
CG4185 NC2beta 3,231 0.317 
CG4212 Rab14 4,027 0.326 
CG4216 term 1,628 0.053 
CG4249 c(2)M 1,492 0.064 
CG42571 CG42571 1,819 0.028 
CG4261 Hel89B 1,556 0.006 
CG4264 Hsc70-4 2,338 0.099 
CG4265 Uch 2,054 0.081 
CG4270 CG4270 1,948 0.036 
CG4287 CG4287 2,203 0.091 
CG4302 CG4302 2,297 0.005 
CG4313 CG4313 1,858 0.028 
CG4318 CG4318 1,424 0.047 
CG4326 mRpS17 2,025 0.078 
CG4341 CG4341 1,312 0.092 
CG4349 Fer3HCH 1,663 0.052 
CG4406 CG4406 1,799 0.210 
CG4428 Atg4 1,661 0.119 
CG4447 CG4447 1,644 0.051 
CG4455 CG4455 2,068 0.031 
CG4471 Tsp42Ep 1,618 0.077 
CG4481 GluRIB 1,798 0.031 
CG4497 CG4497 1,847 0.034 
CG4510 Surf6 2,018 0.087 
CG4542 CG4542 2,103 0.082 
CG4560 Arpc3A 1,479 0.101 
CG4577 CG4577 1,817 0.053 
CG4610 CG4610 3,243 0.139 
CG4661 CG4661 1,689 0.068 
CG4680 Grp 1,867 0.012 
CG4716 CG4716 1,866 0.051 
CG4720 Pk92B 2,053 0.154 
Appendices 
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CG4785 CG4785 1,807 0.084 
CG4797 CG4797 2,201 0.172 
CG4802 CG4802 1,757 0.069 
CG4821 Tequila 1,630 0.011 
CG4863 RpL3 1,410 0.124 
CG4869 betaTub97EF 1,788 0.195 
CG4891 CG4891 1,448 0.057 
CG4938 Aats-ser 2,200 0.055 
CG4952 dac 2,190 0.009 
CG4994 Mpcp 2,223 0.091 
CG4996 CG4996 1,910 0.047 
CG5005 HLH54F 1,634 0.050 
CG5057 MED10 1,858 0.114 
CG5059 CG5059 1,589 0.130 
CG5070 CG5070 2,049 0.020 
CG5081 Syx7 1,221 0.150 
CG5092 Tor 2,228 0.017 
CG5103 CG5103 2,057 0.006 
CG5161 l(3)72Dh 1,248 0.133 
CG5169 GckIII 1,612 0.050 
CG5171 CG5171 1,803 0.143 
CG5178 Act88F 1,772 0.050 
CG5186 slim 2,041 0.017 
CG5191 CG5191 1,644 0.140 
CG5201 Dad 1,842 0.140 
CG5242 mRpL40 2,044 0.041 
CG5252 Ranbp9 1,897 0.064 
CG5261 CG5261 1,786 0.055 
CG5300 Klp31E 2,813 0.089 
CG5346 CG5346 1,887 0.030 
CG5370 Dcp-1 2,568 0.144 
CG5385 CG5385 2,315 0.061 
CG5399 CG5399 1,575 0.150 
CG5407 Sur-8 2,038 0.185 
CG5473 SP2637 1,705 0.168 
CG5501 Myo95E 1,716 0.191 
CG5505 scny 1,650 0.072 
CG5506 CG5506 1,780 0.073 
CG5517 Ide 1,535 0.131 
CG55183 CG55183 1,650 0.043 
CG5541 CG5541 1,341 0.106 
CG5577 CG5577 1,286 0.111 
CG5596 Mlc1 1,941 0.079 
CG5625 Vps35 1,804 0.018 
CG5654 yps 1,693 0.121 
Appendices 
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CG5670 Atpalpha 1,827 0.135 
CG5675 X11L 1,975 0.117 
CG5676 CG5676 2,256 0.183 
CG5686 chico 2,035 0.039 
CG5695 jar 1,598 0.055 
CG5714 ecd 2,102 0.042 
CG5727 CG5727 2,585 0.140 
CG5735 orb2 1,876 0.091 
CG5738 lolal 1,550 0.093 
CG5741 orb2 1,559 0.043 
CG5742 CG5742 1,955 0.058 
CG5744 Frq1 1,678 0.113 
CG5778 CG5778 2,317 0.144 
CG5793 CG5793 1,539 0.146 
CG5809 CaBP1 1,424 0.068 
CG5835 CG5835 1,519 0.122 
CG5848 cact 1,635 0.069 
CG5869 CG5869 2,346 0.125 
CG5874 Nelf-A 2,300 0.029 
CG5886 CG5886 1,341 0.133 
CG5915 Rab7 1,941 0.226 
CG5969 CG5969 1,458 0.042 
CG6004 Muc68D 2,244 0.154 
CG6015 CG6015 1,473 0.067 
CG6022 Cchl 1,651 0.118 
CG6024 CG6024 1,849 0.054 
CG6026 CG6026 1,421 0.083 
CG6139 Vmat 1,265 0.174 
CG6143 Pep 1,919 0.050 
CG6185 Ir68a 1,387 0.196 
CG6208 CG6208 1,754 0.043 
CG6211 gce 1,053 0.260 
CG6214 MRP 1,716 0.176 
CG6315 fl(2)d 1,689 0.033 
CG6329 CG6329 1,863 0.036 
CG6332 CG6332 1,467 0.159 
CG6347 CG6347 1,285 0.075 
CG6354 Rb97D 1,689 0.155 
CG6362 CG6362 1,803 0.276 
CG6382 Elf 2,129 0.005 
CG6395 Csp 1,675 0.077 
CG6407 Wnt5 1,667 0.050 
CG6418 CG6418 2,630 0.155 
CG6425 CG6425 1,817 0.039 
CG6431 CG6431 2,432 0.089 
Appendices 
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CG6447 TwdlL 2,064 0.055 
CG6455 CG6455 1,670 0.029 
CG6477 RhoGAP54D 1,391 0.089 
CG6480 CG6480 1,343 0.088 
CG6483 Jon65Aiii 1,718 0.041 
CG6488 CG6488 2,384 0.149 
CG6492 Ucp4A 1,588 0.103 
CG6541 Mst33A 1,501 0.092 
CG6625 Snap 1,283 0.231 
CG6642 a10 1,717 0.088 
CG6646 DJ-1alpha 2,083 0.090 
CG6673 GstO2 1,375 0.142 
CG6700 CG6700 1,938 0.007 
CG6720 UbcD2 1,794 0.099 
CG6721 RasGAP1 1,892 0.049 
CG6757 SH3PX1 1,571 0.049 
CG6768 DNApol-epsilon 2,641 0.037 
CG6769 CG6769 1,999 0.081 
CG6778 Aats-gly 3,046 0.132 
CG6793 CG6793 1,914 0.006 
CG6817 foi 1,558 0.007 
CG6834 CG6834 2,229 0.068 
CG6846 RpL26 1,397 0.113 
CG6878 CG6878 1,566 0.059 
CG6883 trh 1,482 0.062 
CG6889 tara 1,513 0.040 
CG6900 CR6900 2,109 0.109 
CG6912 CG6912 1,674 0.083 
CG6985 CG6985 1,402 0.226 
CG7011 CG7011 1,777 0.115 
CG7051 Dic61B 1,630 0.206 
CG7075 Ntl 1,731 0.096 
CG7091 CG7091 1,719 0.046 
CG7098 dik 2,028 0.072 
CG71295 CG71295 1,726 0.029 
CG7188 BI-1 1,659 0.083 
CG7189 Gr66a 1,569 0.042 
CG7206 CG7206 1,888 0.074 
CG7228 pes 2,220 0.065 
CG7236 CG7236 1,688 0.024 
CG7245 eys 1,408 0.106 
CG7269 Hel25E 2,737 0.207 
CG7293 Klp68D 1,371 0.163 
CG7313 CheA75a 1,470 0.181 
CG73255 CG73255 1,561 0.118 
Appendices 
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CG7333 CG7333 1,488 0.101 
CG7407 CG7407 1,562 0.110 
CG7408 CG7408 1,435 0.113 
CG7519 CG7519 1,942 0.121 
CG7523 CG7523 1,741 0.066 
CG7532 l(2)34Fc 1,927 0.035 
CG7548 CG7548 2,103 0.084 
CG7557 CG7557 2,024 0.077 
CG7565 CG7565 1,842 0.057 
CG7570 hale 2,720 0.132 
CG7582 CG7582 1,556 0.084 
CG7604 Eig71Ee 2,437 0.115 
CG7619 Rpn10 1,783 0.009 
CG7628 CG42575 2,082 0.044 
CG7638 CG7638 1,819 0.198 
CG7653 CG7653 1,954 0.140 
CG7668 CG7668 2,513 0.094 
CG7772 CG7772 1,985 0.055 
CG7787 CG7787 1,562 0.005 
CG7825 Rad17 2,798 0.328 
CG7851 Scgalpha 1,853 0.051 
CG7876 Muc18B 1,452 0.098 
CG7893 Vav 1,930 0.089 
CG7902 bap 2,193 0.090 
CG7912 CG7912 1,360 0.087 
CG7937 C15 1,842 0.027 
CG7972 mus301 1,431 0.034 
CG7989 wcd 2,458 0.302 
CG7990 CG7990 2,086 0.053 
CG8023 eIF4E-3 1,424 0.156 
CG8044 HP4 1,793 0.084 
CG8049 Btk29A 1,979 0.058 
CG8058 Hydr1 1,512 0.025 
CG8063 yellow-f2 2,239 0.100 
CG8067 CG8067 1,474 0.070 
CG8119 CG8119 3,497 0.057 
CG8128 CG8128 1,878 0.003 
CG8176 CG8176 3,227 0.005 
CG8186 Vha36-1 1,696 0.006 
CG8198 l(1)G0136 1,781 0.137 
CG8210 Vha14-1 1,485 0.074 
CG8222 Pvr 1,902 0.054 
CG8226 Tom7 1,897 0.098 
CG8256 Gpo-1 1,679 0.085 
CG8268 Srp9 1,421 0.063 
Appendices 
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CG8280 Ef1alpha48D 2,662 0.089 
CG8282 Snx6 1,653 0.087 
CG8287 Rab8 2,096 0.025 
CG8322 ATPCL 1,425 0.109 
CG8417 CG8417 2,410 0.156 
CG8426 l(2)NC136 2,299 0.068 
CG8441 CG8441 3,024 0.442 
CG8443 clu 2,127 0.159 
CG8448 mrj 1,718 0.096 
CG8472 Cam 1,774 0.089 
CG8481 CG8481 1,754 0.091 
CG8511 Cpr49Ag 1,797 0.016 
CG8523 Mdr50 1,625 0.017 
CG8526 CG8526 1,663 0.012 
CG8534 CG8534 1,412 0.152 
CG8553 SelD 1,985 0.031 
CG8562 CG8562 1,595 0.067 
CG8568 CG8568 2,348 0.152 
CG8589 tej 1,806 0.109 
CG8591 CTCF 2,167 0.053 
CG8622 Acp53Ea 2,562 0.032 
CG8669 crc 1,568 0.024 
CG8681 clumsy 2,155 0.069 
CG8725 CSN4 1,612 0.049 
CG8734 beta3GalTII 1,472 0.150 
CG8772 CG42708 1,520 0.009 
CG8877 Prp8 1,420 0.150 
CG8884 Sap47 1,800 0.053 
CG8885 Scox 2,284 0.016 
CG8922 RpS5a 1,987 0.005 
CG8924 CG8924 1,875 0.012 
CG8927 CG8927 2,083 0.094 
CG8928 Rrp47 2,306 0.028 
CG89295 CG89295 1,535 0.018 
CG8967 otk 1,814 0.064 
CG8974 CG8974 2,050 0.010 
CG8975 RnrS 1,476 0.102 
CG9004 CG9004 1,391 0.130 
CG90093 CG90093 1,864 0.116 
CG9014 CG9014 1,961 0.021 
CG9044 CG9044 1,469 0.023 
CG9072 CG9072 1,533 0.217 
CG9080 Listericin 1,580 0.046 
CG9096 CycD 1,546 0.033 
CG9128 Sac1 2,074 0.115 
Appendices 
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CG9138 uif 2,629 0.043 
CG9198 shtd 1,865 0.118 
CG9222 CG9222 2,126 0.073 
CG9231 CG9231 2,188 0.132 
CG9238 CG9238 1,498 0.070 
CG9263 CG9263 1,735 0.114 
CG9286 CG9286 1,615 0.017 
CG9294 CG9294 1,555 0.062 
CG9307 Cht5 1,187 0.197 
CG9316 CG9316 1,687 0.085 
CG9333 Oseg5 1,657 0.096 
CG9345 Adgf-C 1,856 0.082 
CG9350 CG9350 1,146 0.135 
CG9354 RpL34b 1,710 0.068 
CG9364 Treh 1,791 0.102 
CG9375 Ras85D 2,184 0.145 
CG9391 CG9391 1,953 0.117 
CG9412 rin 1,739 0.114 
CG9438 Cyp6a2 2,467 0.227 
CG9441 Pu 1,624 0.102 
CG9473 MED6 1,422 0.176 
CG9528 retm 1,676 0.192 
CG9533 rut 1,780 0.054 
CG9539 Sec61alpha 1,633 0.135 
CG9554 eya 2,972 0.071 
CG9581 CG9581 1,796 0.044 
CG9582 CG9582 1,248 0.189 
CG9589 CG9589 1,700 0.035 
CG9610 Poxm 1,299 0.084 
CG9632 CG9632 2,341 0.113 
CG9640 CG9640 1,642 0.094 
CG9673 CG9673 1,194 0.144 
CG9676 CG9676 1,946 0.087 
CG9688 mRpS18C 1,319 0.158 
CG9717 CG9717 1,382 0.119 
CG97390 CG97390 2,838 0.189 
CG9745 D1 1,409 0.159 
CG9746 ird1 0.907 0.364 
CG9761 Nep2 1,305 0.146 
CG9774 rok 1,335 0.064 
CG9837 CG9837 1,638 0.157 
CG9843 CG9843 1,960 0.008 
CG9862 Rae1 1,539 0.064 
CG9863 CG9863 1,677 0.068 
CG9882 Art7 1,742 0.053 
Appendices 
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CG9935 CG9935 3,267 0.327 
CG9970 CG9970 2,093 0.155 
CG9986 CG9986 1,707 0.038 
CG9989 CG9989 3,012 0.266 
CG6308 CG6308 3,249 0.132 
Appendices 
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Table A3 List of downregulated genes upon rotenone treatment 
id Symbol Mean  SEM 
CG10035 CG10035 0.427 0.222 
CG10361 CG10361 0.450 0.118 
CG10513 CG10513 0.269 0.103 
CG10516 CG10516 0.449 0.100 
CG10535 Elp1 0.259 0.099 
CG10536 cbx 0.677 0.157 
CG105399 CG105399 0.400 0.008 
CG10706 SK 0.553 0.009 
CG10749 CG10749 0.075 0.140 
CG10814 CG10814 0.589 0.099 
CG10858 CG10858 0.092 0.139 
CG10868 orb 0.232 0.118 
CG10897 tou 0.115 0.041 
CG11159 CG11159 0.672 0.084 
CG11181 cup 0.427 0.193 
CG11207 feo 0.749 0.130 
CG11242 TBCB 0.746 0.111 
CG11266 CG11266 0.670 0.143 
CG11282 caps 0.410 0.106 
CG11317 CG11317 0.632 0.061 
CG11320 CG11320 0.697 0.094 
CG11330 cort 0.484 0.070 
CG11378 CG11378 0.472 0.675 
CG11379 CG11379 0.396 0.036 
CG11391 CG11391 0.612 0.275 
CG11438 CG11438 0.537 0.099 
CG11577 CG11577 0.276 0.001 
CG11601 CG11601 0.126 0.129 
CG11793 Sod 0.835 0.145 
CG11798 chn 0.325 0.177 
CG11912 CG11912 0.635 0.005 
CG11963 skap 0.635 0.048 
CG11968 RagA-B 0.572 0.053 
CG12025 CG12025 0.601 0.030 
CG121426 CG121426 0.508 0.056 
CG12159 CG12159 0.758 0.104 
CG12256 CG12256 0.524 0.074 
CG12367 Hen1 0.428 0.009 
    
CG12379 CG12379 0.449 0.054 
CG12424 ckn 0.375 0.171 
CG12436 CG43373 0.531 0.035 
Appendices 
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CG12492 CG34355 0.500 0.084 
CG12519 CG12519 0.336 0.097 
CG125761 CG125761 0.661 0.139 
CG12656 CG12656 0.071 0.109 
CG12701 vfl 0.326 0.111 
CG12728 CG12728 0.099 0.267 
CG12821 CG12821 0.641 0.092 
CG12822 CG12822 0.314 0.211 
CG12840 Tsp42El 0.521 0.032 
CG12923 CG12923 0.179 0.044 
CG12993 p-cup 0.076 0.161 
CG13102 CG13102 0.557 0.060 
CG13111 Shawl 0.645 0.084 
CG13290 CG33993 0.808 0.177 
CG13320 Sans 0.479 0.085 
CG13391 Aats-ala 0.333 0.191 
CG13417 Gr93a 0.065 0.113 
CG13645 Nmnat 0.754 0.083 
CG13705 CG13705 0.470 0.201 
CG13868 CG13868 0.502 0.061 
CG13924 CG13924 0.118 0.097 
CG13936 CG13936 0.175 0.141 
CG13980 CG42534 0.062 0.134 
CG14014 CG14014 0.040 0.211 
CG1402 CG1402 0.124 0.236 
CG14032 Cyp4ac1 0.178 0.141 
CG14070 CG14070 0.365 0.110 
CG14096 CG14096 0.037 0.190 
CG14182 CG14182 0.425 0.151 
CG14191 CG14191 0.232 0.117 
CG14298 CG14298 0.706 0.095 
CG14380 CG14380 0.318 0.385 
CG14401 CG14401 0.554 0.027 
CG14532 CG14532 0.482 0.053 
CG1455 CanA1 0.823 0.139 
CG14614 CG14614 0.502 0.002 
CG1462 Aph-4 0.544 0.082 
CG14792 sta 0.433 0.250 
CG14841 CG14841 0.119 0.159 
CG1487 krz 0.773 0.267 
CG14957 CG14957 0.345 0.241 
CG14995 CG14995 0.099 0.061 
CG15088 List 0.129 0.032 
CG15202 CG15202 0.352 0.120 
Appendices 
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CG15203 CG15203 0.845 0.202 
CG15280 CR15280 0.512 0.197 
CG1529 CG1529 0.277 0.070 
CG15479 CG15479 0.202 0.155 
CG15483 CG15483 0.340 0.036 
CG15727 Aven 0.666 0.163 
CG15749 dmrt11E 0.609 0.023 
CG1629 yellow-h 0.540 0.032 
CG1637 CG1637 0.545 0.041 
CG16705 SPE 0.501 0.018 
CG16740 Rh2 0.608 0.167 
CG16894 CG16894 0.145 0.185 
CG16979 CG16979 0.818 0.159 
CG16983 skpA 0.133 0.068 
CG17010 CG17010 0.852 0.193 
CG17034 CG42321 0.533 0.075 
CG1710 Hcf 0.020 0.774 
CG17107 CG17107 0.737 0.167 
CG17146 Adk1 0.678 0.096 
CG17148 Est-P 0.064 0.187 
CG17187 CG17187 0.493 0.015 
CG17200 Ugt86Dg 0.172 0.077 
CG17208 Gfrl 0.117 0.088 
CG17224 CG17224 0.541 0.134 
CG17361 CG17361 0.610 0.014 
CG17436 vtd 0.470 0.105 
CG17601 CG17601 0.444 0.022 
CG17726 CG17726 0.451 0.124 
CG17746 CG17746 0.381 0.061 
CG17785 Golgin84 0.041 0.104 
CG17816 CG17816 0.583 0.021 
CG17820 fit 0.384 0.249 
CG17829 CG17829 0.404 0.139 
CG17883 CG17883 0.501 0.199 
CG17919 CG17919 0.374 0.136 
CG17921 HmgZ 0.549 0.058 
CG17935 Mst84Dd 0.519 0.024 
CG17944 CG17944 0.303 0.069 
CG18094 CG18094 0.609 0.090 
CG18112 Vps16B 0.521 0.182 
CG18144 Hand 0.701 0.108 
CG18178 CG18178 0.403 0.065 
CG18271 slx1 0.122 0.268 
CG18348 Cpr67Fb 0.734 0.156 
Appendices 
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CG18416 CG18416 0.510 0.251 
CG1851 Ady43A 0.412 0.057 
CG18536 CG18536 0.339 0.031 
CG18557 CG18557 0.606 0.147 
CG18619 CG18619 0.273 0.081 
CG18676 Teh3 0.208 0.009 
CG18678 CG43795 0.629 0.196 
CG18743 Hsp70Ab 0.768 0.166 
CG187699 CG187699 0.675 0.108 
CG1912 Gycalpha99B 0.421 0.095 
CG2009 bip2 0.674 0.036 
CG2038 CSN7 0.696 0.050 
CG2102 cas 0.376 0.227 
CG2165 PMCA 0.613 0.000 
CG2221 l(1)G0289 0.767 0.090 
CG2229 Jon99Fii 0.814 0.107 
CG2249 CoVIIc 0.673 0.080 
CG2262 Smox 0.545 0.035 
CG2297 Obp44a 0.824 0.166 
CG2316 CG2316 0.615 0.018 
CG2621 sgg 0.665 0.229 
CG26372 CG26372 0.301 0.031 
CG2684 lds 0.339 0.010 
CG2746 RpL19 0.470 0.042 
CG27742 CG27742 0.235 0.007 
CG2808 CG34340 0.504 0.163 
CG2890 PPP4R2r 0.354 0.096 
CG2998 RpS28b 0.751 0.238 
CG30028 gammaTry 0.934 0.238 
CG30051 CG30051 0.638 0.214 
CG30071 CG30071 0.187 0.013 
CG3011 CG3011 0.207 0.005 
CG30160 CG30160 0.756 0.142 
CG30192 CG30192 0.278 0.240 
CG3027 pyd3 0.866 0.152 
CG30286 CG30286 0.454 0.094 
CG3029 or 0.407 0.159 
CG30322 Sema-2b 0.401 0.008 
CG30353 CG30353 0.042 0.142 
CG30381 CG30381 0.570 0.036 
CG30428 CG30428 0.550 0.008 
CG30473 Obp51a 0.053 0.341 
CG3064 futsch 0.340 0.102 
CG3069 Taf10b 0.087 0.336 
Appendices 
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CG3083 Prx6005 0.547 0.008 
CG31013 CG31013 0.323 0.038 
CG31032 CR31032 0.333 0.114 
CG3107 CG3107 0.104 0.081 
CG31161 CG31161 0.491 0.023 
CG31196 14-3-3epsilon 0.272 0.001 
CG31202 CG31202 0.341 0.122 
CG31308 CG31308 0.545 0.072 
CG31314 Meltrin 0.146 0.147 
CG31348 Octbeta3R 0.621 0.023 
CG31364 l(3)neo38 0.534 0.160 
CG31389 CG31389 0.079 0.009 
CG31484 CG31484 0.699 0.138 
CG31526 CG31526 0.216 0.275 
CG31542 CG31542 0.827 0.132 
CG31546 CG31546 0.524 0.208 
CG31605 Bsg 0.327 0.161 
CG31620 Gr39b 0.077 0.170 
CG31626 CG31626 0.090 0.146 
CG31798 CG31798 0.401 0.112 
CG31937 CG31937 0.571 0.088 
CG32013 CG32013 0.517 0.165 
CG32044 CG42268 0.112 0.277 
CG32083 CG32083 0.292 0.062 
CG32250 CG32250 0.203 0.101 
CG32444 CG32444 0.308 0.081 
CG32532 CG32532 0.699 0.074 
CG32568 CG32568 0.070 0.084 
CG32582 CG32582 0.431 0.292 
CG32633 CG32633 0.387 0.124 
CG32662 CG43154 0.691 0.102 
CG3267 CG3267 0.083 0.272 
CG3288 CG3288 0.491 0.043 
CG32954 Adhr 0.491 0.072 
CG32956 Chrac-14 0.589 0.046 
CG33007 Ack-like 0.387 0.122 
CG3301 CG3301 0.547 0.085 
CG33044 CG33044 0.383 0.082 
CG330452 CG330452 0.623 0.130 
CG331167 CG331167 0.131 0.149 
CG33151 Gr59e 0.473 0.123 
CG33169 CG33169 0.446 0.102 
CG3318 Dat 0.579 0.051 
CG33204 Doa 0.741 0.205 
Appendices 
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CG33255 CG33255 0.628 0.094 
CG33276 CG33276 0.440 0.182 
CG33486 asparagine-synthetase 0.830 0.158 
CG3523 CG3523 0.392 0.266 
CG3605 CG3605 0.392 0.071 
CG3613 qkr58E-1 0.503 0.073 
CG3624 babos 0.351 0.050 
CG3772 cry 0.457 0.016 
CG3773 CG3773 0.460 0.078 
CG3805 CG34126 0.340 0.206 
CG3812 CG3812 0.211 0.051 
CG3948 zetaCOP 0.796 0.165 
CG39540 CG39540 0.740 0.084 
CG40002 CG40002 0.528 0.100 
CG40182 CR40182 0.459 0.113 
CG40274 CG40274 0.601 0.114 
CG4103 l(2)35Bc 0.588 0.036 
CG4180 l(2)35Bg 0.357 0.089 
CG4214 Syx5 0.478 0.208 
CG4291 CG4291 0.519 0.055 
CG4293 CG4293 0.484 0.089 
CG4306 CG4306 0.253 0.049 
CG4457 Srp19 0.595 0.053 
CG4482 mol 0.624 0.048 
CG4648 CG42399 0.472 0.106 
CG4669 CG4669 0.276 0.022 
CG4699 wah 0.096 0.147 
CG4804 Spn31A 0.688 0.095 
CG4921 Rab4 0.531 0.038 
CG5079 CG5079 0.226 0.218 
CG5084 CG5084 0.568 0.012 
CG5085 Sirt2 0.413 0.039 
CG5108 mRpS7 0.793 0.118 
CG5168 CG5168 0.619 0.027 
CG5185 Tom 0.434 0.083 
CG52270 CG52270 0.092 0.077 
CG5262 CG5262 0.230 0.238 
CG5315 CG5315 0.462 0.200 
CG5327 CG5327 0.303 0.020 
CG5334 CG5334 0.260 0.021 
CG5390 CG5390 0.365 0.226 
CG5428 St1 0.325 0.036 
CG5435 CG5435 0.233 0.163 
CG5476 TwdlN 0.047 0.260 
Appendices 
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CG5494 Cpr92F 0.565 0.028 
CG5618 CG5618 0.317 0.229 
CG5652 drd 0.230 0.058 
CG5922 Ir40a 0.402 0.095 
CG5954 l(3)mbt 0.867 0.179 
CG5970 cbc 0.521 0.039 
CG5994 Nelf-E 0.770 0.092 
CG6038 crim 0.568 0.037 
CG6042 Cyp12a4 0.547 0.066 
CG6094 CG6094 0.684 0.066 
CG6181 Ge-1 0.792 0.163 
CG62248 CG62248 0.497 0.010 
CG6289 Spn77Bc 0.680 0.110 
CG6340 CG6340 0.164 0.016 
CG6375 pit 1,264 0.501 
CG6415 CG6415 0.514 0.293 
CG6416 Zasp66 0.563 0.021 
CG6449 NijA 0.842 0.167 
CG6459 P32 0.515 0.084 
CG6463 CG6463 0.255 0.195 
CG6475 CG6475 0.609 0.242 
CG6545 lbe 0.229 0.283 
CG6549 fws 0.656 0.008 
CG6579 atilla 0.569 0.100 
CG6620 ial 0.034 0.538 
CG6634 mid 0.248 0.128 
CG6661 CG6661 0.750 0.282 
CG6709 CG6709 0.387 0.021 
CG6724 CG6724 0.661 0.234 
CG6733 CG6733 0.710 0.230 
CG6766 CG6766 0.431 0.091 
CG6775 rg 0.494 0.204 
CG6813 CG6813 0.451 0.004 
CG6874 HipHop 0.447 0.042 
CG6891 CG6891 0.084 0.187 
CG6932 CSN6 0.468 0.099 
CG70188 CG70188 0.678 0.245 
CG7074 mio 0.543 0.124 
CG7105 Proct 0.327 0.024 
CG7112 GAPcenA 0.634 0.016 
CG7118 Jon66Ci 0.708 0.281 
CG7130 CG7130 0.793 0.203 
CG7158 CG7158 0.660 0.111 
CG7227 CG7227 0.454 0.100 
Appendices 
 
159 
CG7260 byn 0.593 0.013 
CG7324 CG7324 0.578 0.115 
CG7382 CG7382 0.774 0.115 
CG7429 CG7429 0.696 0.166 
CG7595 ck 1,257 0.324 
CG7704 Taf5 0.876 0.173 
CG7749 kug 0.694 0.169 
CG7779 Cng 0.710 0.135 
CG7781 CG7781 0.636 0.042 
CG7791 CG7791 0.255 0.128 
CG8042 CG8042 0.635 0.124 
CG8053 eIF-1A 0.641 0.068 
CG8062 out 0.545 0.009 
CG8190 eIF2B-gamma 0.726 0.227 
CG8195 CG8195 0.711 0.078 
CG8254 exex 0.136 0.087 
CG8300 CG8300 0.521 0.048 
CG8311 CG8311 0.395 0.109 
CG8320 CG8320 0.665 0.100 
CG8328 E(spl)mdelta-HLH 0.230 0.196 
CG8333 E(spl)mgamma-HLH 0.293 0.300 
CG8404 Sox15 0.349 0.048 
CG8431 Aats-cys 0.614 0.010 
CG8476 CG8476 0.740 0.170 
CG8627 Dbi 0.427 0.000 
CG8760 dysc 0.455 0.023 
CG8806 prel 0.620 0.014 
CG8977 Cctgamma 0.548 0.005 
CG8979 PI31 0.678 0.151 
CG9000 ste24a 0.722 0.080 
CG9033 Tsp47F 0.082 0.192 
CG9093 Tsp26A 0.937 0.186 
CG9106 CG9106 0.455 0.002 
CG9186 CG9186 0.105 0.020 
CG9335 CG9335 0.493 0.036 
CG9372 CG9372 0.373 0.082 
CG9373 rump 0.446 0.110 
CG9386 CG9386 0.306 0.043 
CG9426 CG9426 0.708 0.088 
CG9427 CG9427 0.647 0.122 
CG9449 CG9449 0.578 0.044 
CG9456 Spn42Dd 0.561 0.048 
CG9590 CG9590 0.617 0.003 
CG9669 CG9669 0.974 0.188 
Appendices 
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CG9677 Int6 0.301 0.128 
CG9682 CG9682 0.536 0.058 
CG9684 CG9684 0.913 0.169 
CG9790 Cks85A 0.782 0.094 
CG9804 CG9804 0.347 0.108 
CG9822 CG9822 0.520 0.057 
CG9850 CG9850 0.563 0.036 
CG9999 RanGAP 0.601 0.030 
 
 
 
